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Abstract: Despite the ostensible prevalence of academic worry at the college and 
university level, there is a paucity of research in this area. In addition, there is an even 
greater dearth of research investigating treatments for excessive and uncontrollable 
academic worry. Further, the research on non-pharmacological treatment strategies for 
reducing pathological worry (as seen in its most severe form in generalized nxiety 
disorder; GAD) is limited. The primary goal of this study was to investigate the potential 
benefits of two self-administered interventions for reducing pathological academic worry. 
Participants experiencing pathological academic worry (N = 113) were randomized to 
one of four conditions: (a) worry exposure (WE), (b) expressive writing (EW), (c) a 
credible placebo control, consisting of pulsed audio-photic stimulation (APS), and (d) 
wait-list control (WLC). Participants were instructed to practice their interventions three 
times per week for one month. Participants in all three of the intervention conditions 
showed significant improvement on self-report measures, while no such changes were 
observed for the control group. Findings were mixed on the objective measures. In 
general, neither the WE nor EW conditions consistently outperformed placebo, and in 
some cases, EW failed to outperform the waitlist control group at post-treatment. Overall, 
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those assigned to WE showed greater improvement than those assigned to EW at post-
treatment, but few significant differences between the three intervention groups emerged 
at follow-up.  These mixed findings suggest that either the efficacy of each of the 
treatments does not go beyond the that which would be expected of non-specific 
treatment effects, or that the pulsed audio-photic stimulation did in fact exert more of an 
effect than a typical placebo, suggesting there may have been an unanticipated active 
treatment component. Despite this, several participants in WE and EW showed marke
improvement, and even continued improvement by follow-up, suggesting that, while 
perhaps not highly potent treatments when delivered in isolation, these may be easy, cost-
effective interventions for pathological worry. Further research is needed with clinical 





















Table of Contents 
Chapter 1. Background and Significance………………………………. 1 
1.1 Epidemiology and Nature of Generalized Anxiety Disorder…….. 1 
1.1.1 Overview….……………………………….…………… 1 
1.1.2 Classification and Comorbidity…….…………………... 2 
1.1.3 Medical Utilization………….………………………….  4 
1.1.4 Impairment…………….………………………………..  5 
1.2 Psychosocial Models of Models of GAD………………………… 6 
 1.2.1 Overview………………………………………………  6 
 1.2.2 “Meta-Worry” Cognitive Models of Pathological Worry… 7 
 1.2.3 Cognitive Avoidance Model of Worry………………  8 
 1.3 The Current Status of GAD Treatment………………………….… 13 
 1.3.1 Commonly Studied Treatment Strategies………………………  13 
 1.3.2 Efficacy Data for GAD Treatment……………………………..  18 
 1.4 The Significance of Academic Worry……………………………  22 
 1.5 Self-administered treatments and public health…………………..  23 
Chapter 2. The Current Study…………………………………………..  27 
 2.1 Introduction………………………………………………………. 27  
2.2 Specific Aims and Hypotheses…………………………………...  32 
Chapter 3. Research Design and Methods……………………………… 36 
 3.1 Study Participants………………………………………………… 36 
 3.1.1 Inclusion and Exclusion Criteria…………………………. 38 
 3.1.2 Recruitment, Selection, and Screening………………........ 38 
 3.1.3 Procedure for Obtaining Informed Consent……………… 38 
 3.2 Measures…..……………………………………………………… 39 
 3.2.1 Diagnostic Assessment…………………………………..... 39 
 3.2.2 Screening and Outcome Measures………………………... 40 
  3.2.2.1 Primary Outcome Measures. ……………..............  40 
  3.2.2.2 Secondary Outcome Measures………………………... 41 
 3.2.3 Treatment Credibility and Treatment Fidelity……………. 43 
 3.2.4 Measures Assessing for Putative Moderators and Predictors 
     of Treatment Outcome…………………………................. 45 
 3.2.5 Intervention Process Measures…………………………….. 46 
3.3 Procedure……………………………………………… ……….. 48 
 3.3.1 Procedures for Screening, Informed Consent, and Assessments.. 49 
 3.3.2 Treatment Conditions……………………………………….. 51 
 3.3.3 Treatment Adherence……………………………………….. 58 
 3.3.4 Treatment Integrity………………………………………….. 60 
Chapter 4: Statistical Analyses……………………………………………….. 62 
4.1 Statistical Power Considerations…………………………………….. 62 
4.2. Attrition…….………………………………………….…….……… 62 
 4.2.1 Sample breakdown and Definition of Completer and Dropout.. 62 
 4.2.2 Intent-to-treat Analyses………………………………………. 63 
 4.2.3 Treatment Completion and Attrition Analyses………………. 64 
4.3. Randomization Check……………………………………………….. 65 
 
viii  
4.4. Treatment Fidelity……………………………………….…………… 65 
4.5 Credibility Check….………………………………………………….. 66 
4.6 Testing of Hypotheses……………………………………………… 66 
 4.6.1 Aim 1………………………………………………………. … 66 
 4.6.2 Aim 2…………………………………………………………. 70 
 4.6.3 Aim 3…………………………………………………………. 70 
 4.6.4 Aim 4…………………………………………………………. 71 
 4.6.5 Aim 5………………………………………………………. … 73 
Chapter 5: Results………………………………………………………… 76 
5.1 Equivalence of Groups at Baseline………………………………… … 76 
5.2 Treatment Completion and Attrition……………………………….. … 77 
 5.2.1 Between-group Differences…………………………………… 77 
 5.2.2 Predictors of Attrition…………………………………………. 79 
5.3 Treatment Fidelity……………………………………… ……….. … 79 
5.4 Treatment Credibility………………………………………………. … 82 
5.5 Testing of Hypotheses: Aim 1………………………………………… 82 
 5.5.1 Treatment Effects: Continuous Analyses of Clinical 
 Self-report Measures……………………………………………….. 82 
 5.5.1.1 Academic Worry Questionnaire (AWQ) at Post-treatment..... 82 
 5.5.1.2 AWQ at Follow-up………………………………………….. 86 
 5.5.1.3 Penn State Worry Questionnaire (PSWQ) at Post-treatment. 88 
 5.5.1.4 PSWQ at Follow-up………………………………………… 89 
 5.5.1.5 Perceived Stress Scale (PSS) at Post-treatment…………... 89 
 5.5.1.6 PSS at Follow-up……………………………………………. 90 
 5.5.1.7 Beck Depression Inventory (BDI) at Post-treatment………. 91 
 5.5.1.8 BDI at Follow-up……………………………………………. 92 
 5.5.2 Clinically Significant Change: Achieving Clinically Meaningful  
 Improvement…………………………………………………….... 93 
 5.5.2.1 AWQ at Post-treatment………………………………………….. 93 
 5.5.2.2 AWQ at Follow-up…………………………………………… 94 
 5.5.2.3 PSWQ at Post-treatment………………………………………… 95 
 5.5.2.4 PSWQ at Follow-up……………………………………………. 95 
 5.5.5 Diagnostic Status from Pre-treatment to Follow-up……….… 96 
5.6 Testing of Hypotheses: Aim 2……………………………………….. 97 
 5.6.1 Treatment Effects on Health Outcomes…….………………. 97 
 5.6.1.1 SF-36 at Post-treatment…..……………………………….. 97 
 5.6.1.2 SF-36 at Follow-up…………………………………  98 
 5.6.1.3 Health Center Visits: Acute Effects at Post-treatment……….. 101 
 5.6.1.4 Health Visits at Follow-up…………………………………….. 101 
 5.6.1.5 Physiological Measure of Health: Cortisol Level…………. 102 
5.7 Testing of Hypotheses: Aim 3……………………………………….. 104 
 5.7.1 Treatment Effects on the Objective Academic Measures…… 104  
5.7.1.1 Grade-point Average (GPA): Acute Effects at Post-
treatment…………………………………………………………… 104 
5.7.1.2 GPA at Follow-up………………………………………….. 106 
 
ix
5.7.1.3 Number of Course Hours Completed: Acute Effects at Post-
treatment……………………………………….………………….. 110 
5.7.1.4 Number of Course Hours Completed at Follow-up………….. 110 
5.8 Testing of Hypotheses: Aim 4 (Treatment Moderators)……………… 110 
 5.8.1 Number of Treatment Sessions Completed…………………. 111 
 5.8.2 Meta-cognitions Questionnaire (MCQ)……………………… 111 
 5.8.3 Time in Semester when Randomized……………………….. 113 
 5.8.4 Major………………………………………………………… 114 
 5.8.5 Gender……………………………………………………….. 114 
 5.8.6 Major………………………………………………………… 115 
 5.8.7 Educational Status…………………………………………… 115 
 5.8.8 Race/Ethnicity……… ……………………………………. 115 
5.9 Testing of Hypotheses: Aim 5…………………………………………….. 115 
 5.9.1 Treatment Process Analyses………………………………….. 115 
 5.9.1.1 Change in AWQ Scores During Treatment…………………. 115 
 5.9.1.2 Treatment Process Variables as Predictors of Change………. 116 
 5.9.2 Mechanisms of Change During Treatment……………………. 117 
 5.9.2.1 Worry exposure and Expressive writing: Fear Decline as  
 Predictors of Outcome………………………………………………. 117 
 5.9.2.2 Expressive Writing: Predictors of Outcome………………… 118 
Chapter 6: Discussion………………………………………………………. 121 
6.1 Treatment Outcome……….……………………………………………. 121 
 6.1.1 Pre to post-treatment change…………………………………… 121 
 6.1.2 Between-group differences at post-treatment………………….. 124 
 6.1.3 Post-treatment to follow-up change…………………………… 129 
 6.1.4 Between-group differences at follow-up………………………. 132 
6.2 Treatment Moderators………………………………………………………. 137 
6.3 Treatment Process Analyses……………………………………………… 145 
6.4 General Discussion of Issues Relevant to the Interventions………………. 151 
6.5 Overall Treatment Implications……………………………………………. 159 
6.6 Public Health Implications…………………………………………………. 162 
6.7 Limitations and Directions for Future Research……………………………. 164  
Appendix A: Manualized Protocol………………………………….………… 169  







Chapter 1. Background and Significance 
1.1 Epidemiology and Nature of Generalized Anxiety Disorder (GAD) 
1.1.1. Overview 
Generalized anxiety disorder (GAD), characterized by excessive, uncontrollable 
worry about daily life events, impairs the lives of approximately 5.1% of the U.S. 
population (Wittchen, Zhao, Kessler, & Eaton, 1994). The nature of GAD worries are 
typically future-oriented, rather than worry about immediate problems (Dugas, Freeston, 
Ladouceur, Rheaume, Provencher, & Boisvert, 1998). To meet criteria for the disorder, 
the worry must be pervasive, last for at least six months, and must be associated with at 
least three of the following symptoms: (a) restlessness or feeling keyed up, (b) becoming 
easily fatigued, (c) difficulty concentrating, (d) irritability, (e) muscle tension, and (f) 
sleep disturbance. As with all the anxiety disorders, patients must experience sig ificant 
distress and/or life interference to meet criteria for the disorder.  
Patients with GAD often report that they have been “worriers” since childhood 
(Anderson, Noyes, & Crowe, 1984), but the onset of the disorder usually manifests in 
mid to late adolescence and early adulthood (Blazer, Hughes, & George, 1987; Beck, 
Stanley, & Zebb, 1996).  However, while research indicates most patients develop GAD 
earlier in life, some research has discovered a subset of GAD patients whose onset occurs 
in later adulthood (Wittchen at al., 1994). Early-onset GAD has been associated with a 
history of childhood fears, inhibited or avoidance behavior, developmental, academic, 
and social difficulties, marital dysfunction, interpersonal sensitivity, depression, and a 
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more severe course of the disorder (Hoehn-Saric, Hazlett, & McLeod, 1993; Woodman, 
Noyes, Black, Schlosser & Yagla, 1999).  
GAD is a chronic psychological disorder, with approximately only 20% of GAD 
sufferers showing a complete remission of symptoms within two years (Keller, 2000; 
Ballenger, Davidson, Lecrubier, Nutt, Borkovec, Rickels, Stein & Wittchen, 2001). 
According to the National Comorbidity Study (NCS; Kessler et al., 1994), GAD is twice 
as likely to affect women as men, with lifetime prevalence rates of 6.6% and 3.6%, 
respectively (Wittchen et al., 1994).  
1.1.2 Classification and Comorbidity 
Perhaps more than any other anxiety disorder, the conceptualization and 
diagnostic criteria for GAD have changed significantly with each new revision of the 
Diagnostic and Statistical Manual (DSM). In the DSM-III (APA, 1980), GAD was 
classified as a residual category, similar to the current “Anxiety Disorder, Not Otherwise 
Specified” diagnosis. By the DSM-III-R (APA, 1987), the diagnosis for GAD could be 
made even if patients met diagnostic criteria for another anxiety disorder. Patients met 
criteria if they reported unrealistic and excessive worry in two or more sph res of life for 
at least six months and experienced several somatic symptoms associated with anxiety.  
In order to improve reliability and validity of the diagnosis, major changes were 
made to the DSM-IV diagnostic criteria for GAD. Patients no longer needed to rport two 
or more spheres of worry; rather, worry considered pervasive was sufficient, as da a 
indicated that GAD patients often worried about several minor events that did not always 
fall into a particular sphere of worry (Borkovec, Shadick, & Hopkins, 1991; Craske, 
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Rapee, Jackel & Barlow, 1989). Further, the 18 somatic symptoms associated with GAD 
in the DSM-III-R (many of which were identical to symptoms of a panic attack, 
indicating autonomic arousal) were reduced to six associated symptoms. This decision 
was based on research that indicated GAD patients did not show autonomic arousal, but 
displayed symptoms of autonomic suppression (Hoehn-Saric, McLeod, & Zimmerli, 
1989; Borkovec & Hu, 1990).  
One difficulty with the six associated symptoms retained in the DSM-IV is the 
high degree of overlap between these GAD symptoms and symptoms of a major 
depressive episode (MDE). While some have argued that there is a lack of discriminant 
validity between GAD and major depressive disorder (MDD; Brown, Barlow & 
Leibowitz, 1994; Brown, Marten & Barlow, 1995), research has also found support for 
GAD as a distinct diagnosis, separate from depression (e.g., Joorman & Stober, 1999). 
 As data are currently being collected and evaluated in order to revise the 
diagnostic criteria for the DSM-V, researchers are addressing the issu  of discriminant 
validity between GAD and  MDD, as well as suggesting a change from the criteria that 
symptoms persist for six months or longer to 1-12 months. This recommendation is based 
on a study which found that cases in which patients met all other diagnostic critera for 
GAD for 1-5 months did not differ from those with episodes lasting six months or more 
on age of onset, pervasiveness, impairment, or comorbidity (Kessler, Brandenburg, Lane, 
Roy-Byrne, Stang, Stein, & Wittchen, 2005).  
Although there is mounting evidence suggesting GAD is a distinct disorder in its 
own right, GAD is often comorbid with other psychological disorders. One large-scale 
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study of a clinical sample found that 68% of GAD patients met for another Axis I 
disorder (Brown, Campbell, Lehman, Grisham & Mancil, 2001). Of those, 36% met for 
social phobia, 26% met for MDD, and 18% met for panic disorder. In addition, 64% 
reported a history of experiencing a major depressive episode. Interestingly, the NCS 
study also found high rates of comorbidity between GAD and alcohol-related disorders 
(Swendsen, Merikangas & Canino, 1998). 
1.1.3 Medical Utilization 
A large body of evidence suggests GAD is associated with high medical 
utilization. GAD is the most prevalent anxiety disorder found in primary care settings 
(Barrett, Barrett, & Oxman, 1988; Wittchen et al., 2001; see Wittchen 2002, for reviews), 
and among patients classified as high in medical care utilization, 40% met criteria for a 
lifetime history of GAD (Katon, von Korff, & Lin, 1990). The World Health 
Organization (WHO) multi-center Psychological Problems in General Helth Care 
(PPGHC) study revealed that 8% of primary care utilizers met diagnostic criteria for 
GAD (Ustun & Sartorius, 1995).  
This high rate of health care utilization is perhaps not surprising, as patients wth 
pathological worry must present with at least three associated symptoms to meet criteria 
for the diagnosis, many of which are somatic. Approximately one-third of GAD patients 
seek medical attention for their somatic symptoms (Judd, Kessler, Paulus, Zeller, 
Wittchen, & Kunovac, 1998), a significant portion of which are visits to the 
gastroenterologist (Kennedy & Schwab, 1997). According to the most recent primary 
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care study of GAD health care utilization, GAD patients were twice as likely to visit a 
primary care doctor than patients with MDD (Wittchen et al., 2002).  
In addition to GAD patients seeking non-mental health services at primary care 
facilities, GAD patients also utilize primary care settings for help with their anxiety. 
Maier, Gaensicke, Freyberger, Linz, Heun & Lecrubier (2000) found that 25% of patients 
visiting a primary care physician for a psychological problem met for GAD with no 
comorbid diagnoses. Wittchen et al. (2001) found that only 28% of GAD patients 
presenting with anxiety symptoms in primary care facilities were corre tly diagnosed by 
their primary care physicians, and that these patients were rarely treated with empirically 
supported pharmacological and non-pharmacological treatments for GAD.  These data 
suggest that evaluating pre to post treatment changes in medical utiliztion in patients 
with GAD may be an important outcome variable to consider and may be an important 
public health issue to evaluate (Telch, Smits, Brown & Beckner, 2002). 
1.1.4. Impairment 
Individuals with GAD experience significant levels of impairment. An analysis 
combining the results from the NCS study and the Midlife Development in the United 
States Survey indicated that GAD was associated with marked impairment n role
functioning and social life (Kessler et al., 1999). This impairment was found to be 
equivalent to that of patients with major depression (MDD).  
Providing further support, Wittchen, Carter, Pfister, Montogmery, & Kessler 
(2000) compared the level of impairment observed between GAD and MDD. After 
controlling for age, gender, and other psychopathology, GAD without MDD, MDD 
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without GAD, and comorbid GAD and MDD were each associated with high levels of 
impairment, as defined by at least three days of limited or impaired functioning within 
the past month, poor self-perceived health, and low self-reported quality of life. No 
differences on these measures of impairment were found between GAD alone and MDD 
alone.  
1.2 Psychosocial Models of GAD 
1.2.1 Overview and Etiology 
Current conceptual models of the etiology of GAD suggest that early experiences 
of uncontrollability may be risk factors for the development of the disorder (Barlow, 
1988). GAD has been described as the “basic” anxiety disorder (Barlow, 1998; Brown, 
Chorpita & Barlow, 1998), consisting of negative affect, a sense of uncontrollability, and 
attention to threat-related stimuli, all features that have been considered vulnerabiliti s to 
other emotional disorders (Clark, Watson, & Mineka, 1994). Research has consistently 
demonstrated that patients with GAD show a preattentive bias towards threatening 
information ( e.g., MacLeod, Matthews, & Tata, 1986) and interpret ambiguous 
information as threatening (e.g., Eysenck, MacLeod, & Matthews, 1987). Because GAD 
patients show a preattentive bias to threat but do not show biased recall of threat words 
during memory tasks, Matthews (1990) has argued that, while threat information is 
quickly encoded, GAD patients may display a subsequent rapid cognitive avoidance. 
Researchers have proposed that, given the early onset of GAD relative to 
comorbid diagnoses, conceptualizing GAD as a predisposing factor to the development of 
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other anxiety and mood disorders may explain the high rates of comorbidity (Brown et 
al., 1994). 
1.2.2. “Meta-Worry” Cognitive Models of Pathological Worry 
Wells’ (1995) meta-cognitive model of pathological worry has been instrumental 
in the development of cognitive therapy aimed at addressing pathological beliefs about 
worry that serve as maintaining factors in GAD. Wells (1995) proposed a distinction 
between two types of worry. Type I worries are the general worries concerned with daily 
life events, while Type II worries are meta-worries, or worries about worry. Wells 
considers this “worry about worry” (Type II) to be the hallmark feature of and 
maintaining factor in pathological worry.  
More specifically, Wells discusses that positive beliefs about worry (e.g., that it is 
useful for problem solving) may initiate the worry process (with Type I worries). These 
positive beliefs are maintained when the goals of worrying are met (i.e., pati nts perceive 
that a negative outcome did not occur because of worry, or a positive outcome did occur 
because of worry). However, often during these worry episodes, negative beliefs about 
worry may be activated (e.g., “I must control my worry or I will cease to function”), thus 
leading to Type II worry. This Type II worry influences emotional (i.e., increase in 
anxiety) and behavioral (i.e., avoidance or use of behaviors to reduce anxiety) changes, as 
well as attempts to control thoughts, all of which then maintain negative beliefs about the 
uncontrollability or harmful nature of worry.  
A research group in Montreal has added to this model by including several other 
cognitive factors involved in the maintenance of GAD. This group has used their model 
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to develop innovative treatments for GAD based on their theory that pathological worry 
is maintained by distorted positive and negative beliefs about worry (e.g., “worrying 
helps me succeed in accomplishing my goals” and “worrying is dangerous,” 
respectively), an inflated intolerance for uncertainty in life situations, cognitive avoidance 
of distressing situations, and difficulty with identifying and solving problems. Evidence 
has been found supporting this conceptual model (Dugas, Gagnon, Ladouceur, & 
Freeston, 1998).  
1.2.3 Cognitive Avoidance Model of Worry  
Borkovec’s cognitive avoidance model (Borkovec, Shadick, & Hopkins, 1991; 
Borkovec, 1994) is one of the most widely recognized models of GAD in the research 
community. First, supported by research suggesting verbal thoughts produce less arousal 
than images (Vrana, Cuthbert & Lang, 1986), Borkovec posits that worry is a 
verbal/linguistic thought process used to avoid future aversive events and imagery. 
Research has suggested that worry takes a verbal, rather than image-based form 
(Borkovec & Lyonsfield, 1993; Borkovec & Inz, 1991). In a comparison of obsessions 
(as seen in obsessive compulsive disorder, OCD) and worries (as seen in GAD), 
Langlois, Freeston, & Ladouceur (2000) found that obsessions were experienced more as
images, while worries were experienced more as verbal thoughts. Borkovec & Roemer 
(1995) found that, on a self-report measure assessing reasons why people worry, GAD 
patients were distinguished from non-GAD control groups in that they endorsed worrying 
as a “distraction from more emotional topics” significantly more than controls.  
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Second, Borkovec (1994) explains that worry is a negative reinforcer because it 
becomes a means to escape from or avoid more threatening imagery and somatic 
activation. This negative reinforcement comes from: (a) the non-occurrence of egative 
outcomes after worrying (consistent with Wells’ meta-cognitive model in which worry 
produces distorted positive beliefs about worry); (b) the ability to avoid more distrssing 
topics while worrying; and perhaps most importantly, (c) reductions in somatic arousal, 
or the absence of experiencing the somatic component of anxiety. Research has 
repeatedly found that worry itself (both in GAD and non-GAD samples) inhibits 
autonomic activity (Borkovec, Lyonfields, Wiser, & Deihl, 1993; Borkovec & Hu, 1990; 
Lyonfields, Borkovec, & Thayer, 1995; Wells & Papageorgeiou, 1995), and that GAD 
patients show overall autonomic suppression (Thayer, Friedman, Borkovec, Johnson, & 
Molina, 2000; Thayer, Friedman & Borkovec, 1996; Lyonsfields et al., 1995).  
Borkovec & Hu (1990) found that socially phobic individuals who were 
instructed to worry before engaging in imaginal exposure to a speech showed no increase 
in heart rate (HR) during the imaginal exposure, while socially phobic individuals who 
were instructed to relax before imagining giving the speech showed an increase in HR. 
Similarly, Butler, Wells & Dewick (1992) exposed participants to a gruesom fil . After 
the film, participants were randomized to four minutes of either: (a) engaging in imaginal 
rehearsal of the gruesome images, (b) worrying about the film, or (c) “settling down” 
(control group). After the four minutes, those in the worry and control conditions 
reported significant decreases in anxiety, while those who imagined scenes from the film 
showed significantly greater anxiety than the control group. However, over the next three 
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days, those in the “worry” condition showed a greater increase in intrusive thoughts than 
the imagery and control conditions. Another study using an identical paradigm found 
similar results (Wells & Papageorgiou, 1995). Interestingly, the latter study also included 
a “worry as usual” group, instructed to worry about everyday topics, rather than the 
content of the film. Both of the “worry” conditions showed a similar increase in 
intrusions over the 3-day period as compared to a control group. These three studies 
suggest that worry:  (a) suppresses autonomic activation, (b) suppresses the activation of 
fear, and (c) maintains anxiety in the longer-term. 
While these two aforementioned studies address the suppression found as a result 
of worrying in non-GAD samples, other studies reveal the overall autonomic suppression 
and inflexibility found in GAD patients. Hoehn-Saric & McLeod (1988) found that, while 
GAD patients did show increased muscle tension compared to controls, their heart rate 
and skin conductance levels showed a restricted range of variability. This finding 
suggests GAD patients show sympathetic nervous system inhibition. Research also 
illustrated the parasympathetic inflexibility found in GAD patients. In particular, the 
vagus nerve (indicative of parasympathetic activity) is the major deteminant of HR 
reactivity. A vagus that is able to rapidly affect changes in heart rate has been thought to 
indicate a flexible and responsive attentional system (Porges, 1992). Lyonsfield et al. 
(1995) demonstrated that GAD patients show overall low vagal tone and autonomic 
inflexibility compared to nonanxious controls. More specifically, nonanxious controls 
showed incremental decreases in vagal tone from relaxing to focusing on aversive 
imagery to engaging in worrisome thinking, while GAD patients showed the sam 
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consistent, low levels of vagal tone whether they were instructed to relax, worry or 
imagine threat (Lyonsfield et al., 1995).  
Thayer et al. (2000) argued that the sustained attentional resources directed 
towards a stimulus when engaging in worrisome thinking produce vigilance, suppression 
of HR variability, and vagal withdrawal. Measuring HR reactivity using a cued threat 
paradigm, Thayer et al. (2000) found that nonanxious controls showed greater habituation 
to novel neutral stimuli than GAD patients. Further, GAD patients showed greater HR 
acceleration (“defensive response”) when presented with threatening stimuli, while the 
control group showed greater HR deceleration (“orienting response”) after the 
introduction of the threatening stimulus. Finally, the GAD group showed an anticipatory 
HR deceleration before the second presentation of threat words, presumably in order to
cope with perceived threat (Thayer et al., 2000).  Overall, the findings of Lyonsfield, 
Thayer, and colleagues indicate that patients with GAD show autonomic (particularly 
parasympathetic) inflexibility, as evidenced by low vagal tone. Additionally, Thayer et al. 
(2000) propose that these findings suggest GAD patients show: (a) an attentional bias 
toward detecting threat, (b) overall vigilance, and (c) a defensive attempt to avoid 
threatening information. 
Borkovec (1994) proposed that the presence of muscle tension, yet otherwise 
suppressed and inflexible autonomic system found in GAD patients may be explained by 
the “freezing” response. GAD differs from many other anxiety disorders in that there is 
no specific phobic target, core fear, or concrete threat. Thus, there is nothing t “f ght or 
flee.” Because GAD patients are attuned to threat, yet there is no actual, concrete threat to 
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confront or avoid, individuals with GAD must rely on cognitive coping strategies (i.e., 
worry) and ultimately tense their muscles in a “freeze” response.   
In order to fully understand Borkovec's theory of cognitive avoidance as a 
maintaining factor in GAD, a basic understanding of  Foa & Kozak's (1986) emotional 
processing theory is imperative. According to the emotional processing theoryof fear 
(Foa & Kozak, 1986), fear is maintained in structures in memory. When an individual 
confronts the feared stimulus (e.g., a snake), the fear structure is activated. As he 
individual is presented with information that is incompatible with beliefs about the fear d 
stimulus (e.g., the snake does not bite), fear begins to habituate. 
Thus, the premise of Foa & Kozak's (1986) emotional processing theory is that 
fear reduction occurs via threat disconfirmation, and that this threat disconfirmation 
occurs via confrontation with the feared stimulus during which new associations are 
formed in memory that are not consistent with the threat. Foa & Kozak (1986) posit that, 
in order for this process to occur, there must be an activation of fear and that fear 
reduction will be most successful when within and between trial habituation occur (i.e., 
fear decline during one period of time with the feared stimulus, and between time periods 
with the feared stimulus, such that each time period, or trial, begins with lower fear than 
the previous trial).  Foa & Kozak (1986) also discuss that distraction will inhibit fear 
reduction by preventing patients from fully processing threat disconfirming information 
that is presented during confrontation with the stimulus. Thus, they suggest that having 




According to Borkovec’s GAD theory, while worry may inhibit more intense 
anxiety in the short-term, worry itself maintains anxiety-producing cognitions because it 
does not allow for the full activation of fear structures in memory, presumably preventing 
the emotional processing of anxiety (Foa & Kozak, 1986). Borkovec (1994) argues that, 
while worry is used to avoid imagery and intense affect, worry itself is likely to conjure 
up aversive imagery, which must be immediately avoided via worrying. Thus, worry 
perpetuates threatening meanings about these images, thereby maintaining anxiety. By 
preventing emotional processing, according to both Foa & Kozak’s (1986) and 
Borkovec’s (1994) theories, long-term anxiety reduction will not occur. This inhibition of 
emotional processing may explain the autonomic suppression also found in GAD 
patients.   
Support for this theory has been found in a few studies. For example, in the Wells 
& Papageorgiou study (1995), recall that although worry reduced autonomic activity and 
reduced anxiety in the short-term, worry was associated with significa t increased 
intrusions over a 3-day period. Presumably, because emotional processing did not occur, 
threatening associations continued in an absence of new learning. Consistent with 
emotional processing theory, Barlow (2002) has argued that, because of the focus on 
future-oriented concerns, rather than present concerns, GAD patients are unable to learn 
new, non-anxious associations. 
1.3 Current Status of GAD Treatment 
1.3.1 Commonly Studied Treatment Strategies 
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 Several cognitive and behavioral treatment strategies for GAD have been the 
subject of empirical investigation and are now commonly presented in treatment manuals. 
Below is a brief description of the most commonly studied strategies. It is worth noting 
that several of these individual strategies have only been tested within the context of 
multi-component treatment packages. 
Progressive Muscle Relaxation (PMR) and Applied Relaxation (AR) 
Progressive muscle relaxation consists of teaching patients to tense and relax 
specific muscle groups in a systematic way.  One of the most commonly used PMR 
protocols for the treatment of GAD was originally developed by Bernstein & Borkovec 
(1973). One major aim of the protocol is to teach patients to become aware of the 
difference in the sensations of tension and relaxation. Applied relaxation takes PMR one 
step further and consists of two parts. First, patients are taught PMR and sometimes other 
relaxation strategies such as pleasant imagery. Second, after mastering th  relaxation 
skills, patients are instructed to monitor their anxiety levels throughout the day an  to use 
these relaxation strategies during situations in their daily lives that cause stress and 
anxiety.  Although AR has been examined as a stand-alone treatment (e.g., Ost & 
Breitholtz, 2000), PMR as a treatment for GAD has only been studied as part of a larger 
treatment package (e.g., Butler, Fennel, Robson & Gelder, 1991) 
Self-control Desensitization (SCD) 
 Self-control desensitization (Goldfried, 1971) consists of three main elements, the 
first few of which are similar to systematic desensitization.  First, patients are taught 
relaxation skills. During relaxation, anxiety-provoking cues are presented in imagination. 
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Patients are instructed to conjure up images of worry-provoking scenarios and to imagine 
themselves relaxed in these situations. In addition, patients are taught cognitive coping 
resources such as self-statements and perspective shifts and are encouraged t  gen rate 
these coping resources during imaginal exposure in order to reduce their anxi ty during 
the worry-provoking scenario. SCD has not been tested for the treatment of GAD in 
isolation, but has been included in some tested multi-component treatment packages (e.g., 
Borkovec & Costello, 1993). 
Behavioral Activation (BA) 
 Although primarily used as a treatment for depression, behavioral activation has 
also been used in the treatment of GAD. Because many patients with depressed mood are 
often not engaging in activities that bring them pleasure, BA aims to improve mood by 
helping patients to counter patterns of avoidance and withdrawal that are often found in 
patients with anxiety and mood disorders. BA consists primarily of helping patients o 
schedule pleasurable activities into their daily lives, as well as incorporating activities 
that provide patients with a sense of mastery or accomplishment. Although part of a 
multi-component treatment package in earlier cognitive therapy, BA was eventually 
established as a stand-alone treatment (Jacobsen et al., 1996).  Although not commonly 
included in GAD treatment protocols, BA has been tested as part of a multi-component 
treatment package for GAD (Butler et al., 1991). 
In vivo exposure 
 Patients with GAD sometimes avoid certain situations they fear may result in 
anxiety, stress, or worry. For example, a GAD patient who worries a lot about 
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relationships may avoid having a much needed discussion with a loved one about a 
particularly difficult issue; likewise, a GAD patient who worries a lot about health may 
avoid medical appointments for fear that the doctor will discover a new health problem 
which would evoke more anxiety. In vivo exposure, a strategy that is used across all of 
the anxiety disorders, consists of creating a hierarchy of anxiety-producing situations that 
patients avoid or experience with significant anxiety and then instructing the patients to 
confront these situations in their lives. Although exposure to worry-provoking situations 
has traditionally taken either an imaginal approach or an applied relaxation apprach in 
the treatment of GAD, in vivo exposure has been included in multi-component treatment 
protocols to address avoidance behavior (e.g., Butler et al., 1991). 
Worry Exposure/Cognitive Exposure 
 Worry exposure consists of having patients repeatedly confront worry-provoking 
scenarios by imagining their feared outcomes associated with these worry scenarios. The 
first worry exposure protocol was developed in line with Borkovec’s cognitive avoidance 
model which posits that worry is a verbal process used to avoid more intense anxiety 
(Craske, Barlow, & O’Leary, 1992). The purpose of worry exposure is to activate anxiety 
through imagery-based techniques and to hold specific worries in mind until the distress 
associated with those worries habituates. Patients create a hierarchy of worry-provoking 
scenarios and typically create and listen to a loop-tape of themselves describing the scene 
to aid in their ability to form an image of it. Despite its presence in CBT manuals and its 
direct link with one of the most widely accepted models of GAD, worry exposure has not 
been tested as a stand-alone treatment. A similar procedure called “cognitive exposure,” 
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in which the worst possible feared outcomes of those worries not amenable to other forms 
of treatment are imagined, has been included as a minor component in a multi-component 
treatment package for GAD (Ladouceur, Dugas, Freeston, Leger, Gagnon, & Thibodeau, 
2000). A more detailed description of worry exposure will follow (see “Chapter 2: The 
Current Study”).  
Cognitive Therapy (CT): Cognitive Restructuring and Behavioral Experiments 
 Originally developed by Beck, the primary goal of cognitive therapy is to identify, 
challenge, and modify dysfunctional thoughts and beliefs. CT for GAD was developed 
based on the cognitive theory of GAD (Beck, Emery & Greenberg, 1985). Cognitive 
restructuring consists of teaching patients to: (a) identify automatic thoughts that precede 
an emotion such as anxiety; (b) examine the evidence for and against that thought or 
belief; and (c) help the patient to come to a more accurate conclusion about the accuracy 
of the thought. Several techniques are available to therapists to accomplish this goal, such 
as Socratic questioning.  
Behavioral experiments, while technically part of this CT approach, bridge 
behavioral and cognitive approaches by designing “experiments” to test out specific 
beliefs a patient may have. For example, if a patient with academic worrycomes to class 
ten minutes early every day because she believes “If I miss a single mi ute of class I will 
be completely lost for the rest of the lecture,” the therapist may instruct the patient to 
conduct an experiment in which she comes to class five minutes late and sees how well 
she can understand the rest of the lecture.   
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Cognitive therapy approaches have been subjected to research in the treatment for 
GAD as stand-alone treatments (e.g., Ost & Breitholtz) and as part of CBT packages 
(e.g., Ladouceur et al., 2000). 
1.3.2 Efficacy Data for GAD Treatment 
Because GAD has only been clearly defined since the DSM-IV (APA, 1994), 
research in the area of pathological worry is sparse compared to the research in other 
anxiety disorders. Although a plethora of pharmacological treatment studies have been 
conducted in the last decade on treatments for GAD (see Meunnier, Brawman-Mintzer, 
Wolitzky, and Labatte, 2004 for reviews), the literature on psychosocial treatments in this 
area is still far behind.  
While empirically supported psychosocial treatments have been established, not 
all of the components of these multi-faceted treatment packages have been empirically 
tested individually. Further, there has been relatively little consistency across research 
groups in what treatment components should be included in a cognitive-behavioral 
treatment (CBT) package, yet each of these research groups uses the generic label of 
“CBT” in their papers. This may mislead clinicians who read one article finding support 
for CBT to believe that all CBT is effective for GAD.  
Borkovec and Costello (1993) found that applied relaxation (AR) and CBT both 
outperformed non-directive therapy for GAD. CBT was comprised of self-control 
desensitization (SCD), applied relaxation (AR), and cognitive therapy (CT). In this 
study’s literature review, Borkovec & Costello (1993) comment that, due to the “possible 
function of worry for escaping anxiety-provoking imagery to avoid somatic anxiety,” 
 
19
treatments should focus on exposures to anxiety-provoking imagery. However, while this 
statement was made during an effort to introduce the rationale for the treatments they 
chose to investigate, none of the treatments examined in this study directly test this 
hypothesis. Although SCD does instruct patients to conjure up anxiety-provoking stimuli, 
patients are then told to think about how they might employ positive coping skills to 
make themselves less anxious in these situations. While this treatment may i cre se self-
efficacy for addressing distressing situations, the theoretical basis behind SCD is 
inconsistent with the authors’ argument that patients should confront anxiety-producing 
images in order to experience the anxiety they presumably avoid via worry.  
Butler et al. (1991) found that CBT outperformed behavior therapy (BT), with 
32% of those receiving CBT and 16% of those receiving BT achieving clinically 
significant change (defined as scoring more than two standard deviations towards 
improvement on the outcome variables at post-treatment). BT consisted primarily of 
PMR, graded exposure to situations which patients were avoiding, and introducing 
pleasurable activities into participants’ lives. CBT consisted of the samebehavioral 
strategies used in the BT condition, with the addition of cognitive therapy (CT),
consisting solely of cognitive restructuring (i.e., no behavioral experiments).  
In their study of comparing CT to AR, Ost & Breitholtz (2000) found that both 
treatments were equally effective in reducing GAD symptoms, with 53% in AR and 62% 
in CT achieving clinically significant change. Borkovec, Newman, Pincus, and Lytle 
(2002) compared (a) CT, (b) AR + SCD, and (c) CT+AR+SCD, which the authors label 
“CBT.” At post-treatment, 43.48% of participants in CT, and 56.52% of participants in 
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the other two conditions had achieved clinically significant improvement, with no 
significant differences between conditions.  
In line with their cognitive model of GAD (Ladouceur et al., 2000) designed a 
cognitive-behavioral treatment which targeted intolerance of uncertainty, erroneous 
beliefs about worry, poor problem orientation, and cognitive avoidance. At follow-up, 
77% of participants no longer met diagnostic criteria for GAD. In a similar vein, Dugas, 
Freeston, Ladouceur, Leger, Langlois, Provencher, & Boisvert (2003) tested a similar 
cognitive behavioral treatment in a group setting and found that 52% of those receiving 
the experimental treatment (labeled “CBT”) achieved clinically significant change, 
defined as reliable change (see Jacobsen & Truax, 1991) and scores moving more than 
two standard deviations towards improvement on outcome measures. 
Taken together, these studies show that cognitive and behavioral treatments for 
GAD are efficacious. However, several limitations are worth noting. First, there is room 
for improvement, with the majority of these randomized clinical trials (RCTs) producing 
clinically significant change only for approximately half of the participants. Second, 
many of these studies devise treatment protocols that incorporate several diffent 
treatment components, and thus do not provide any information about which components 
are most efficacious and which are unnecessary. Even those studies attempting to conduct 
as analyses of treatment components, using constructive designs (i.e., Borkovec et al., 
2002), do not evaluate each treatment component in isolation. 
Third, the Borkovec model (1994) for GAD, suggesting worry is a means to avoid 
experiencing more intense anxiety, has yet led to the investigation of treatments that 
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target worry from this perspective, despite Borkovec & Costello’s (1993) suggestion to 
do so. While two studies from the Montreal group did include some exposure to specific 
types of worry-provoking images in a multi-component treatment package consisting 
primarily of cognitive restructuring, problem solving, and self-monitoring (Ladouceur et 
al., 2000, individual sessions; Dugas et al., 2003, group sessions), that this CBT package 
outperformed waitlist control conditions provides little to no information about the 
efficacy of the exposure treatment component aimed at reducing cognitive avoidance. 
Thus, research is needed to: (a) design and evaluate treatments that will produce higher 
rates of clinically significant change, (b) dismantle multi-faceted tr atment protocols in 
order to evaluate which components of treatment are most efficacious, and (c) examine 
treatments that target worry using Borkovec’s model of worry as emotional avoidance.  
Surprisingly, several components of CBT for GAD, as outlined in various popular 
CBT treatment manuals (e.g., Zinbarg, Craske & Barlow, 1993; Rygh & Sanderson, 
2004) have not been empirically tested. Thus, there exist several widely used treatment 
techniques accepted by the research community, such as worry exposure and scheduled 
worry time, which have yet to be investigated1. Given that these treatments are already 
being disseminated, it may be in the research community’s best interest to make these 
treatments a priority for investigation. 
Interestingly, worry exposure was designed to address the cognitive avoidance in 
which GAD patients engage in order to avoid more intense anxiety. Consistent with 
Borkovec’s model (1994), this treatment aims to reduce worry by having patients 
                                                                
1 With worry time, patients are instructed to set aside a time every day to worry “on purpose,” with the
intention of teaching control over worry, as well as sending the message that worrying is not dangerous. 
Worry exposure will be described in more detail in subsequent sections.  
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confront their anxiety more intensely. Patients are taught to hold anxiety-provoking 
images in their minds without using any problem solving or coping skills, pleasant 
imagery, or cognitive restructuring (worry exposure will be described in moredetail in 
the “Methods” section).  
1.4 The significance of academic worry 
Occupational worry (i.e., worry about school or work) is the third most common 
sphere of worry, with approximately 50% of patients meeting criteria for GAD reporting 
significant worry in this domain (Sanderson & Barlow, 1990). Thus, it is a highly 
relevant sphere of worry for patients with GAD. Further, academic worry may also be a 
common area of worry in non-GAD samples potentially at risk for developing GAD and 
thus may lend itself nicely to systematic testing of interventions designed to reduce 
worry.  
Hazlett-Stevens & Craske (2003) found that introductory psychology students 
who scored within the clinical range for GAD on a valid and reliable self-report 
instrument assessing GAD symptoms (GAD-Q-IV; APA, 1994) rated the worry topic of 
“achievement” as more threatening than non-anxious counterparts, whereas there were no 
differences in threat rating between groups for worry topics such as “health,” “safety,” 
and “environment.”2 Further, results from coded interviews indicated that a fear of failure 
was coded significantly more in the interviews with the analog-GAD group than 
nonanxious controls. Clearly, achievement and failure are salient themes in academic 
environments.  
                                                                
2 Consistent with the literature, analog-GAD participants also rated “social interactions” and “economics” 
as more threatening than their nonanxious counterparts. 
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In addition to its utility in testing interventions for pathological worry, academic 
worry is also an important issue to consider in and of itself. Research suggests that 
perceived academic stress is linked to anxiety and depression in college students and high 
school students (Aldwin & Greenberger, 1987; Yadusky-Holahan & Holahan, 1983). 
While these studies do not establish temporal precedence between academic stress and 
psychopathology, interventions that can reduce academic worry and the distress 
associated with it may have profound public health implications. Further, while not 
surprising, academic stress has been found to correlate with lower grades (Struthers & 
Perry Menec, 2000), suggesting interventions designed to reduce academic worry may 
also have an impact on grade improvement.  
Despite the impact of academic stress on students, research has yet to evaluate the 
efficacy of interventions designed to target this problem. While several college and 
university counseling centers provide “academic stress management” programs, these are 
neither empirically supported nor targeting excessive and uncontrollable worry about 
school. Because of the number of academic stress management programs available at 
colleges and universities, it can be implied that academic stress and academic worry may 
be important problems to address. Thus, research should evaluate interventions to reduce 
pathological academic worry.  
1.5 Self-administered treatments and public health 
Given the current managed health care system in the United States, coupled with 
the high prevalence of anxiety disorders, many have argued that disseminating 
information about treatments supported by controlled research to a wider audience, as 
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well as delivering more cost-effective, brief treatments, is essential i  meeting the current 
needs and demands in the mental health field (e.g., Newman, 2000; Marks, 1991).  The 
annual cost of anxiety disorders is estimated to be $42.3 billion, which is approximately 
31% of the total annual mental health care costs in the U.S. (Greenberg, Sisitsky, Kessler, 
Finkelstein, Berndt, Davidson, Ballenger, & Fyer, 1999; Rice & Miller, 1995).  The 
Greenberg et al. (1999) study took the costs of medical and psychiatric treatment, s well 
as indirect workplace costs and the costs of mortality into account when calculating this 
estimate. In addition, as mentioned previously, patients with GAD not only contribute to 
the mental health costs in the U.S., but also utilize primary care settings frequently 
(Barrett et al., 1988).Although there has been a fair amount of research on self-help 
and/or self-administered treatments for issues such as smoking cessation and depression 
(see Curry, Ludman & McClure, 2003, and McKendree, Floyd, & Scogin, 2003, 
respectively, for reviews), there has been relatively little research on self-administered 
treatments for anxiety disorders. Three meta-analyses examining the effects of self-
administered treatments found moderate to large effect sizes for self-administered anxiety 
treatments when compared to waitlist control groups (Gould & Clum, 1993; Marrs, 1995; 
den Boer, Wiersma & van den Bosch, 2004). Further, these treatments were comparable 
to therapist-directed interventions in two of the meta-analyses (Gould & Clum, 1993; 
Marrs, 1995) and comparable to brief psychiatric treatment in the third (van den Boer et 
al., 2004). Very few studies have examined the efficacy of self-administered tr atments 
for GAD. In their review, Newman, Erickson, Przeworski, and Dzus (2003) note that 
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there are no known published studies examining self-administered treatments for GAD in
their purest form (i.e., contact with therapist only at the time of assessment).  
 Bowman, Scogin, Floyd, Patton, & Gist (1997) investigated a predominantly 
self-help treatment for GAD. Patients used a self-help manual that included problem 
solving training, and received four five-minute phone “check-in’s” by the research rs. 
This treatment outperformed waitlist control groups at post-treatment and a three month 
follow-up.  
Three other GAD treatment studies claiming to test “minimal therapist contact” 
interventions were found to be superior to waitlist control groups3 (Jannoun, 
Oppenheimer, & Gelder, 1982; Newman, Consoli & Taylor, 1999; White, Keenan, & 
Brooks, 1992).  However, upon closer inspection, these studies each involved six sessions 
with the patients before giving them the self-help tools for the remainder of the study, and 
thus do not significantly differ from therapist-directed treatment studies conducted in the 
field. Further, that they are only compared to a no-treatment control group is a significant 
limitation of all of these studies. However, it is worth noting that one study did find a 
general decrease in medical utilization (presumably an important measure of meaningful 
change in GAD), with a significant decrease in general practitioner visits and anxiolytic 
prescriptions for the treatment group compared to no-treatment controls (White et al., 
1992). 
Clearly, there is a lack of sound, well-controlled research in the area of self-
administered treatments for GAD. Only one known published study has examined a self-
                                                                
3 note that two of these studies used participants meeting for DSM-III and DSM-III-R criteria 
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administered treatment for GAD, and the study did not compare the treatment to a 
placebo control or another active treatment. Due to the heavy burden placed on the 
medical field by GAD and other anxiety disordered patients, the development, empirical 
testing, and dissemination of cost-effective, efficacious treatments for GAD may have 
significant public health implications.  
 
27
Chapter 2. The Current Study 
2.1 Introduction 
The purpose of this study was to evaluate the efficacy of self-administered 
interventions to reduce pathological worry. Participants with or without GAD who 
experienced excessive and uncontrollable worry about academics were randomly 
assigned to receive one month of either: (a) worry exposure (WE), (b) expressive writing 
(EW), (c) a credible placebo, consisting of pulsed audio-photic stimulation (APS) or (d) 
wait-list control (WLC). All interventions were self-administered. 
There are several gaps between research and clinical practice in the treatm nt of 
GAD. More specifically, worry exposure, a commonly accepted behavioral strategy for 
reducing the severity of and distress associated with pathological worry, has not been 
carefully tested in an RCT. Despite this, several highly respected manuals, book chapters, 
and review articles authored by academic researchers discuss worry exposure as an 
established treatment component for GAD (Lang, 2004; Brown, O’Leary, & Barlow, 
2001; Zinbarg, Craske, & Barlow, 1993, Craske et al., 1992; see “Worry Exposure 
Condition” in Methods section).  
Experimental laboratory research provides some preliminary support for the 
promising nature of worry exposure. Roemer and Borkovec (1994) instructed high-
worriers with and without GAD to identify a target anxiety-provoking situation. Next, 
participants were instructed to either relax (i.e., suppress thoughts/worries about the 
situation) or to express thoughts (i.e., think about the distressing situation). Then all 
participants were told to express the negative target thoughts. Those in the initial 
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“suppress worry” condition showed significantly greater increases in statemen s about the 
distressing situation than those who were initially instructed to express their negative 
intrusive thoughts. Those instructed to “express” both times showed decreases in the 
number of statements about the target thought. This study supports the hypothesis that 
worry can habituate.  However, it should be noted that efforts were not made in this 
experiment to ensure participants were thinking about the worrisome scenarios vi  
imagery. 
Research on non-CBT alternative psychological treatments for GAD has received 
little attention.  For example, Pennebaker’s expressive writing paradigm, in which
participants who write about emotional topics show improved health and academic 
outcomes, may be particularly important to test as a self-help worry interveion (see 
Pennebaker, 1997; Smyth, 1998; Frisina, Borod & Lepore, 2004; and Frattaroli, 2006, for 
reviews). Though this writing paradigm has not been tested in the reduction of worry, 
there is reason to believe that it may be a promising intervention. In an interest g study, 
participants who experienced the recent death of a spouse and did not talk to others about 
the death often ruminated about it (Pennebaker & O’Heeron, 1984). In contrast, people 
who disclosed to others about their spouses’ death did not experience as many intrusive 
thoughts about the death. 
Additionally, in line with research on autonomic suppression in GAD (e.g., 
Borkovec & Hu, 1990; Thayer et al., 2000), Pennebaker & Beall (1986) found that 
participants who wrote about a traumatic event displayed higher blood pressure and 
reported negative moods following the writing, but had fewer health visits in the long-
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term (i.e., six months later) than those who wrote about trivial topics. This finding runs 
somewhat parallel to Foa & Kozak’s (1986) theory of emotional processing, in which 
confrontation with the feared stimulus will result in initial fear activation followed by a 
decline in distress over time as emotional processing occurs.  
In their review, Sloan & Marx (2004a) comment on the various theories regarding 
the mechanisms of change in expressive writing. They highlight emotional processing 
theory (Foa & Kozak, 1986) as a likely explanation. Sloan & Marx (2004a) explain that 
repeated writing sessions may be one medium of exposure to threatening material and 
that the writing intervention may activate fear and provide corrective information thus 
altering the meaning about the stimuli. Sloan & Marx (2004a) suggest that writing may 
help people to overcome a tendency to avoid or suppress distressing thoughts and 
emotions, which has been put forth as a major maintaining factor in psychopathology 
(Hayes, Wilson, Gifford, Follette, & Strosahl, 1996), particularly GAD (Borkovec, 1994). 
Pennebaker (1997) also discusses that inhibition increases the “probability of stress-
related physical and psychological problems,” and that writing is a means to confr nt this 
inhibition (pp. 9-10). Further, expressive writing has been found to reduce anxiety, 
depression, fatigue, and tension in students who experienced a traumatic event 
(Schoutrop, Lange, Hanewald, Davidovich, & Saloman, 2002). This provides some 
preliminary evidence suggesting repeated writing about academic worries may reduce 




The expressive writing intervention fits nicely within the Borkovec conceptual 
model of worry, given that the nature of chronic worry in particular is seen as a form o  
inhibition or avoidance of confrontation with feared stimuli and emotional processing 
(see Borkovec, 1994). In addition to the emotional benefits of writing seen in numerous 
studies, many studies have shown that expressive writing leads to both reductions in 
visits to health services (e.g., Pennebaker, Colder, & Sharp, 1990) and grade 
improvement, which is particularly relevant when studying academic worry (e.g., 
Pennebaker & Francis, 1996). These data provide a compelling reason for studying he 
efficacy of expressive writing among those displaying pathological worry associated with 
academic performance.  
Further, from an experimental point of view, including expressive writing (which 
can be argued is a verbal/linguistic means of emotional processing) is a direct test of 
whether decreases in overall worry can be accounted for by repeated focus on the sphere 
of worry (in this case, academics) regardless of the type of focus (i.e., verbal s. image-
based), or whether imagery-based exposure to worry-provoking scenarios is necessary for 
anxiety reduction, as would be predicted by Borkovec’s model (1994).  Interestingly, 
Roemer & Borkovec’s (1994) study (see above) suggests that worry in its verbal form 
may habituate (i.e., without the use of imagery). 
Although Pennebaker & Chung (2006) recommend using an instructional set that 
allows participants to explore whatever topics may emerge when writing about a specific 
problem or event, participants in the current study were instructed to try to stay as close 
to the topic of academic worry as possible. However, in order to maintain the integrity of 
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the original paradigm as much as possible, participants were encouraged to explore this 
topic loosely, in whatever ways were relevant for them. The rationale for this 
instructional set was that, in order to most systematically compare these two theory-
driven approaches to emotional processing of pathological worry, confounding variables 
should be controlled. Thus, the best test of the relative efficacy of these approaches 
involves manipulating only one parameter (i.e., modality of exposure to stimuli). Sloan & 
Marx (2004) comment that the mixed findings in the expressive writing literature on 
changes in post-traumatic stress disorder (PTSD) symptoms may be due in part to the 
differences in the instructional set across studies (i.e., writing topics loosely defined vs. 
more concretely defined), but acknowledge that, while loosely defining the topicsmay 
work for many studies, researchers hoping to use expressive writing as a form of 
exposure argue convincingly that repeated exposure to the same stimulus is necesary for 
fear habituation (see Foa & Kozak, 1986).  
Finally, no GAD treatment study has compared active treatments for excessive 
and uncontrollable worry to a credible placebo.  Pulsed audio-photic stimulation (APS) 
has been used in our laboratory as a method for inducing dissociation (Leonard, Telch & 
Harrington, 1999; Leonard, Telch & Owen, 2000; Horowitz & Telch, 2008), and as a 
placebo control condition in specific and social phobia treatments (Powers, Smits & 
Telch, 2004; Smits, Powers & Telch, 2005; Wolitzky & Telch, in press). Interestingly, 
while placebo control groups are commonplace in pharmacological research, 
psychosocial treatment studies rarely test their active treatments against placebo. In a 
recent meta-analysis of specific phobias conducted in our laboratory (Wolitzky, 
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Horowitz, Powers, & Telch, in press), only five of the 35 studies included a placebo 
condition. Including the APS as a placebo control is important in controlling for 
expectancy effects. 
This study provides a preliminary test of these interventions by using a sample of 
participants who experience excessive and uncontrollable worry about academics, but 
may or may not meet criteria for GAD.  Since all participants in this study experienced 
their worry as excessive and uncontrollable, even those not meeting for GAD could be 
distinguished from typical non-GAD worry samples, and thus can be thought of as a sub-
clinical, or analogue-GAD sample. Because, after instruction, these interve ions lend 
themselves to being administered at home, this study also tested the efficacy o  these 
treatments as self-administered interventions. Demonstration of efficacy or these self-
administered interventions has important public health implications. 
2.2 Specific Aims and Hypotheses 
The current study has five specific aims: 
 
Aim I.  Test the efficacy of two self-administered interventions (i.e., worry exposure and 
expressive writing) in reducing academic worry in students with excessive and 
uncontrollable academic worry relative to a credible psychological placebo and wait-list 
control conditions.  
Hypothesis I: Both active interventions will outperform placebo, which in turn will in 
turn will outperform waitlisted participants. More specifically, those reciving active 
interventions will report greater reductions in duration of academic worry, distress and 
interference due to academic worry, as well overall score on the primary self- eport 
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measure of academic worry than those in the placebo and waitlist control groups. It is 
also hypothesized that those assigned to the active interventions will report greater 
reductions in general worry, depression, and stress. 
Aim II.  Examine the effects of the interventions on health outcomes including number of 
visits to the university student health center and perceived physical and mental health. 
Hypothesis II: In line with previous research, the expressive writing condition will show 
improved health outcomes relative to all other treatment conditions, which will not differ 
from each other. 
Aim III. Test the effects of the interventions on students’ grade point averages (GPA).
Hypothesis III:  Those receiving active interventions will show greater improvements in 
GPA and more hours of coursework completed compared to those assigned to the wait-
list or placebo control groups. 
Aim IV. Investigate potential moderators of treatment outcome including: number of 
home practice sessions completed, time during semester when intervention began, meta-
cognitions (e.g., degree to which participants endorse positive or negative beliefs about 
worry), GAD status, gender, ethnicity, educational status (i.e. undergraduate/graduate 
student), and major field of study. 
Hypothesis IV: It is predicted that: (a) consistent with previous research in CBT for 
anxiety disorders (Schmidt & Woolaway-Bickel, 2000), those who practice their 
intervention more will reduce their level of academic worry more than those who do not, 
(b) those who endorse more positive and negative beliefs about worry before starting the 
intervention will not benefit as much from the interventions as those who do not hold 
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dysfunctional beliefs about worry, (c) earlier randomization and intervention practice 
during the semester will be associated with more improved outcomes, while those who 
begin the study later in the semester will show less improvement (in line with research 
which would predict increases in anxiety or distress in the short-term and improvement in 
the longer-term for the EW and WE conditions), and (d) that those meeting diagnostic 
criteria for GAD will improve most from the worry exposure, as this intervention is 
specifically designed to facilitate emotional processing that, according to theory, may be 
essential for GAD symptom reduction.  
Because the use of expressive writing is exploratory for this population, no 
specific hypotheses are made regarding the moderating effects of GAD severity for those 
in the expressive writing condition. No specific predictions have been made regarding 
other potential moderating variables. 
Aim V. Investigate treatment process variables and potential mediators of treatment 
outcome for the worry exposure and expressive writing conditions. 
Hypothesis V: For the expressive writing condition, it is predicted that: (a) consistent 
with previous work, those who use a high number of positive emotion words, a moderate 
amount of negative emotion words, and an increase in cognitive processing words over 
time (see Pennebaker & Seagal, 1999) will benefit more than those who do not; (b) use of 
more self-referencing words in the expressive writing condition will predict poorer 
outcome, as use of self-referencing words (e.g., “I”) has been associated with depression 
(Rude, Gortner & Pennebaker, 2004; Mehl, 2004); (c) use of the past tense will be 
associated with less favorable outcome, while use of the future tense (i.e., worrying rather 
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than ruminating) will be associated with more favorable outcome; and (d) use ofsensory 
words (in essence, measuring use of imagery) during the writing sessions will be
associated with more favorable outcome (as would be expected with the Borkovec model 
for this population). Although exploratory, it is also hypothesized that use of more social 
words may be associated with greater improvement, as might be expected by those 
subscribing to a social integration explanation for the efficacy of expressive writing 
(Pennebaker, 2006, personal communication). 
It is expected that anxiety slopes across home sessions will decline for both the 
worry exposure and expressive writing conditions. Consistent with the emotional 
processing theory of fear (Foa & Kozak, 1986), greater improvement at post-treatment 









Chapter 3. Research Design and Methods 
3.1 Study Participants      
Study participants (N=113) were recruited through announcements made to the 
University of Texas Counseling and Mental Health Center, university-based academi  
enrichment and mentoring programs, and academically-oriented Greek organizations. 
Administrators from a variety of departments sent email announcements to students and 
research assistants made verbal announcements in lecture hall classrooms. These email 
announcements and classroom visits permitted access to a wide range of departments and 
colleges, including, but not limited to engineering, natural sciences, liberal arts, public 
health, law, business, and nursing. Advertisements were printed in the Daily Texan 
newspaper, and recruitment flyers were posted around the University of Texas, St. 
Edwards University, and Concordia University campuses. In addition, an announcement 
was also made on our laboratory website.  
A total of 545 students expressed interest after hearing about the study. After 
receiving further information, 178 of those students completed the online screening 
questionnaire (the Academic Worry Questionnaire). 159 of those 178 students were 
deemed eligible for the face-to-face laboratory assessment based on their lin  
screening questionnaire scores. Of those 159 students invited to the laboratory, 130 
completed the comprehensive pre-treatment assessment. 117 of those participants met 
criteria for the treatment phase of the study. However, four of these participan s declined 
further participation. Thus, a total of 113 participants were enrolled in the study and 
randomized to one of the four treatment conditions. 84 participants completed treatment. 
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Of the 29 participants who did not complete the treatment phase of the study, eight were 
willing to complete a post-treatment assessment anyway. 17 participants who completed 
the post-treatment assessment (9 treatment completers and 8 non-completers, not 
including those in WLC, who did not complete a follow-up) did not complete their three-
month follow-up assessment. 
The final group of participants enrolled and randomized (N=113) was primarily 
female (75.2%) and undergraduate (85%). Majors and areas of study spanned a wide 
array of fields, with 21.3% natural sciences, 18.5% health sciences, 15.7% liberal arts, 
13% business, 12% engineering, 6.5% law school, 3.7% school of public policy, 2.8% 
social sciences, 2.8% undeclared, 1.9% with a double major in public policy and liberal 
arts, 0.9% double majoring in a natural science and a liberal art, and 0.9% with a double 
major in the social sciences and liberal arts. The sample represented a diverse ethnic 
group, consisting of 45.1% Caucasian, 24.8% Asian-American, 16.8% Hispanic, 3.5% 
African-American, 8% biracial or multiracial, 0.9% Native American, and 0.9% Pacific 
Islander.  
Slightly less than one-third of the sample (31.2%) met full DSM-IV criteria for a 
current diagnosis of GAD. That percentage rose to 40.4% when considering the number 
of participants who met for GAD at some point within the last year. Participants also met 
criteria for a number of current comorbid psychiatric diagnoses. Eleven percent of 
participants met diagnostic criteria for major depressive disorder, 1.8% met for 
dysthymia, 0.9% met criteria for bipolar disorder, 18.3% met for social anxiety disorder, 
11% met for specific phobia, 5.5% met for panic disorder, 3.7% met for obsessive 
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compulsive disorder, 0.9% met for post-traumatic stress disorder, 4.6% met for a 
substance use disorder, and 0.9% met diagnostic criteria for an eating disorder.  
3.1.1 Inclusion and Exclusion Criteria 
Inclusion and exclusion criteria were as follows: 
Inclusion Criteria 
a. Score of a 2 or higher on the distress question (Q5) OR the life interference 
question (Q9) on the Academic Worry Questionnaire (AWQ), indicating at least a 
moderate level of distress and/or life impairment due to academic worry. 
b. Fluent in English (written and spoken). This was required because several of the 
instruments are validated only in English and principal investigator and research 
assistants were not fluent in other languages. 
c. 18 years of age or older 
d. Enrolled in a college, university, or graduate education training program. 
Exclusion Criteria 
a. Currently taking psychotropic medication and unwilling to stay on the same dose 
during the treatment phase of the study (from assessment date until post-treatment 
date).  
b. Planning to start or terminate psychotherapy for worry, stress, or anxiety and 
unwilling to wait until after the post-treatment assessment. 
c. History of seizure disorder (due to slight increased risk of seizure during pulsed 
audio-photic stimulation for those with a history of seizure disorder). 
3.1.3 Procedure for Obtaining Informed Consent 
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Prior to undergoing the face-to-face screening phase, all participants provided 
written informed consent. Those who met criteria for the intervention were invited to 
participate in the next phase of the study. Written informed consent was obtained befor 
the intervention phase began.                                                                                                             
3. 2 Measures 
3.2.1 Diagnostic Assessment 
Composite International Diagnostic Interview (CIDI, World Health Organization, 
1997). Assessment of DSM-IV diagnoses of GAD and other Axis I disorders were 
conducted using the computerized version of the CIDI-Auto (World Health organization, 
1997). The CIDI-Auto has been widely used for the assessment of DSM-IV diagnoses. 
The anxiety disorder module has demonstrated good psychometric properties including 
good sensitivity (.86) and acceptable specificity (.52). Moreover, the agreement between 
the clinical standard diagnosis and the CIDI-Auto was acceptable (73%) and similar to 
the clinician-administered version of the CIDI (Peters & Andrews, 1995). The CIDI has 
been used in several anxiety disorder clinical trials (e.g. Powers et al., 2004; Roy-Byrne, 
Katon, Cowley, & Russo, 2001; Roy-Byrne, Craske, Stein, Sullivan, Bystrisky, Katon, et 
al, 2005; Smits, Powers, Buxkamper, & Telch, 2006).  
It should be noted that although this was a computerized diagnostic assessment, 
trained interviewers conducted the assessment, rather than instructing participants to 
answer the questions presented on the computer. A comprehensive diagnostic assessment 
was conducted using the CIDI at the pre-intervention assessment. The GAD module of 
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the CIDI was also administered either via telephone or in person at the three-month 
follow-up assessment. 
3.2.2 Screening and Outcome Measures  
3.2.2.1 Primary Outcome Measures 
Academic Worry Questionnaire (AWQ; Wolitzky & Telch). This 10-item 
questionnaire assesses several domains of academic worry. Participants rated on  5-point 
scale the degree to which they have experienced these different characteristics of worry 
in the past week. Domains include frequency of worry episodes, overall duration of 
worry per week, distress associated with worrying, anxiety experienced during worry 
episodes, negative beliefs about worry, positive beliefs about worry, controllability of 
worry, impairment due to academic worry, and use of safety behaviors to cope with 
academic worry (e.g., overpreparing for exams, arriving extremely ear  for class). This 
measure demonstrates good internal consistency (Cronbach’s α=.87) and test-retest 
reliability (r = .83), as well as convergent and discriminant validity.  
Penn State Worry Questionnaire (PSWQ; Meyer, Miller & Metzger, 1990). This 16-
item questionnaire uses a 5-point Likert scale. Participants rated how typical each 
statement was for them. Statements rated tap into frequency and controllabili y of worry, 
as well as general propensity to worry. Items include statements such a  “I am always 
worrying about something,” “My worries overwhelm me,” and “Once I start worrying I 
can’t stop.” This measure shows good internal consistency, as well as convergent and 
discriminant validity (Brown, Antony & Barlow, 1992). 
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Health Care Utilization.  The number of medical visits was obtained from student 
health records as a measure of health outcome and medical utilization (with written
permission of the participant via informed consent). Additionally, participants who 
reported seeing medical professionals in the community were given the option t s g a 
separate release form to release this same information from a community doctor to the 
specified research staff in the laboratory (e.g., the Principal Investigator, Principal 
Investigator’s advisor, or PI and specified research assistants). This information was 
collected for the semester prior to participation, the semester of partici tion, and the 
semester after participation.  
Semester grades. Overall GPA and credit hours completed were obtained from the 
registrar with written permission of the participant via informed consent. This 
information was collected for the semester prior to participation, the semester of 
participation, and the semester after participation. No information about specific classes 
was obtained. 
3.2.2.2 Secondary Outcome Measures 
Perceived Stress Scale (PSS; Cohen, Kamarck & Mermelstein, 1983). This 10-item 
questionnaire uses a 5-point scale. The PSS is a widely used psychological instrume t for 
measuring the perception of stress. It measures the degree to which participants a praise 
life situations as stressful. Items were designed to tap how unpredictable, uncontrollable, 
and overloaded people find their lives to be. The scale also includes a number of direct 
queries about current levels of experienced stress. The PSS demonstrates good internal 
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consistency (Cronbach’s α=.86), good test-retest reliability, r = .85, and correlated highly 
with measures of physical symptomology and health care utilization. 
Beck Depression Inventory-II (BDI-II; Beck, 1996). This 21-item questionnaire uses a 
4-point scale. The measure taps various domains of depression, including emotional 
symptoms (e.g. feelings of sadness, pessimism, feelings of worthlessness) a d vegetative 
symptoms (e.g. fatigue, sleep changes, eating changes). This measure demonstrates good 
internal consistency, with a Cronbach’s α=.89 (Whisman, Perez, & Ramel, 2000). 
SF-36 (Ware & Sherbourne, 1992). This widely used 36-item instrument asks 
participants to report their perceptions of their own physical and mental health on a 5-
point Likert scale. The first section asks participants to rate their physical health and 
degree to which they may have difficulty completing physical tasks such as vigorous 
exercise or climbing stairs. The second part of the questionnaire asks participants to rate 
their psychological well-being asking questions such as “How much of the time during 
the past 4 weeks did you feel worn out?” and “How much of the time during the past 4 
weeks have you felt happy?” Participants rate their levels of physical and mental 
functioning with higher scores associated with better health. The SF-36 shows good 
internal consistency (.85; Brazier, Harper, Jones, O’Cathain, Thomas, Usherwood & 
Westlake, 1992).  
Cortisol Levels. A large body of evidence suggests that psychological stressors can 
activate the HPA axis, which regulates the release of cortisol, a hormone implicated in 
psychological and physical health (see Dickerson & Kemeny, 2004, for reviews). 
Prolonged cortisol activation, presumably caused by repeated exposure to psychological 
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stressors, has been linked to immunosuppression and development of chronic physical 
diseases (e.g. Boomershine, Wang & Zwilling, 2001) and psychopathology (e.g. Brown
& Suppes, 1998). In their meta-analysis, Dickerson & Kemeny (2004) found that 
perceived uncontrollability was associated with higher levels of cortisol elease. In 
addition, an interesting study revealed that cortisol levels upon waking were higher on 
weekdays than weekends, and that this difference was significantly more apparnt for 
those who reported chronic levels of work overload and worrying (Schlotz, Hellhammer, 
Schultz, & Stone, 2004).  
Given these above findings, investigating potential pre to post cortisol changes after 
treatment may be an important physiological index of treatment efficacy. Participants 
were given a cotton swab to collect a saliva sample at pre-treatment (before 
randomization) and at the post-treatment assessment. Participants were brought int  the 
laboratory at the same time of day (within two hours) for the two assessments to hance 
consistency and accuracy of the analysis, as cortisol release varies throughout the day. 
Samples were stored in a freezer. A laboratory in Washington analyzed samples for tho e 
participants who completed both pre and post-treatment assays. Cortisol levels in th  
saliva samples were measured in nano moles (nM). 
3.2.3 Treatment Credibility and Treatment Fidelity 
Reaction to Treatment Questionnaire (RTQ; Borkovec & Nau, 1972). This 
questionnaire, given before the instructional intervention session begins, asks four 
questions regarding how logical and credible the intervention seems to the participant. On 
a 0 to 100 scale, participants are asked, “At this point, how logical does the intervention 
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offered to you seem?”  “At this point how successful do you think the intervention will be 
in reducing your worry about school?” “How confident would you be in recommending 
this intervention program to a friend who experiences similar problems?” and “By the 
end of the intervention period, how much improvement in your academic worry do you 
think will occur?” This questionnaire served to evaluate whether all three interve tion 
conditions (i.e., worry exposure, expressive writing, and audio-photic stimulation) 
seemed equally credible to the participants. Although the original Borkovec & Nau 
(1972) scale uses a 0-9 point scale, the scale was modified to 0-100 in the current study. 
Assessment of Treatment Activities (ATA). Participants completed a two-part, 
author-constructed questionnaire measuring treatment fidelity. In Part A, participants 
answered basic Yes/No questions about what they did during treatment, such as “I 
listened to a tape,” or “I wrote about my academic worries.” Part B asked participants to 
rate on an 11-point Likert scale (0-10) how much they agreed with statements abou  their 
treatment activities, such as “I expressed my innermost thoughts and feelings about 
academic worry-related topics” and “I focused on worry-related images during my home 
practice of my intervention.”  
Some of the items refer to the degree to which the participants were able to 
engage in behaviors that were important to the integrity of the treatment condition (e.g., 
the degree to which participants used imagery in the worry exposure condition), while 
others refer to the degree to which the treatment exerted its expected and desired impact 
on participants (e.g., degree to which participants were distracted by the placebo device). 
Overall, the measure is meant to provide a general picture of both of these concepts. 
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3.2.4 Assessment of Putative Moderators of Treatment Outcome 
Meta-Cognitions Questionnaire-30 (MCQ-30; Wells & Cartwright, 2004). This 
questionnaire was created from the original MCQ which had 65 items. This consolidated 
questionnaire taps the same constructs of dysfunctional thoughts about worry with 30 
items and uses a 4-point Likert scale. The measure assesses positive and negative b liefs 
associated with worry. The questionnaire is divided into five factors: (a) positive beliefs 
about worry; (b) beliefs about the uncontrollability and danger of worry; (c) concerns 
about memory and cognitive confidence; (d) beliefs about the need to control thoughts 
and worries; and (e) cognitive self-consciousness, or general “worry about worry.” The 
Cronbach’s α for each factor ranges from .72-.89, and the test-retest reliability for each 
factor ranges from .76-.94, suggesting it is a reliable measure. This measure also 
demonstrates concurrent and predictive validity. This measure was administered once 
during the pre-intervention assessment. 
Online diagnostic interview for GAD (Telch & Lee, 2005). In order to explore the 
feasibility of obtaining diagnostic information through web-based, self-administered 
diagnostic interviews, an online diagnostic interview for GAD on our laboratory website 
was administered at pre-treatment and at the 3-month follow-up assessment. GAD status 
at baseline was assessed as a treatment moderator. Cases in which there was a 
discrepancy between the CIDI-Auto and the GAD online interview diagnoses was 
resolved through a careful diagnostic assessment conducted by the PI and confirmati  of 
this diagnosis by the PI’s mentor.  
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Dropout/completer status. Participants were considered completers if they 
completed at least one-third of the prescribed treatment sessions plus a post-treatment 
assessment.  
3.2.5 Intervention Process Measures 
 Treatment process measures were obtained through an online record system that 
participants completed after each home practice. Each online record asked questions tha  
pertained specifically to the individual interventions. However, a measure of peak anxiety 
was obtained for all conditions. Data gathered from these online records were used not 
only for treatment process analyses but also as additional checks on treatment fidelity. A 
description of each online record log is provided below. 
Worry Exposure Home Practice Log. Participants completed a brief self-
monitoring form online after each home practice worry exposure. The form instructed the 
participants to record the start and stop time of the worry exposure, rate their peak 
anxiety during the worry exposure, rate how much they were able to engage in imagery, 
describe in a few sentences the content of the worry, rate how much they were able to 
stay on the worry topic, and rate how much they were able to concentrate on the worry 
scenario. All ratings were done on a 0-100 scale, with 0 being no anxiety/no 
imagery/unable to stay on topic/completely distracted and 100 being extreme 
anxiety/total use of imagery/completely able to stay on topic/complete conc ntration. In 
keeping with the worry exposure self-monitoring form proposed by Brown, O’Leary & 
Barlow (2001) in their description of worry exposure implementation, participants were 
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then asked to describe alternative outcomes for the worry scenario in a few sent nces.  
The Worry Exposure Daily Log was used only for the worry exposure group. 
Expressive Writing Home Practice Log. Participants completed a brief self-
monitoring form online after each home practice expressive writing session. This online 
record of expressive writing home practice was similar to the Worry Exposure Daily Log, 
but was more relevant to the specific intervention. Participants recorded the start and stop 
time of expressive writing, rated their peak anxiety during the expressive wr ting, rated 
how much they were able to stay on the topic of academic concerns, and rated how much 
they distracted themselves or were not able to concentrate on the topic during the 
expressive writing. Participants were also asked to rate how much they felt they were 
able to express their innermost thoughts and feelings during the expressive writing 
session. All ratings were done on the 0-100 scale described above. 
APS Home Practice Log. Participants in the APS (placebo) condition completed 
an online log of their APS use after each home session. Participants recorded start and 
stop time of their use of the APS that day. They then rated their peak anxiety during the 
administration of the APS, how much they were able to relax during the use of the APS, 
and how much they concentrated on an academic worry during the use of the APS, and 
how much they believed the APS distracted them from their worries during that session. 
All ratings were the 0-100 scale.  
Linguistic Inquiry Word Count (LIWC; Pennebaker, Francis, & Booth, 2001). A 
software program (LIWC) was used to assess potential mediators in the expressive 
writing condition. The program is composed of a set of words, phrases and parts of 
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speech made of 2,300 words grouped into over 70 linguistic dimensions, including 
standard language categories (e.g., articles, prepositions, pronouns), psychological 
processes (e.g., emotion words), relativity-related words (e.g., time, verb tense), and 
traditional content dimensions (e.g., sex, death). The program was run on numerous 
essays containing over 8 million words. The original categories that had very low 
reliability, consistency, or that were identified at very low rates were eliminated (less 
than 0.3% of the original categories). Francis & Pennebaker (1993) reported that the
categories of emotions, a number of cognitive strategies, several thematic contents, and 
various language composition elements showed appropriate external validity.  
3.3 Procedure 
Figure 1 shows the flow of participants through the study.  
Figure 1. Participant Flow Through the Study 
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Intervention Training and Practice in Laboratory 
 
4 weeks of treatment at home, 3 x week 
 
Post-treatment assessment (online and cortisol in lab) 
 
3-month follow-up assessment (online and brief phone or face-to-face interview) 
3.3.1 Procedures for Screening, Informed Consent, and Assessments 
Participants who contacted the laboratory were instructed to complete the AWQ 
online as a screening measure. Those who reported at least moderate impairment or 
distress due to academic worry (i.e., scores of 2 or higher on items 5 or 9) were invit d to 
come to the laboratory for a pre-intervention face-to-face interview. After signing 
informed consent, participants completed a full CIDI assessment and the pre-interv ntion 
assessments, which included the AWQ, MCQ-30, SF-36, BDI-II, PSS, PSWQ, and the 
online GAD interview. These screening assessments were used as pre-intervention scores 
for the participants who met criteria and continued with the intervention phase of the 
study.   
Participants who continued with the intervention phase of the study signed 
informed consent again and were provided a thorough description of the study as part of 
the informed consent procedure. Before randomization, participants provided a saliva 
sample, which was put in a freezer and later sent to be analyzed for cortisol levels. 
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Participants were then randomized to one of four treatment conditions: (a) worry 
exposure (WE), (b) expressive writing (EW), (c) audio-photic stimulation (APS), or (d) 
wait list control condition (WLC). Randomization was conducted by using a random 
sequence table generated on the internet. After randomization, participants in each 
condition underwent a 30-40 minute training session in order to ensure that participants 
could effectively implement their respective interventions at home. These instructional 
sessions varied slightly depending on the condition (see below for details). Participants 
were instructed to use their respective interventions at least three times per week at home, 
either when they were experiencing academic-related worry, when they wer  about to 
study, or any other time they wished. They were also instructed to complete online record 
forms after any use of the intervention at home (details of these online record forms are 
described in the Measures section). 
Participants were instructed to continue practicing their interventions for one 
month. They completed an online questionnaire (AWQ) once a week and completed a 
more comprehensive assessment battery (see Measures) at the end of the 4th week. 
Participants were asked to return to the lab for a short visit, in which they returned any 
items borrowed from the lab (e.g., tape player for worry exposure, APS device), 
completed the treatment fidelity questionnaire, and gave a post-treatment saliva sample. 
Participants (except those who were assigned to the WLC condition) were then asked to 
complete a 3-month follow-up online assessment battery, consisting of questionnaires 
and the online GAD interview, as well as a phone or face-to-face interview, consisting of 
the GAD module of the CIDI.   
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The large majority of participants chose to come to the lab for their 3-month 
follow-up CIDI, at which point they received their $30 financial compensation. In the 
few cases in which only a telephone assessment was possible, the financial compensation 
was mailed to the participants. Participants in the WLC condition were offered worry 
exposure at post-treatment and thus did not complete a follow-up assessment. They were 
provided with compensation at the post-treatment assessment. 
3.3.2 Treatment Conditions 
A brief description of each treatment rationale and protocol follows: 
Worry exposure.  The worry exposure protocol used in this study was based on 
the protocol proposed by Brown, O’Leary & Barlow (2001), which is also outlined in a 
treatment manual by Rygh & Sanderson (2004). Worry exposure consists of having the 
participant actively engage in worrying about a specific target concern for a specific 
amount of time, using imagery instead of verbal forms of worry. First, the rationale for 
worry exposure was provided to participants in this condition (see Manualized Protocol 
for exact wording, as described in lay terms).  
Namely, worrying over and over with a very specific image in mind will lead to 
habituation of distress or anxiety associated with the worry scenario, such that t at the 
participant no longer associates distress with the previously troublesome thoughts, r is 
no longer distressed by “worrying” about the particular scenarios.  
Many people with pathological worry often do not focus on one topic while 
worrying, which may explain why their normal worry does not habituate. Further, 
worriers often worry to avoid more intense anxiety and anxiety-provoking images 
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(Borkovec et al., 1993; Borkovec, 1994). One way worriers accomplish this avoidance is 
by worrying through verbal means in order to avoid distressing images of negative 
outcomes (Borkovec & Lyonsfield, 1993; Langlois et al., 2000). Worry exposure requires 
that participants focus on images rather than verbal means of worrying. Participants were 
informed that it is to be expected that their anxiety may increase a bit at first, as they are 
now confronting images they often avoid through verbal means of worrying.   
Although not proposed by in the original conceptualization of worry exposure, 
there may be other mechanisms of change at work. Simply by setting aside a specific 
time and way in which to “worry,” worry exposure may reduce the uncontrollability of 
pathological worry by imposing stop/start rules on worry time. In addition, simply the act 
of worrying on purpose (and under the prescription of experts) may send messages 
directly to the brain that there is nothing dangerous about worrying, addressing the 
characteristic “worry about worry,” or negative beliefs about worry, often seen in GAD. 
This theory is in line with research suggesting that simply engaging in specific actions 
may directly affect emotion without higher-order cognitive processing (e.g., Dimberg, 
1988; Wolitzky & Telch, in press).  
Participants received the following worry exposure training: 
1. Imagery training by guided instruction to imagine pleasant scenes (e.g., 
walking on the beach). (approx. 5-7 minutes) 
2. Construction of a list of approximately five worry-provoking images relating to 
school (e.g. failing a test, forgetting to turn in a paper, getting an F in a class). The list 
was constructed by the therapist and participant, and created in a hierarchy such that less 
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distressing images were at the beginning. Participants were taught the subjective units of 
distress scale (SUDS) and were instructed that the least distressing image should fall in 
the 40-60 range, on a 0-100 scale. 
3. Beginning with the first image on the list, the participant was instructed to 
worry out loud into a tape recorder about each school-related concern for approximately 
five minutes per image. Participants were told to focus on the image and to use as much 
detail as possible about the situation, including sensory experiences (e.g. “My teacher is 
telling me I failed a test and my hands are getting clammy and my stomach is in knots”). 
Participants described each worry image (using the present tense) for approximately five 
minutes. If participants had difficulty describing the worry scenario in this manner, the 
tape was stopped, the therapist coached the participant, and that worry scenario was 
repeated in an improved manner into the tape. 
4. After 25-30 minutes of taping the worry exposure stimuli, participants were 
told to take the tape home. They were instructed to listen to one worry image on the tape 
over and over for approximately 25-30 minutes at least three times a week, beginning 
with the first worry image. They were told to move onto the next worry on the tape only 
after they could rate their distress as relatively low for the preceding worry image (30 or 
below on a scale from 0-100, 0 = no distress, 100 = extreme distress). Participants were 
also encouraged to avoid distraction as much as possible and were encouraged to focus 
on the description of the scenario using as much imagery as possible. Finally, participants 
were told that once they habituated to all five of the worry scenarios they described on 
the tape during the weeks of home practice, that they could use the tools they learned to 
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either make a new tape of worry images, or try the same techniques without using a taped 
recording for any remaining time in the acute treatment phase of the study.  
5. Participants were provided with the laboratory phone number and the email 
address of the PI and the research assistant who would be monitoring their compliance. 
Participants were told they could contact either the PI or the research assistant in case 
they had any questions about the protocol during the month of home practice. Participants 
were also given a Walkman-type tape player to borrow from the lab. 
6. After each home practice worry exposure, participants accessed the online 
system in order to complete a Worry Exposure Log (see “Measures”), which took no 
more than 5-10 minutes per worry exposure. Before leaving the laboratory instructional 
session, participants were given instructions for accessing the necessary online forms, 
including the online testing system through the Laboratory for the Study of Anxiety 
disorders.  
Expressive writing. Participants were provided with the rationale for expressive 
writing, as outlined by Pennebaker and colleagues (see Manualized protocol for exact 
wording in lay terms). In other words, participants were told that writing about a specific 
topic (in this case, academic concern and worries) can lead to positive psychological and 
physical health outcomes. Pennebaker and colleagues have consistently found that 
writing about a traumatic event leads to improved health and well-being outcomes (see 
Smyth 1998; Frisina et al., 2004; and Frattaroli, 2006, for reviews). This is the first study 
to explore the possibility that writing about worries may alleviate symptoms of 
pathological worry, and may also lead to improved health outcomes. Repeated exposure 
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to academic worries (in this case in its verbal form) may result in habituation of anxiety 
or distress associated with worry. The protocol for expressive writing was as follows: 
1. Participants were instructed to write, in as much detail as possible, about their 
academic worry for 20 minutes per session at least three times per week. Participants 
were encouraged to explore their deepest thoughts and feelings regarding their acad mic 
worries, concerns, pressures, and demands. While they were instructed to stay on the 
same topic of worry as much as possible, it was emphasized that this topic could be 
defined loosely, and differently for each individual. Examples of academic worries that 
spanned a wide range of possibilities were given to participants, from the more obvious 
(e.g., failing an exam) to the more exploratory (e.g., the pressures of parental 
expectations). 
2. Training in the laboratory included setting up the participant to write through 
the online expressive writing system and to complete the online Expressive Writing Log 
through the online system. Participants were also given directions for accessing the 
Laboratory for the Study of Anxiety Disorders’ online testing system in order to complete 
the questionnaire batteries. 
3. In order to make sure all conditions received the same amount of in-session 
contact with researchers, participants in the expressive writing condition spent the 
remainder of time (approximately 20 minutes) practicing the expressive writing in-
session, by logging onto the writing system online and completing one writing entry. 
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4. Participants were instructed to complete 20-minute writing sessions at home at 
least three times a week, and were told to complete the expressive writing record online 
after each expressive writing home session.  
Credible Placebo Control; Pulsed Audio-Photic Stimulation (APS). Our 
laboratory group has considerable experience with pulsed audio-photic stimulation as a 
credible placebo treatment for specific phobia and social phobia. In four independent 
investigations, (Powers et al., in press; Powers et al, 2004; Smits et al, 2005; Wolitzky & 
Telch, in press), participants assigned to one 30–min. APS treatment displayed significant 
improvement in subjective and behavioral indices of phobic symptoms. The APS device 
flashes lights through goggles and makes a metronome-like noise through headphones at 
12 Hz. The creator of the APS devices (Dave Seiver, Mind Alive, Inc.), asserts that 
audio-photic stimulation reduces anxiety and depression by altering brain wave activity. 
Participants in the APS condition were provided with the following rationale: 
Recent evidence suggests that phobia-related thoughts and emotions are 
stored in the brain and that different emotional states have patterns of brain wave 
activity associated with them. Since the 1920s researchers and clinicians have 
written about how flickering light at certain frequencies can alter brain wave 
activity and reduce anxiety. This procedure of introducing pulsed flickering lights 
into the visual field and pulsed audio tones into the auditory system has been 
called brainwave entrainment (BWE) or more commonly today “Audio Visual 
Entrainment” (AVE). Some clinical studies suggest that AVE may be beneficial in 
the treatment of anxiety, phobias, and stress-related problems.  
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The device will deliver pulsed light through these goggles and pulsed 
tones through these headphones at a special frequency designed to induce a 
pattern of brain wave activity called alpha that is associated with deep states of 
relaxation and meditation. During the procedure, it is important that you keep 
your eyes closed and focus only on the lights and sounds. For the procedure to 
have maximum benefit, it is important that you keep your mind free of any 
thoughts and focus only on the flickering lights and pulsing sounds. If you find 
your mind wandering, focus your attention back to the pulsing lights and sounds.  
1. Participants were instructed to self-administer APS at least three tim s per 
week. The session was pre-programmed to administer 25-minute sessions. Participants 
were instructed to complete the 25-min pre-programmed session every time they used the 
device. The device automatically turned off when the session was completed. If 
participants needed to end a session early, there was an option on the device to end the 
session at any time, in which case the device skipped to the final 2-min of the program 
and then turned off. Participants in this condition were told that the APS would be most 
effective in relaxing them when they were about to study or while experiencing a worry 
episode, but that they could use it at other times if they wished. 
2. Participants were instructed to complete the online record of APS use following 
every home session. 
3.  In order to make sure all conditions received the same amount of in-session 
contact with researchers, participants in the APS condition spent the remainder of time 
(approximately 20 minutes) using the APS in-session. 
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Wait list control. Participants in the wait list control group completed the pre and 
post-treatment assessments and did not receive any intervention until the post-
intervention assessment was completed at the end of the 4th week of the intervention. 
After that assessment, participants in the wait-list control condition had the opportunity to 
come in for a 30-minute session in which they created a worry exposure tape to take 
home for home practice. No assessments were conducted on this group after the post-
treatment assessment. Participants in this condition received financial compensation upon 
completion of the post-treatment assessment. 
3.3.3 Treatment Adherence 
 Participants were given typed and verbal instructions before leaving the 
laboratory session outlining how to log onto their daily home practice online records. 
Participants were reminded that they should complete these records after each use of the 
intervention. 
 When participants logged onto the online system to complete their records of 
home practice, they were automatically reminded to complete their home practice at least 
three times per week. Those in the expressive writing condition logged onto the same 
system to do both their home practice writing intervention and the home practice record.
The computerized program was designed such that every time participants completed 
their online records (and writing sessions, in the case of the expressive writng condition), 
the data were sent directly to a private folder for the principal investigator as a text 
document. In the case of the expressive writing condition, the entire written en ry was 
also available, in addition to the responses on the record of home practice. The PI 
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checked regularly to ensure that participants were completing their home practice. If a 
participant was not completing the home practice records, the PI instructed a research 
assistant to contact the participant through email or phone to remind the participant to 
complete the home practice three times per week. Research assistants were also assigned 
to track the compliance of specific participants as an additional check, and were 
instructed to send reminder emails as needed. 
In addition, adherence was monitored for those receiving the placebo control 
(APS) through the device’s program itself. More specifically, the device was 
programmed for a certain number of sessions. Each time a session was completed, the 
number of sessions remaining was reduced by one. Thus, in addition to the online data 
gathered, monitoring of number of home sessions completed was as simple as recording 
how many sessions were left when the participant returned the device at the end of the 
one-month intervention phase of the study (there is a feature in which researchers can 
obtain the number of sessions remaining when the device is returned). 
 In order to increase compliance with online measures completed at home, 
research assistants also used an excel spreadsheet tracking system to ke p track of when 
participants should complete their measures (the AWQ weekly and the post and 3-month 
follow-up batteries of questionnaires) and sent email reminders to complete the masures 
when they were due. 
 Finally, participants who contacted researchers stating they wished to discontinue 
the study received one follow-up email stating they may discontinue if they wish, but that 
they are encouraged to finish the study. Any particular questions or issues that arose for 
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the individual were addressed in that email. For example, some participants forgo  that 
they may experience a slight increase in anxiety at the beginning of worry exposure and 
decided the treatment was not working and wanted to stop. If participants expressd thi  
in their email, education was provided, reminding them about initial fear activation and 
normalizing their experience. These encouragement emails often gave participants 
additional motivation to complete the study. Participants who wished to discontinue after 
the encouragement email was sent were no longer contacted unless they agreed to 
complete their online post-treatment and follow-up questionnaire batteries for the intent-
to-treat (ITT) analyses (see Statistical Analyses section).   
3.3.4 Treatment Integrity 
In order to assure the greatest possible treatment integrity, assessments and 
treatments were manualized and administered by trained experimenters. 
Manualized Protocol. The protocol (see Appendix A) describes each step for all 
assessments and treatment training. Scripts were provided throughout the manual to be 
read aloud by experimenters.    
Experimenter Training. The training of experimenters involved (a) didactic 
orientation to the project provided by the PI; (b) observation of assessment and treatment 
procedures; (c) role-plays of procedures with trained experimenters; and (d) conducting 
of assessments with the direct supervision of the PI once training steps (a)-(c) were 
successfully completed. Experimenters were observed and monitored, and were provid d 
with additional training as needed throughout the process. Experimenters were not 
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Chapter 4. Statistical Analyses 
4.1 Statistical Power Considerations 
The following steps were taken in order to ensure that statistical power was 
maximized in this study (≥ .70): 
• Recruited a large sample size (initially proposed N = 100, actually 
recruited N = 113) for a 4-cell study assuming a moderate effect siz (d = 
0.50). Power analysis assuming this effect size, set at alpha = .05 would 
require n = 25 per cell (Cohen, 1977; Howell, 2002). 
• Assigned fewer participants to the waitlist control condition than the 
intervention conditions, as it was expected that fewer participants were 
needed to detect differences between intervention and waitlist than were 
needed to detect differences between different interventions.  
• When appropriate, pre-intervention scores were used as covariates to 
maximize power (see Stevens, 1992). 
4.2 Attrition 
 
4.2.1. Sample Breakdown and Definition of Completer and Dropout 
 
Based on pilot testing, it was expected that approximately 20% of participants 
randomized and trained to implement an intervention at home would drop out of the 
study (i.e., would complete fewer than one-third of the recommended home practices). 
Thus, it was expected at the time of proposal that there would be 80 completers in the 
sample and 20 dropouts. Due to the nature of the study, in which we are investigating the 
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potential for these interventions to be successfully implemented at home, attrition data 
were considered important in and of itself.  
Because the dose of treatment (3 x week for one month, for a total of 12 sessions) 
was highly recommended but not required (i.e., participants were not dropped from the 
study if they did not complete all treatment sessions), participants were considered 
treatment drop-outs if they completed fewer than one-third of the recommended 
treatment sessions (0-3 home practices) and were considered completers if they 
completed four or more home practice sessions.  
This allowed the distinction between completers and dropouts to be standardized, 
rather than relying on participants’ report of whether they completed treatment or not. For 
example, pilot testing revealed that some participants contacted the research rs before 
doing any home practices stating they wished to discontinue the study, and others 
contacted the researchers after completing nine or ten treatments sayi g they could not 
complete the study. Thus, relying on participants reporting they would like to “drop-out” 
yielded inconsistencies in categorization. Further, other participants did not co tact the 
lab to withdraw; rather, they ceased contact with researchers and stopped completing 
their home practices at varying times during their participation. It is important to note that 
number of home practice sessions was examined as a potential moderator of treatmen  
outcome. 
4.2.2 Intent-to-treat Analyses 
Separate analyses were conducted on the completers’ sample and intent-to-tr at 
(ITT) samples (i.e., all participants who were randomized). Any differencs in findings 
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between these two groups might suggest interesting treatment implementation and 
feasibility implications. In the case that participants did not complete a particul  
assessment, ITT scores were entered. However, if participants were cat gorized as 
dropouts but were willing to complete the online assessments at the appropriate post-
treatment and follow-up dates, these available scores were used to index treatment 
outcome4. As is good practice in conducting randomized clinical trials, two different 
types of ITT analyses were conducted: ITT-Liberal (ITT-L) and ITT-Conservative (ITT-
C). At post-treatment, all measures except for the AWQ had only one type of ITT sample, 
with baseline scores used as the dependent variable for those who did not complete the 
post-treatment assessment. Because participants completed the AWQ throughout 
treatment, outcome analyses were conducted for both the liberal ITT sample (ITT-L) and 
conservative ITT sample (ITT-C). ITT-L carried the last obtained AWQ score forward, 
while ITT-C carried the AWQ baseline score forward as the post-treatment score for 
those who did not complete the post-treatment assessment. ITT statistics are report d if 
they differed from their completers sample counterparts.  
At follow-up, the procedure for conducting ITT analyses was identical to that of the 
post-treatment analyses with one exception: now all measures include an ITT-L (last 
score obtained used as the follow-up dependent variable if no follow-up assessment 
completed) and an ITT-C (baseline score used as the follow-up dependent variable if no 
follow-up assessment was available).  
4.2.3 Treatment Completion and Attrition Analyses 
                                                                
4 Although the actual scores were entered, it is important to note these participants were still only 
analyzed with the other dropouts, and these scores were not included in the completers analyses. 
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One-way ANOVA (for sessions completed) and chi-square (for 
dropout/completer status) tests were used to assess whether completion of treatmen  and 
attrition differed between groups. Further probing of significant inter-group differences 
was conducted using Tukey’s post hoc tests for continuous measures and chi-square tests 
for categorical indices.  
Logistic regression was used to examine predictors of attrition. Gender, race, 
undergraduate/graduate status, major, time during semester in which intervention began, 
all current diagnoses assessed in the CIDI at baseline, and pre-treatment AWQ score were 
all entered as predictors, with dropout/completer status as the dependent variable.  
4.3 Randomization Check 
Analyses were conducted to assess whether any significant differences at baseline 
were present between groups on both demographic and clinical status variables. One-way 
ANOVAs were used to assess continuous variables, with Tukey’s post hoc tests used to 
assess specific inter-group comparisons. Chi-square tests were used to analyze
differences between categorical variables, with planned pairwise comparisons used to 
further investigate any significant differences.  
4.4 Treatment Fidelity 
Chi-square tests were used to examine between-group differences on Part A of the 
treatment fidelity questionnaire (Yes or No questions assessing the use of the m st basic 
activities of each condition). Significant omnibus tests were followed up by planned 
comparisons, examining the condition expected to report a “yes” on the particular iem 
compared to the condition(s) expected to report a “no.” One-way ANOVAs were 
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conducted to assess whether participants experienced what was intended for each of their 
conditions relative to those in the other conditions for Part B of the treatment fidelity 
questionnaire. Tukey’s post-hoc tests were used to further explore significant differences. 
In addition, information gathered during the treatment sessions (see “Treatment 
Process Analyses”) was averaged for each participant and used as additional measures of 
treatment fidelity. These variables provided a more in vivo report regarding the degree to 
which the participants were able to successfully engage in behaviors and activities during 
treatment that were theoretically important to the integrity of the treatment condition. 
Examples include the degree to which participants in the worry exposure condition used 
imagery during the session, or the degree to which participants in the expressive writing 
condition expressed emotions. Because different data were collected for each condition, 
these data provide only descriptive information about the magnitude of these facet of 
treatment, and do not provide information needed for between-group analyses, except in 
the cases in which there was overlap (e.g., degree to which participants focused n worry 
content during treatment was assessed for WE and EW and subjected to a -test).   
4.5 Credibility Check 
In order to ensure that the three interventions were deemed equally credible by 
participants, a one-way ANOVA was conducted used to assess any differences between 
groups on the RTQ. 
4.6 Testing of Hypotheses 
 
4.6.1 Aim 1:  
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To evaluate the relative efficacy of the interventions, data on self-report outcome 
measures were assessed using continuous and categorical analyses. For post-treatment 
analyses, a series of 2 (assessment time; pre, post) x 4 (condition; WE, EW, APS, and 
WLC) repeated measures ANOVAs were conducted on each of the major outcome 
variables (i.e., AWQ, PSWQ, BDI, and PSS) from pre to post-treatment to assessmain 
effects of time and most importantly the time x condition interaction. Follow-up tests 
were conducted to determine which conditions, in particular, showed significant change 
from pre to post-treatment. Simple effects tests were conducted for any significant or 
marginally significant time x condition omnibus tests by conducting a univariate 
ANCOVA with post-treatment score as the dependent variable, condition as the fixed 
factor, and pre-treatment score as the covariate5. Pairwise comparisons using LSD tests 
were used to evaluate inter-group differences at post-treatment. The assumption of 
homogeneity of variances was tested on all omnibus tests. The sphericity assumption was 
tested for all repeated measures ANOVAs. 
A similar approach was taken to analyze the effects of treatment at the 3-month 
follow-up. 2 (post, follow-up) x 3 (WE, EW and APS) repeated measures ANOVAs were 
conducted to assess whether change occurred from post to follow-up on the self-report 
measures (recall that WLC participants did not complete a follow-up assessment). In 
addition, univariate ANCOVAs were conducted to assess differences between groups at 
                                                                
5 Although this is somewhat statistically redundant, the univariate ANCOVA allowed for the 
examination of inter-group differences via LSD tests, while the repeated measures approach 
allowed for an examination of changes across time. 
 
68
follow-up while controlling for pre-treatment scores6. LSD pairwise comparisons were 
used to further explore the inter-group differences when a condition effect was present.  
The assumptions of homogeneity of variance and sphericity were evaluated as they were 
with post-treatment analyses. 
In addition to continuous analyses of treatment outcome, a categorical approach to 
treatment response and clinically significant improvement was also taken on the primary 
outcome variables (i.e., AWQ and PSWQ; see Jacobsen & Truax, 1991). This approach 
involves two-pronged criterion in which participants are classified as achieving clinically 
significant change (CSC) if they: (a) display responder status and (b) clinically significant 
improvement. First, each participant’s responder status (yes vs. no) was determined based 
on whether their pre to post-treatment improvement was statistically reliable based on the 
reliable change index (RCI; Jacobsen & Truax, 1991). Specifically, participants who 
achieved an RCI greater than or equal to 1.96 were classified as treatment responders. 
Second, a measure by measure approach was taken to determine the algorithm for 
which clinically significant improvement would be determined. Jacobsen & Truax (1991) 
propose three viable ways in which to determine whether a participant meets criteria for 
clinically significant improvement: (a) participant shows a level of improvement greater 
than or equal to two SDs from the baseline mean of the “clinical” group (i.e., the sample); 
or (b) participant’s post-treatment score falls within two SDs of the mean of a “n rmal” 
                                                                
6 These simple effects tests at follow-up were conducted regardless of significance of the time x 
condition effect on the post-to-follow-up repeated measures ANOVA because between-group 
differences at follow-up while controlling for pre-treatment scores may be observed even if there 
is no differential treatment effect from post to follow-up. In contrast, simple effects univariate 
ANCOVAs at post were only conducted when the time x condition repeated measures ANOVA 




(“functional”) population; or (c) score is closer to the mean of the functional population 
than the “dysfunctional” (i.e., clinical) population. The decision to use one of these thre 
acceptable methods is based on factors such as the availability of normative data (as well 
as the nature of that data)7 for the measure in question, the degree of overlap between the 
two populations, and the range of potential pre to post improvement in the sample. These 
factors were considered in order to choose the most stringent, feasible, and accurate 
picture of percentage of participants achieving clinically significant improvement for 
each individual measure.  
The final percentages reported refer to the stringent test for clinically significant 
change (CSC). That is, percentage of participants who achieve a level of pr t  post-
treatment change that is both statistically reliable and clinically meaningful. Chi-square 
tests were used to test for differences between groups in the proportion of participants 
who achieved clinically significant change. An identical approach was used to determine 
percentage of participants achieving clinically significant change at the 3-month follow-
up, with the addition of ITT-L and ITT-C analyses for this variable (see “Intent-to-treat 
Analysis” above).  
In addition, GAD status at follow-up was examined as a clinically meaningful 
index of change. Although not all participants met criteria for GAD at pre-treatment, 
percentage of participants meeting criteria for GAD at pre-treatment and at the follow-up 
assessment across conditions (completers sample) was assessed. A series of chi-square 
                                                                
7 For example, many apparently normal samples contain responses from participants who may 
report scores in the clinical range, as in a student sample. Thus, these norms may be 




analyses were used to assess potential between-groups differences in percentag  of 
participants meeting criteria for GAD at follow-up. 
4.6.2 Aim 2: 
In order to assess potential differential treatment effects on objective and 
subjective measures of health, an identical analytical approach as described in Aim 1 was 
used to assess differences between conditions on perceived health (SF-36), cortisol 
levels, and number of visits to the health center at post-treatment and follow-up. For the 
health visits variable, number of visits for the semester before the intervention ered as 
time 1 (“pre”) and the number of visits for the semester during the intervention entered 
time 2 (“post”) in a repeated measures ANOVA, with condition as the fixed factor. For 
follow-up analyses, semester during the intervention was entered as time 1, and semester 
after the intervention number of visits was entered as time 2. Because the number of 
health visits were obtained for any semester in which the participant was enrolled at the 
university, regardless of dropout/completer status in the study, the “ITT” analysis for this 
variable simply included the actual available data obtained for the full sample 
randomized to treatment. It should also be noted that follow-up data for the health visits 
variable was collected for the waitlist control group, and thus included in follow-up 
analyses, unlike the self-report measures. 
4.6.3 Aim 3: 
In order to assess potential intervention effects between groups on grades and 
credit hours completed, an identical analytical approach was used as described in Aims 1 
and 2. A 2 (semester before intervention, semester of intervention) x 4 (condition) 
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repeated measures ANOVA was conducted to assess whether improvement in grades 
occurred even as early as in the semester in which the intervention occurred (post-
treatment analysis). To assess change at follow-up, the repeated measures ANOVA 
included semester of intervention as time 1 and semester after intervention as time 2. An 
identical approach was taken to assess number of credit hours completed. 
As with the health visit data, GPA and number of credit hours completed for each 
relevant semester were obtained for any semester in which the participant was enrolled at 
the university, regardless of dropout/completer status in the study. Thus, the “ITT” 
analysis for these two variables simply includes the actual available data obt ined for the 
full sample randomized to treatment. Also similar to the health visit data, grade 
information was obtained for those in the waitlist control group for the semester after the 
intervention. Thus, the waitlist control group was assessed at follow-up on these 
measures. 
4.6.4 Aim 4: 
 Moderator analyses were conducted as outlined by Baron & Kenny (1986). 
Although it was expected that some variables would simply be general predictors of 
outcome (i.e., a significant main effect for a particular putative moderator but no variable 
x condition interaction), analyses were conducted using a series of hierarchical linear 
regressions for all of the following variables in order to assess for treatment moderation: 
(a) number of treatment sessions completed; (b) beliefs about worry at baseline, as 
measured by the MCQ (with each of the five factors examined separately as putative 
moderators); (c) time during semester when entered study (participants were classified as 
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either beginning in the first half or second half of the semester); (d) major field o  study 
(classified as either “engineering,” “natural sciences,” “liberal a ts,” “social sciences,” 
“law school,” “business,” “health professions,”  “public policy,” or “other”); (e)GAD 
status at baseline; (f) educational status (i.e., undergraduate vs. graduate/professional 
school student); (g) race/ethnicity; (h) major; and (i) gender.  
 The ITT sample was used to assess whether number of treatment sessions 
moderated treatment outcome, while the completers sample was used for the other 
measures.  Dummy coded variables and interaction terms were created. Pre-treatm nt 
scores for the measure of interest were entered in the first block, with the outcome 
measure as the dependent variable (i.e., AWQ, PSWQ, and GPA at post-treatment). In 
the second block, the condition terms (dummy coded) and moderator term were entered. 
The third block consisted of interaction terms. If the final model with the interaction 
terms was significant, the variable significantly moderated treatment outcome. In order to 
interpret the direction of differential condition x moderator effects, predict  values at 
post-treatment for each category of the moderator/condition interaction (adjusted for pre-
treatment) were calculated by constructing equations based on the final model of 
significant predictors. If no significant condition x moderator interaction was observed, a 
simplified model excluding the interaction terms was analyzed to assess for significant 
main effects of the putative moderator on the outcome variable. If this simplified model 
was significant and the putative moderator provided a unique contribution to the model, 
the variable was considered a general predictor of outcome.  
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Because of the large number of categories for the variables major and 
race/ethnicity, dichotomous variables were created to maximize power (sci nce vs. non-
science and Caucasian vs. non-Caucasian, respectively).  Models were run firstwith all of 
the categories’ dummy codes and their interaction terms. If no significant interactions 
were observed, the dichotomous variables were entered into a separate model. WLC 
cases were excluded from the moderator analyses. 
4.6.5 Aim 5: 
Change in AWQ Scores During Treatment 
 The completers sample was used to examine the potential differential declne 
slopes of AWQ scores between conditions, taken across five time points from the 
beginning to the end of treatment: baseline, week 1, week 2, week 3, and post-treatment. 
A 2-level HLM was conducted with AWQ score as the outcome variable, assessment 
period as the level-1 predictor, and three dummy-coded variables to represent the four 
conditions (with WLC as the reference category) as the level-2 predictors. 
Treatment Process Variables as Predictors of Change 
Some data gathered throughout treatment that were not necessarily expected to 
change over time, nor theoretically required to change in order to confer benefits (i.e., 
overall level of ability to engage in imagery during WE, overall level of ability to distract 
during APS, overall level of relaxation during the APS, overall ability to stay focused on 
thoughts and emotions regarding academic worry for the EW condition, and ability to 
focus on academic worry content during WE and EW) were averaged for each participant 
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and examined as predictors of outcome.8 Each variable of interest was entered into a 
linear regression model in the second block, with AWQ at post-treatment as the 
dependent variable and AWQ at pre-treatment statistically controlled in block 1 f the 
regression. 
Mechanisms of Change During Treatment 
 In order to assess whether fear significantly declined for either or both of the two 
intervention conditions, as well as whether these slopes differed between groups, a 2-
level HLM was conducted with fear as the outcome variable, intervention session as the 
level-1 predictor, and treatment condition as the level-2 predictor. A residual file was also 
created to obtain slopes and fear intercepts for each individual participant, which were 
then used in a series of hierarchical linear regressions to assess whether these treatment 
process parameters predicted outcome on the AWQ. Mediation was tested using the 
MacArthur guidelines as outlined by Kraemer, Wilson, Fairburn & Agras (2002). In this 
approach, a variable can be considered a mediator of treatment outcome if it (a) occurs 
during treatment; (b) is correlated with treatment condition; and (c) has eit er a direct 
relation with the outcome variable or interacts with the treatment variable in its relation 
with the outcome. Treatment process parameters that failed to meet the requirm nts for 
mediation were still examined as general predictors of outcome.  
 Additionally, the LIWC output for each EW participant (see “Treatment Process 
Measures”) was used to conduct a series of hierarchical regressions to assess whether the 
following were associated with greater improvement on the AWQ at post-treatment and 
                                                                
8 These averages were also used as additional measures of treatment fidelity. 
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follow-up: (a) an increase in use of positive emotion words; (b) a decrease in negative 
emotion words across writing sessions; and (c) an increase in use of cognitive processing 
words across writing sessions. Additionally, average percentage of positive and negative 
emotion words were also entered as predictors of outcome in two separate models. 
Regressions were also performed to assess whether use of the following types of word 
categories were associated with outcome: (a) self-referencing words; (b) social words; (c) 
sensory words; and (c) past, present, and future tenses. These categories were all chos n 
based on theory-driven hypotheses. AWQ at pre-treatment was entered into the first
block of each regression to control for these scores.  
In cases in which a change in percentage of words across sessions was the 
variable of interest, residualized change scores were calculated by regressing the average 
percentage of words in that category during the first half of the sessions onto that of the 
second half of the sessions. This approach is consistent with previous statistical analysis 
in the expressive writing literature.  
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Chapter 5: Results 
5.1 Equivalence of Groups at Baseline 
 
Despite random assignment to condition, some variables differed between groups 
at baseline. A significant difference was found for gender, χ2 (3) = 8.22, p < .05. Pairwise 
comparisons revealed that significantly more males were assigned to the EW condition 
than the APS condition [χ2 (1) =6.14, p < .01] and the WE condition [χ2 (1) = 4.59, p < 
.05]. No other differences were found on demographic variables, including status in 
school (undergraduate vs. graduate/professional school), ethnicity, diagnosis of GAD, 
and psychiatric comorbidity.  Additionally, no differences were found between groups on 
the time during the semester in which participants began the intervention (i.e., first hal  of 
semester vs. second half).  
Means and standard deviations of the baseline clinical measures across conditions 
(for all randomized participants) are presented in Table 1. Unfortunately, differences 
between groups at baseline were also observed on three clinical outcome measures: the 
AWQ [F (3,109) = 3.19, p < .05], the PSWQ [F (3,109) = 2.72, p < .05], and the physical 
health factor on the SF-36 [F (3, 109) = 3.05, p < .05]. Post hoc tests revealed that those 
receiving WE reported significantly higher levels of academic worry (AWQ) and 
generalized anxiety (PSWQ) than those in the APS condition (all ps < .05), and that those 
in the EW condition reported marginally significantly higher levels of academic worry 
than those in the APS condition (p = .09). In addition, those assigned to EW reported 
marginally significantly better physical health (SF-36 P) at baseline than those assigned 
to WE and APS (ps = .07). Thus, pre-treatment PSWQ, AWQ, and SF-36 P scores were 
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controlled for in subsequent analyses of these variables. Furthermore, although between-
group differences at baseline were not statistically significant on the PSS, pre-treatment 
PSS scores were entered as covariates in analyses including post-treatment or follow-up 
PSS scores, because the p-value for the between-group difference was below .25 (p = 
.17). 
5.2 Treatment Completion and Attrition 
5.2.1 Between-group differences 
Table 1 also reports treatment completion and attrition data. Differences between 
groups on number of treatment sessions approached significance, F (2,92) = 2.59, p = 
.08. Further probing of the inter-group differences revealed that those in the APS 
condition tended to complete more sessions than those assigned to EW (p < .07). 
Although no significant between-group differences were observed on 
completer/dropout status (p = .16), a significant between-group difference emerged on 
the number of participants who completed the entire study, χ2 (2) = 7.45, p < .05. More 
participants completed the entire study in the APS condition (N = 23) than in the EW 
condition (N =15), χ2 (1) = 7.46, p < .01. No other significant between-group differences 




Table 1. Means and Standard Deviations of Baseline, Attrition, and Credibility Measures for All Randomized 
Participants 
Condition                                                              Measure 
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5.2.2 Predictors of Attrition 
Only two variables were associated with dropout/completer status. Female gend r 
was associated with greater likelihood of completion (OR = 6.34 vs. males, 95% CI = 
1.39 to 28.91, Wald = 5.69, p < .05). Time in which treatment began during the semester 
also uniquely contributed to the model (see “Statistical Analyses” for the full details of 
the model), with increased likelihood of dropout associated with randomization occurring 
later in the semester (OR = 9.09 vs. randomized during first half of semester; 95% CI = 
1.81 to 45.34, Wald = 7.21, p < .019).  
5.3 Treatment Fidelity 
For Part A of the ATA questionnaire, all omnibus chi-square tests were 
significant: “listened to a tape,” χ2  (2) = 25.57, p < .001 (100% “yes” for WE, 0% “yes” 
for EW, 14% “yes” for APS); “wrote about worries,” χ2  (2) = 21.81, p < .001 (15% “yes” 
for WE, 100% “yes” for EW, 0% “yes” for APS); “wore headset and goggles,” χ2  (2) = 
29.00, p < .001 (0% “yes” for WE, 0% “yes” for EW, 100% “yes” for APS); “formed 
images of worry scenes,” χ2  (2) = 6.64, p < .05 (54% “yes” for WE, 22% “yes” for EW, 
0% “yes” for APS); and “expressed thoughts through words,” χ2  (2) = 16.68, p < .001 
(38% “yes” for WE, 100% “yes” for EW, 0% “yes” for APS). Planned comparisons 
revealed that those in the APS condition did in fact wear a headset and goggles, χ2 (1) = 
29.00, p < .001, more than those assigned to WE or EW. Furthermore, those in EW 
reported that they wrote about their worries, χ2  (1) = 21.36, p < .001, and expressed their 
                                                                
9 The model predicted completion, with OR = .11 for “time” (reference group first half of 
semester). Thus, the reported OR is the inverse, in order to present a positive OR for dropout. 
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worries through words, χ2  (1) = 13.98, p < .001, more than those assigned to the other 
two intervention conditions. Finally, those who received WE treatment listened to a tape, 
χ
2  (1) = 4.27, p < .05, and reported forming images of worry scenes, χ2  (1) = 5.73, p < 
.05, more than those in the other intervention conditions. 
On Part B of the ATA questionnaire, no difference was observed on the omnibus 
test for question 1 (relaxation question), suggesting that contrary to expectation, those 
assigned to APS did not feel significantly more relaxed during treatment than those in the 
other two conditions. However, questions 2-6 [distraction, F (2, 52) = 8.14, p < .001; 
expressed thoughts and feelings, F (2, 52) = 21.17, p < .001; focused on worry content, F 
(2, 52) = 30.47, p < .001; worry images about school, F (2, 52) = 30.47, p < .001; and 
worry-related images, F (2, 52) = 16.23, p < .001, respectively; see Appendix for 
complete questionnaire] all revealed significant differences between groups.  
 As expected, post-hoc tests revealed that those receiving APS reported that they 
were significantly more distracted from their worries while undergoing treatment as 
compared to those in the WE (p < .001) and EW (p < .01) conditions. Also as expected, 
those in the EW condition reported expressing more thoughts and feelings than those in 
APS (p < .001). While not surprising, those in WE also reported expressing more 
thoughts and feelings than those in APS (p < .001). However, the EW condition was not 
uniquely defined by this expression, as no significant differences were observed betw en 
those in WE and EW. Consistent with prediction, participants in both the WE and EW 
conditions reported focusing on the content of their worries more than those in APS (ps < 
.001). Also consistent with expectation, those in WE reported conjuring up more worry 
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related images of school than those in EW (p < .01) and APS (p < .001) during treatment, 
with those in EW also reporting more worry related images of school during treatment 
than those in APS (p < .001). Contrary to prediction, those in WE did not report focusing 
on worry-related images more than those in EW (p = .21). However, those assigned to 
WE or EW focused on worry-related images more than those in APS (ps < .001).   
 Overall, these findings suggest that participants completed the basic activities 
unique to each of their treatment conditions, and that, for the most part, treatment 
activities and objectives were appropriately differentiated. While not surpri ing, the least 
distinctive aspect of the treatments was degree of emotional expression between the WE 
and EW conditions. Although no differences were observed between WE and EW on one 
of the three imagery items, the fact that significant differences did emerg  for the other 
two items provides evidence that those assigned to WE did in fact use more worry-related 
imagery than those assigned to EW.  
 In addition, treatment process data showed that, on average, participants in the 
WE condition used “a lot” of imagery (M = 67.70, SD = 17.99 on the 0-100 scale); that 
participants in the WE and EW conditions focused on the content of their worries during 
treatment “a lot” (MEW = 66.87, SDEW = 16.96; MWE = 64.37, SD WE = 16.77 on the 0-100 
scale), with no significant differences between the two conditions (p = .59); and that 
those in the EW condition reported expressing thoughts and emotions during the 
treatment sessions “a lot” (M = 73.21, SD = 21.97).  
 Finally, the mean percentage of “school” words used in the EW condition (as 
obtained by LIWC) was 3.71% (SD = 1.65), which is more than one SD above the norm 
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(Pennebaker et al., 2001; Mnorm = 1.5%, SDnorm = 1.9) based on 43 studies using the 
expressive writing paradigm. This indicates that participants did write about school more 
than those who were in studies not focusing on academic worry.  
5.4 Treatment Credibility 
As shown in Table 1, a one-way ANOVA revealed no significant difference 
between groups on the RTQ (p = .50), indicating that participants across the three 
intervention conditions viewed their treatments as equally credible. The mean RTQ score 
across conditions was M = 61.00 (SD = 18.98), suggesting that, overall, participants 
found their treatments to be at least moderately credible. 
5.5 Testing of Hypotheses: Aim 1 
5.5.1 Treatment Effects: Continuous Analyses of Clinical Self-Report Measures 
The assumptions of ANOVA assessed (see “Statistical Analyses”) were m t for 
all analyses. Figures 2-5 show the means for each condition across assessment periods for 
each measure. Table 2 presents the means and standard deviations across assessment 
periods for the AWQ, PSWQ, PSS, and BDI (completers sample). 
5.5.1.1 Academic Worry Questionnaire (AWQ) at Post-treatment. A significant 
effect of time was observed across groups on the AWQ, F (1 80) = 52.77, p < .001, η = 
.40, power = 1.00. Further analysis revealed that those in the WE, APS, and EW 
conditions all showed significant reductions in AWQ scores from pre to post-treatment (p 
< .001 for WE and APS, p < .01 for EW), while those in the WLC condition did not show 
a statistically significant change in AWQ score (p = .09).  These findings show that those 
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assigned to an intervention showed significant reductions in AWQ scores, while those 
assigned to no treatment showed only marginal improvement over time.  
 The time x condition effect approached significance, F (3, 80) = 2.42, p =.07, η = 
.08, power = .59.  Simple effects tests revealed a significant between-group difference at 
post-treatment, F (3, 79) = 3.21, p < .05, η = .11, power = .72. Pairwise comparisons 
indicated that those receiving WE marginally outperformed WLC (p = .08), while those 
in APS outperformed both WLC and EW (ps < .05). Contrary to expectation, no 
differences were observed between EW and WLC; nor did WE outperform APS.  
 The same pattern of findings was observed using the ITT-L sample, with the 
exception of inter-group differences at post-treatment: those in the WE condition reported 
significantly greater improvement on AWQ scores than those in the EW condition (p < 
.05), while those receiving the APS reported significantly greater improvement on AWQ 
scores than those in both EW (p < .01) and WLC (p < .05). No other specific between-
group differences emerged. When considering the ITT-C sample (baseline AWQ scores
entered at post-treatment for dropouts), WE marginally outperformed EW (p = .08), and 
APS outperformed both WLC (p < .05) and EW (p < .01), with no other significant 
differences. Thus, with each successively more conservative analytical approach, those in 
WE and EW did not perform as well, while those in APS showed similar performance.  
Because of the nature of the AWQ as a tool to identify the presence and degree of 
several different facets of academic worry, univariate ANCOVAs controlli g for pre-
treatment scores were conducted on an item by item basis on the completers sample to 
shed light on between-group differences in specific domains of academic worry.  
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Interestingly, a condition effect at post-treatment was only significat for two of 
the ten items [items two, F (3, 79) = 3.68, p < .05, η = .12, power = .78, and three, F (3, 
79) = 4.16, p < .01, η = .14, power = .74] and approached significance on two other items 
[items eight, F (3, 79) = 2.24, p = .09, η = .08, power = .55, and ten, F (3, 79) = 2.32, p = 




Table 2. Means and SDs Across Assessment Periods for Self-Report Clinical Measures 
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On item two, “total time spent worrying about school,” those receiving WE and 
APS reported spending less time worrying about school than those in the WLC group (p 
< .05 for WE and p < .01 for APS) and the EW group (approaching significance, p < .06, 
for WE and p < .05 for APS).  No differences were found between EW and WLC or 
between WE and APS. On item three, “duration of a typical worry episode,” a similar 
pattern emerged. Those in WE and APS reported experiencing shorter worry episodes 
than those in WLC (approaching significance, p < .06, for WE and p < .05 for APS) and 
EW (all ps < .01), with no other differences observed. These findings suggest that, at 
post-treatment, the WE and APS interventions may have had the most impact on duration 
of time spent worrying, and that the impact of these two treatments on duration of worry 
was greater than that of the EW intervention.  
 On item eight, which taps into the belief that worry is dangerous and harmful, 
those in the WLC condition believed worry to be more harmful than those who received 
WE (p < .05) or APS (approaching significance, p < .07).  Those assigned to APS 
reported significantly lower scores on item ten (which taps into the degree of safety 
behavior utilization in an effort to reduce worry or mitigate anxiety) than those in EW (p 
< .05), and marginally lower scores than those assigned to WE (p = .06), suggesting that 
those who received the APS treatment used fewer safety behaviors at post-treatment than 
those assigned to the other two treatment conditions. No other inter-group differences 
emerged. 
5.5.1.2 AWQ at Follow-up. A significant effect of time was observed from post to 
follow-up assessments, F (1, 55) = 19.03, p < .001, η = .26, power = .99, with an overall 
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improvement in scores. Simple effects tests revealed that those who received WE (p < 
.01) and EW (p < .05) showed significant continued improvement from post to follow-up, 
while those who received the APS intervention showed marginally significant 
improvement from post to follow-up ( < .08). This time effect was maintained for both 
ITT samples (ps < .01).  
Neither a time x condition effect (p = .49) nor a condition effect (p = .85) were 
observed. ITT-L and ITT-C analyses also failed to show a time x condition effect. 
However, both ITT analyses revealed a marginally significant condition effect at follow-
up on the simple effects test [F (2, 91) = 2.80, p < .07, η = .06, power = .54 for ITT-L 
and F (2, 91) = 2.82, p < .07, η = .06, power = .54 for ITT-C].  Pairwise comparisons 
revealed that APS outperformed EW (both ps < .05), with no other inter-group 
differences. No between-group differences emerged when considering each item 
individually. 


























5.5.1.3 Penn State Worry Questionnaire (PSWQ) at Post-treatment. A significant 
effect of time from pre to post-treatment was observed on the PSWQ, F (1, 80) = 33.02, p 
< .001, η = .29, power = 1.0, suggesting that change was observed across groups on this 
measure. Follow-up analyses revealed that those in WE, EW, and APS showed 
significant decreases in PSWQ score from pre to post-treatment (p < .001 for WE, ps < 
.01 for EW and APS), while those in the WLC condition showed no significant effect of 
time on this measure (p = .46).  
 A significant time x condition effect was also observed, F (3,80) = 4.12, p < .01, 
η = .13, power = .83. Simple effects tests at post-treatment revealed a significant 
condition effect, F (3, 79) = 3.91, p < .01, η = .13, power = .81. Pairwise comparisons 
showed that those receiving the WE treatment outperformed those in WLC (p < .001) and 
EW (approaching significance, p = .07), while those receiving APS also outperformed 
WLC (p < .05). No other between-group differences were observed.  
 When conducting identical analyses on the ITT sample, findings were identical on 
the repeated measures ANOVA. However, the simple effects test at post-treatment only 
approached significance on the test for a condition effect, F (3 108) = 2.48, p < .07, η = 
.06, power = .60. Pairwise comparisons revealed that those assigned to WE reported 
significantly more improvement on the PSWQ (i.e., lower scores) at post-treatment than 
those assigned to WLC (p < .05) and EW (approaching significance, p = .07). Those 
assigned to the APS condition also showed marginally more improvement on the PSWQ 
compared to those in WLC (p = .08). No other significant differences emerged.  
 
89
5.5.1.4 PSWQ at Follow-up. A significant time effect was observed, F (1, 55) =11.83, p 
< .001, η = .18, power = .92, with overall continued improvement from post-treatment to 
follow-up.  This post to follow-up improvement was significant for those assigned to 
APS (p < .05), but only marginally significant for those assigned to EW (p < .07). Those 
in the WE condition maintained gains, but showed no significant improvement (p = .16).  
Post-to-follow-up improvement was observed for the ITT-L (p < .001) and ITT-C (p < 
.01) samples. 
Neither a significant time x condition effect (p = .89), nor a condition effect on at 
follow-up (p = .56) were observed, indicating no significant between-group differences. 
Both ITT analyses mirrored the completer analyses.  























5.5.1.5 Perceived Stress Scale (PSS) at Post-treatment. A significant effect of time was 
observed from pre to post-treatment on the PSS, F (1 79) = 39.87, p < .001, η = .34, 
power = 1.0. This pre to post reduction was significant for those receiving WE (p < .001), 
 
90
EW (p < .01), and APS (p < .001), but was not significant for those assigned to the WLC 
condition (p =.74). A significant time x condition effect was also observed, F (3, 79) = 
4.57, p < .01, η = .15, power = .87. Simple effects tests revealed a significant effect of 
condition at post-treatment on the PSS, F (3, 78) = 4.22, p < .01, η = .14, power = .84. 
Pairwise comparisons revealed that those receiving WE and APS outperformed WLC (ps 
< .01), with no other inter-group differences attaining statistical significa ce.  
 The only difference between the completers and ITT samples emerged with 
respect to the inter-group differences. On the ITT analyses, the pairwise comparisons for 
the ANCOVA indicated that, in addition to those in WE and APS outperforming those in 
WLC (ps < .05), those receiving WE and APS also outperformed those in EW (ps < .05).  
5.5.1.6 PSS at Follow-up. Like the above measures, a significant time effect was 
observed showing continued improvement from post-treatment to follow-up, F  (1, 55) = 
15.11, p < .001, η = .22, power = .97. The post to follow-up effect of time was significant 
for those assigned to APS (p < .01) and EW (p < .05), while those assigned to WE 
maintained gains (p = .19). Post to follow-up improvement was also significant for the 
ITT-L sample (p < .05), but only marginally significant for the ITT-C sample (p = .06) 
Also similar to the above measures, neither a time x condition effect from post-
treatment to follow-up (p = .53), nor a condition effect at follow-up (= .47), was 
observed using the completers sample. However, like the ITT analyses on the AWQ, a 
between-group effect was marginally significant at follow-up for the ITT-L sample, F (2, 
89) = 2.51, p < .09, η = .05 power = .49, and was statistically significant at follow-up 
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with the ITT-C sample, F (2, 88) = 3.56, p < .05, η = .08, power = .65. In both cases, 
APS outperformed EW (ps < .05), with no other inter-group differences.  

























5.5.1.7 Beck Depression Inventory-II (BDI-II) at Post-treatment. BDI scores 
significantly improved overall from pre to post-treatment, F (1, 80) = 41.68, p < .001, η = 
.34, power = 1.0. Further analysis revealed that those assigned to WE and APS (ps < 
.001) showed significant reductions in BDI score, while those assigned to EW and WLC 
(ps > .10) showed no significant changes from pre to post on this measure.  
 A time x condition effect approached significance, F (3, 80) = 2.32, p = .08, η = 
.08, power = .57. However, simple effects tests revealed no significant between-group 
differences on the BDI at post-treatment (p = .13).  These findings suggest that, while 
those in the WE and APS conditions showed significant reductions in BDI score from pre 
to post-treatment, the differential effect of treatment on BDI score was not significant.  
 Like the completers sample, the ITT sample also revealed a marginally significant 
time x condition effect. Interestingly, despite the lack of significant betwe n-group 
 
92
differences on the completers sample, simple effects tests using the ITT sample revealed 
a marginally significant time x condition effect from pre to post-treatmen  and the simple 
effects tests using the ITT sample did produce a marginally significant effect of 
condition, F (3, 108) = 2.27, p < .09, η = .06, power = .56. Pairwise comparisons 
revealed that those assigned to either WE or APS outperformed those assigned to EW (ps 
< .05). No differences were observed between any of the treatment conditions and WLC.  
5.5.1.8 BDI at Follow-up. A significant time effect from post-treatment to follow-up was 
also observed on the BDI, F (1, 55) = 18.28, p < .001, η = .25, power = .99, with 
continued improvement observed for those assigned to EW (p < .05) and APS (p < .01). 
Post to follow-up gains were maintained for those assigned to WE (p = .30).  The 
significant improvement from post to follow-up was maintained when considering the 
ITT samples (all ps < .01). 
A time x condition effect was not observed from post-treatment to follow-up on 
the BDI (p = .16). Likewise, a between-group effect was not significant at follow-up on 
the ANCOVA (p = .15). In contrast, a significant time x condition effect was observed on 
the BDI when considering the ITT-L sample, F (2, 92) = 4.46, p < .05, η = .09, power = 
.75. Simple effects tests at follow-up for the ITT-L revealed a significant co dition effect, 
F (2, 91) = 5.97, p < .01, η = .12, power = .87, with those in APS outperforming EW (p <
.001) and WE (p < .05). Although a significant post to follow-up time x condition effect 
was not observed for the ITT-C sample, the simple effects test at follow-up did reveal a 
significant condition effect, F (2, 91) = 5.71, p < .01, η = .11, power = .85, with APS 
outperforming EW (p < .001) and WE (p < .05). 
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5.5.2  Clinically Significant Change: Achieving Meaningful Improvement  
5.5.2.1 AWQ at Post-treatment. Because normative data were available for this 
measure, yet there was a high degree of overlap between the “functional” and 
“dysfunctional” populations, criterion c was chosen as the cutoff for clinically significant 
improvement, as recommended by Jacobsen & Truax (1991, see “Statistical Analyses”).  
As shown in Figure 6, at post-treatment, percentages of participants achieving CSC were 
48% for the WE condition, 30% for the EW condition, 67% for those receiving APS, and 
29% for participants assigned to WLC. An omnibus chi-square test, χ2 (3) = 8.10, p < .05, 
suggested differences in percentage achieving CSC were significant between groups. 
Planned comparisons revealed that those in the APS condition achieved higher rates of 
CSC than those assigned to WLC, χ2 (1) = 5.53, p < .05, and EW, χ2 (1) = 5.87, p < .05. 
No other differences were statistically significant.  
When considering the ITT sample, these percentages changed to 48% for WE, 
21% for EW, 59% for APS, and 28% for WLC. Again, a chi-square test, χ2 (3) = 10.25, p 
 
94
< .05, suggested between-group differences were significant. Further exploration of these 
differences revealed that, similar to the completers sample, those assigned to APS 
outperformed EW, χ2 (1) = 9.10, p < .01 and WLC, χ2 (1) = 4.24, p < .05, while those in 
WE also showed marginally significantly higher percentages of CSC than those assigned 
to EW, χ2 (1) = 3.42, p < .06. 
5.5.2.2 AWQ at Follow-up. Overall, percentages of participants achieving CSC at 
follow-up were higher than at post-treatment, with no significant differences between 
groups. For the completers sample, 74% for those assigned to WE, 67% in the EW 
condition, and 65% of participants assigned to APS achieved CSC. When considering the 
ITT samples, these percentages dropped for all conditions. Analysis of the ITT-L sample 
revealed that 48% of those in WE, 39% of those in EW, and 57% of those in APS 
achieved CSC on the AWQ. When considering the ITT-C sample, 45% in WE, 30% in 
EW, and 52% in APS achieved CSC.  






























5.5.2.3 PSWQ at Post-treatment. Because normative data were available for this 
measure and the normal population curve was not highly overlapping with the “clinical” 
sample10, criterion b was chosen as the cutoff for clinically significant improvement, as 
recommended by Jacobsen & Truax (1991). As shown in Figure 7, percentages of 
participants achieving CSC were 30% for WE, 10% for EW, 17% for APS, and 0% for 
WLC. An omnibus chi-square test approached significance, χ2 (3) = 7.53, p < .06. Those 
assigned to WE outperformed WLC, χ2 (1) = 6.27, p < .05, with those in APS marginally 
outperforming those in WLC, χ2 (1) = 3.14, p < .08. No other significant differences 
emerged.  
When considering the ITT sample at post-treatment, a similar pattern emerged, 
with lower rates across conditions: 21% for WE, 6% for EW, 14% for APS, and 0% for 
WLC. A chi-square test comparing between-group differences on percentage of 
participants achieving CSC approached significance, χ2 (3) = 6.50, p < .09. Planned 
comparisons revealed that whose assigned to WE outperformed WLC, χ2 (1) = 4.43, p < 
.05, and marginally outperformed those assigned to EW, χ2 (1) = 3.22, p = .07. No other 
significant differences were observed between groups.  
5.5.2.4 PSWQ at Follow-up. As described above, percentage of participants achieving 
CSC on the PSWQ at follow-up is presented in Figure 7. Like the CSC rates on the 
AWQ, percentage of participants achieving CSC increased from post to follow-up, with 
40% of those in WE, 27% of EW, and 39% of APS meeting criteria. No significant 
between-group differences emerged. When considering the ITT-L sample, these rates 
                                                                
10 In fact, the sample pre-treatment PSWQ descriptives (M = 63.77, SD = 9.52) were similar to 
clinical GAD sample descriptives (M = 68, SD =10).  
 
96
dropped to 24% for the WE condition, 12% for EW, and 32% for APS. Percentages were 
almost identical for the ITT-C sample, with 24% WE, 12% EW, and 31% of those in 
APS meeting the stringent criteria for achieving CSC on the measure of general worry. 
No significant between-group differences were observed on this measure for either of the 
ITT samples. 





























5.5.3 Diagnostic Status from Pre-treatment to Follow-up 
 At pre-treatment, groups did not differ on percentage of participants meeting 
current diagnostic criteria for GAD; nor did they differ on percentage of participants 
meeting criteria for GAD within the last year (ps > .10). Figure 8 shows the percentage of 
participants meeting current criteria for GAD at baseline and follow-up assessments. At 
pre-treatment, 42% and 48% of those in WE, 31% and 44% of those randomized to EW, 
19% and 27% of those in APS, and 28% and 39% of those assigned to WLC met criteria 
for current and within one year GAD diagnoses, respectively. By follow-up, those
percentages dropped significantly across conditions, particularly for those who received 
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WE and EW. Of those participants who completed the follow-up assessment, 13% of 
those who received WE, 0% of those in EW, and 16% of those assigned to APS met 
current diagnostic criteria for GAD. Differences between groups were not statistically 
significant.  Across the sample, percentage of participants meeting current diagnostic 
criteria for GAD dropped from 31% at pre-treatment to 10% at follow-up. 

























































5.6 Testing of Hypotheses: Aim 2 
5.6.1 Treatment Effects on Health Outcomes 
 Assumptions of homogeneity of variances for all ANOVAs and sphericity for all 
repeated measures ANOVAs were met. Table 3 presents the means and standard 
deviations across assessment periods for the SF-36, number of visits to the health center, 
and cortisol levels (completers sample). 
5.6.1.1 SF-36 at Post-treatment. Figure 9 shows the condition means across assessment 
periods for the physical and mental factors of the SF-36. A significant effecto  time was 
found for both the mental factor, F (1, 78) = 44.84, p < .001, η = .37, power = 1.0, and 
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the physical factor, F (1, 78) = 17.77, p < .001, η = .19, power = .99, of the SF-36. On the 
mental factor, participants in the WE (p < .001), EW (p < .001), and APS (p < .01) 
conditions showed significant pre to post-treatment improvement, while those in the 
WLC condition did not (p = .10). A different pattern emerged on the physical factor such 
that those assigned to WE and APS showed significant improvement in physical 
functioning (ps < .01), while those assigned to either EW or WLC showed no such 
improvement (ps > .10). 
 Between-group differences on the mental factor were not significant from pre to
post-treatment (p = .13). However, a significant time x condition effect was observed on 
the physical factor, F (3, 78) = 3.21, p < .05, η = .11, power = .72. Simple effects tests at 
post-treatment revealed a condition effect approaching significance, F (3, 77) = 2.37, p < 
.08, η = .08, power = .57. Pairwise comparisons showed that APS outperformed EW (p < 
.05) and WLC (approaching significance, p < .06), and that WE tended to outperform EW 
(p = .09). No other inter-group differences emerged.  
 While an effect of time was still present on both of the SF-36 factors when 
conducting ITT analyses, time x condition effects were not observed on either factor 
when including all randomized participants.  
5.6.1.2 SF-36 at Follow-up. Overall, participants showed improvement in overall mental 
well-being from post-treatment to follow-up assessment, F (1, 55) = 16.53, p < .001, η = 
.23, power = .98. While those in EW (p < .05) and APS (p < .001) showed continued 
improvement, those in WE maintained gains but showed no significant improvement (p > 
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.10). No significant time x condition effect on the mental factor was observed; nor was a
condition effect observed at follow-up on a univariate ANCOVA. 
When considering the physical factor, a similar pattern emerged. A significant 
time effect was observed from post to follow-up, F (1, 55) = 6.84, p < .05, η = .11, power 
= .73, with significant continued improvement for those in EW (p < .01), marginally 
significant improvement for those assigned to APS (p = .09), and a maintenance of 
treatment gains but no improvement for those receiving WE (p = .24). A significant time 
x condition effect was revealed on the physical factor, F (2, 55) = 6.00, p < .01, η = .18, 
power = .86, and a condition effect at follow-up was marginally significant, F (1  53) = 
2.51, p = .09, with those in EW (p < .05) and APS (approaching significance, p < .09) 
outperforming those in WE. 
When considering the ITT-L sample, a few differences emerged. On the mental
factor, unlike the completers sample, both a marginally significant time x condition 
interaction [F (2, 90) = 2.77, p < .07, η = .06, power = .53] and a significant condition 
effect at follow-up [F (2, 88) = 8.72, p < .001, η = .17] were observed. APS was found to 
outperform both EW (p < .001) and WE (p < .01) at the follow-up assessment. Unlike the 
completer sample, neither the effect of time from post-treatment to follow-up (p = .30) 
nor a time x condition effect (p = .24) was significant for the physical factor in the ITT-L 
sample. However, simple effects tests at follow-up revealed a marginally significant 
condition effect, F (2, 88) = 2.55, p < .09, with APS showing more improvement in 
physical health at follow-up than those assigned to WE (p < .05). 
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Some differences were also revealed between the ITT-L and ITT-C samples. 
While time x condition effects were observed for the mental factor using the ITT-L 
sample, no such interaction effect was observed with the ITT-C sample. While the ITT-L 
sample did not reveal a time or time x condition effect at follow-up on the physical 
factor, the ITT-C sample yielded findings more similar to the completers sample. The 
main differences between the completers sample and ITT-C sample were that the ITT-C 
sample yielded only a marginally significant time x condition effect (p < .09), and yielded 
a significant condition effect at follow-up, F (2, 88) = 4.93, p < .01 η = .10, with those in 
APS outperforming the other two conditions (p  < .05).  








































































5.6.1.3 Health Center Visits: Acute effects at Post-treatment. Figure 10 shows the 
mean number of health visits for each condition across the three assessment periods. No 
time or time by condition effects were observed for this variable on either the completers 
or ITT samples, indicating that, by the end of the semester during which the treatment 
was conducted, no significant changes in health visits were observed across conditions.  
5.6.1.4 Health Visits at Follow-up. No significant effects of time or time x condition 
were observed from post-treatment to follow-up, indicating that no changes were 
observed from post to follow-up on the number of visits to the health center. In addition, 
simple effects examining between-group differences at follow-up revealed no significant 
between-group differences. No differences were observed between the completers and 
ITT samples.  










































5.6.1.5 Physiological Measure of Health: Cortisol level. No significant time or time x 
condition effect was found on the physiological measure of stress (p = .41 for time and p 




Table 3. Means and SDs of Health Outcomes by Condition Across Assessment Periods 
 WE 
Pre   Post    FU 
EW 
Pre   Post    FU 
APS 
Pre   Post    FU 
WLC 
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5.7 Testing of Hypotheses: Aim 3 
5.7.1 Treatment Effects on the Objective Academic Measures 
ANOVA assumptions tested were met unless otherwise specified. Several of the 
repeated measures ANOVAs examining GPA violated the homogeneity of variances 
assumption. Measures taken to attempt to correct for these violations are discusse. 
Figures 11 and 12 show the differential treatment change across the three assessment 
periods for the two academic achievement measures. Table 4 presents the descriptive 
information across assessment periods for GPA and number of hours of coursework 
completed (completers sample). 
5.7.1.1 Grade-point Average (GPA): Acute effects at Post-treatment. A significant 
effect of time was observed from the semester before the intervention (“pre”) to the 
semester during the intervention (“post”), F (1, 58) = 4.35, p < .05, η = .07, power = .54, 
suggesting that grade improvement was observed overall from pre to post-treatment.  
However, Levene’s test of homogeneity of variances was significant, sugge ting 
that the p-value for the effect of time may have been inaccurate. In particular, violation of 
this assumption may result in inflation of Type I error. Because this violation of ANOVA 
assumption would not be relevant for the tests in which within-group change was 
analyzed for each condition, tests were still conducted to assess change across time for 
each condition. These analyses revealed that those assigned to the EW condition showed 
a significant improvement in GPA from pre to post (p < .05), whereas no significant pre 
to post improvement was observed for any of the other conditions (ps > .10). The 
omnibus repeated measures ANOVA revealed no significant time x condition effect.
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Because heterogeneity of variances is likely to result in Type I error, this likely reflects a 
true null finding.  
Measures were taken in order to explore GPA with more certainty that the 
findings did not reflect inaccuracies due to a violation of the ANOVA assumption of 
homogeneity of variances. First, several transformations were conducted on the GPA data 
(i.e., square, square root, inverse, and logarithmic). Unfortunately, none of these 
transformations had the desired effect of creating homogeneous variances across groups. 
Next, a univariate ANCOVA approach was taken instead of repeated measures. This 
approach was more robust, resulting in non-significant Levene’s tests (p = .25 for the 
completers sample). A univariate ANCOVA controlling for pre-treatment GPA was not 
statistically significant for the completers (p = .12) or ITT (p = .58) samples. Overall, 
these findings suggest that GPA did not significantly improve during the semester of th  
intervention and that there were no significant differences between groups.  
To increase power, a planned comparison of the active conditions (WE and EW) 
vs. the control conditions (APS and WLC) on GPA during the intervention (controlling 
for baseline GPA) did reveal a statistically significant difference betwe n groups, F (1, 
61) = 4.39, p < .05, η2 = .07, power = .54 (Levene’s test non-significant). Those assigned 
to the two active conditions obtained significantly higher GPAs for the semester during 
which they participated in the study than those assigned to the control conditions. 
However, this finding was no longer significant when using the “ITT” sample (all those 
participants randomized who had GPA data available for the “pre” and “post” semesters, 
p = .43). 
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Because the average GPA before the semester of the intervention was M = 3.31 
(SD = 0.76), a ceiling effect may have been obscuring changes in GPA within conditions 
from pre to post as well as differential treatment effects. Although GPA did not 
significantly differ at baseline across conditions, it was worth exploring whether a 
different pattern emerged when only selecting participants who had more room for 
improvement: those whose GPAs at baseline were below the mean for this sample. 
Limiting the analysis to below-the-mean GPA completers did not result in a 
violation of the homogeneity of variances assumption (i.e., non-significant Levene’s t st 
for both the “pre” and “post” within-group variables entered). The repeated measures 
ANOVA using this sample yielded a significant effect of time, F (1, 20) = 10.73, p < .01, 
η = .35, power = .88. Simple effects tests within groups revealed significant pre to post 
change for those in WE (p < .05) and EW (p < .01), whereas a marginally significant 
effect of time was observed for those who completed APS (p = .06) and no significant 
time effect was observed for those in WLC (p = .79). Despite these differences across 
groups in change across time, the time x condition effect did not attain statistical 
significance (p = .17). These findings should be interpreted with some caution, given the 
significant decrease in sample size when limiting the analysis to this subset of 
participants (i.e., N < 8 for each condition). The pattern of findings was identical when 
examining the ITT sample. 
5.7.1.2 GPA at Follow-up. An omnibus test revealed no significant changes in GPA 
from post to follow-up in both the completers sample ( = .48) and the “ITT”/full sample 
(p = .74), indicating that grade point averages achieved in the semester during the 
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intervention were largely maintained in the following semester. No significat time x 
condition effects were observed for either of the samples ( = .15 and p = .32 for the 
completers and total samples, respectively). Because Levene’s tests again revealed a 
significant violation of the homogeneity of variances assumption, these findings should 
be interpreted with caution. However, these null findings are likely to reflect true non-
significant differences, since the violation of this assumption typically results in Type I 
error inflation. Despite this, measures were taken to transform the data such that the 
variances were more equal across groups. Unfortunately, none of the transformtions to 
the data resulted in a correction of this violation. 
As with the pre to post-treatment change across time in GPA, simple effects tests 
to examine changes from post to follow-up within each condition could be conducted 
because variance across groups is not relevant when only one group is being analyzed. 
These tests revealed no significant changes from post to follow-up for the WE, APS, and 
WLC conditions (all ps > .20). In contrast, there was a marginally significant trend in the 
EW condition (completers sample), F (1, 18) = 4.31, p = .05, η2 = .19, power = .50, 
indicating that GPAs decreased from the semester during the intervention to the semester 
after the intervention. When considering the full sample (ITT), no such drop in GPA was 




Table 4. Means and SDs by Condition Across Assessment Periods for Academic Achievement Outcomes 
 WE 
Pre   Post    FU 
EW 
Pre   Post    FU 
APS 
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Univariate ANCOVAs with GPA for the semester after the intervention as the 
dependent variable and GPA for the semester before the intervention as the covariate did 
not violate the ANOVA assumption of homogeneity of variances (Levene’s test p-value = 
.20 for completers). This analysis revealed no significant between-group differences on 
GPA at follow-up. Assessing between-group differences at follow-up only for those
participants whose GPAs were below the group mean at baseline also revealed a non-
significant condition effect for the completers sample ( = .11) and the ITT sample (p = 
.14).  
 In order to maximize power, a planned comparison was conducted using a 
univariate ANCOVA to compare the active treatments (WE and EW) to the control 
groups (APS and WLC) controlling for GPA at baseline. Levene’s test was non-
significant (p = .21 for completers sample). A significant condition effect was not 
observed for either the completers (p = .31) or the ITT samples (p = .22). 









































5.7.1.3 Number of course hours completed: Acute effects at Post-treatment 
 Neither a time (p = .38) nor a time x condition interaction (p = .77) was observed 
from the semester before the intervention to the semester of the intervention on number
of hours of coursework completed. Findings were identical when including all 
participants (as opposed to completers only) who had a GPA for the two semesters in 
question (“ITT”). 
5.7.1.4 Number of course hours completed at Follow-up 
 No significant effects of time or time x condition were observed on this measure 
(all ps > .15), indicating that number of course hours completed did not change overall or 
within groups from post-treatment to follow-up, and that there were no significant 
differences between groups on number of course hours completed for the semester after 
completion of the intervention. 



































5.8 Testing of Hypotheses: Aim 4 (Treatment Moderators) 
 
111
5.8.1 Number of treatment sessions completed.  No significant condition x home 
session interaction terms were observed with either the AWQ, PSWQ, or GPA at post-
treatment as the outcome variable. However, tests for main effects revealed that the final 
model was significant, R2 ∆ = .13, F (3, 90) = 5.80, p < .001, with more sessions 
associated with greater improvement on the AWQ at post-treatment, β = -.32, t (90) = -
2.82, p < .01. Likewise, number of treatment sessions completed was also a significant 
predictor of outcome on the PSWQ at post-treatment, R2 ∆ = .10, F (3, 90) = 6.05, p < 
.001, with more home sessions associated with more improvement (i.e., lower PSWQ 
scores) at post-treatment, β = -.72, t (90) = -3.84, p < .001. In addition, a main effects 
final model with GPA as the dependent variable was significant, R2 ∆ = .10, F (3, 58) = 
4.08, p < .01, with more home session practice associated with higher GPAs at post-
treatment, β = .05, t (58) = 3.49, p < .001. Thus, more home practice was associated with 
greater improvement overall, with no significant differences between conditions on the 
degree to which level of home practice impacted outcome. 
 5.8.2 Meta-cognitions questionnaire (MCQ). Of the five MCQ factors, two 
moderated treatment outcome and one revealed a significant main effect. The MCQ 
factor 1 (MCQF1), which assesses positive beliefs about worry, did not reveal a 
significant interaction. However, main effects tests were significant, with the MCQF1 
significantly predicting treatment outcome on the AWQ, R2 ∆ = .13, F (3, 52) = 3.75, p < 
.05 such that endorsing more positive beliefs about worry at baseline (e.g., “worrying 
helps me to succeed”) was associated with less favorable outcome on the AWQ at post-
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treatment,  β = .42, t (52) = 2.79, p < .01.  No significant moderation or main effects were 
observed with the PSWQ as the outcome variable for this factor. 
 The MCQ factor 2 (MCQF2), which assesses beliefs about the danger and 
uncontrollability of worry, was found to moderate treatment outcome on the AWQ at 
post-treatment, R2 ∆ = .14, F (3, 38) = 5.63, p < .01. The regression equation derived 
from the final model was used to explore the nature of this moderation relation. Higher 
levels of negative beliefs about worry in the EW and WE conditions at baseline 
(particularly EW) were associated with poorer outcome on the AWQ, whereas higher
levels of negative beliefs about worry in the APS condition were associated with more 
favorable outcome.  
In order to evaluate whether these specific differences within the overall 
moderator x condition interaction were statistically significant, an “APS vs. not APS” 
dummy coded variable was created based on the pattern of findings and subjected to a 
moderator analysis, with MCQF2 x APS as the interaction term in the final model. The 
final model was statistically significant, R2 ∆ = .09, F (1, 52) = 7.53, p < .01, with a 
significant APS x MCQF2 interaction, β = -1.04, t (56) = -2.74, p < .01, suggesting the 
specific difference between groups on the MCQF2 as a moderator of outcome was such 
that those in those in the APS condition reporting more negative beliefs about worry 
showed more improvement, whereas those in the other two conditions who reported more 
negative beliefs about worry showed less improvement.  
 The final MCQ factor that moderated treatment outcome was factor 5 (MCQF5), 
which assesses cognitive self-consciousness, or “worry about worry.”  When PSWQ at 
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post-treatment was entered as the outcome variable, the final model with the interact on 
terms approached significance, R2 ∆ = .06, F (2, 38) = 3.22, p = .05. Using the equation 
derived from the final model produced adjusted estimates for each condition at various 
levels of the continuous moderator. Consistent with the findings for MCQF2, inspection 
of the pattern of findings revealed that endorsing more “worry about worry” in the EW 
and WE conditions (particularly WE) was associated with poorer outcome, whereas 
endorsing high levels of “worry about worry” was associated with more favorable 
outcome on the APS condition. 
 Based on the regression lines derived from the final model, the “APS vs. not 
APS” dummy code was used to statistically decompose this interaction. The APS x
MCQF5 interaction was entered in the final model and was statistically significant, R2 ∆ 
= .04, F (1, 52) = 4.93, p < .05, with a significant interaction observed, β = -1.14, t (56) = 
-2.22, p < .05.  This demonstrates that the observed differences described above were 
statistically significant. 
5.8.3 Time in semester when randomized. Although no significant interaction was 
observed in the final model for moderation, main effects tests did reveal a marginally 
significant main effect for time in semester when randomized on the AWQ at post-
treatment, R2 ∆ = .07, F (3, 79) = 2.42, p = .07, with randomization during the second 
half of the semester associated with more improvement (i.e., lower AWQ scores), β = -
2.76, t (79) = -2.14, p < .05. Likewise, this same pattern was observed with the PSWQ at 
post-treatment as the outcome variable. A significant main effect was observed after 
controlling for baseline scores, R2 ∆ = .10, F (3, 79) = 4.70, p < .01 such that 
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randomization occurring in the latter half of the semester was associated with greater 
improvement, β = -5.63, t (79) = -2.71, p < .01. Contrary to prediction that earlier 
randomization would result in more improvement, particularly on the GPA measure 
which is assessed at the end of the semester for all participants, time during semester 
when randomized neither moderated nor generally predicted GPA at post-treatment. 
5.8.4 Major. No significant major x condition interaction was observed; nor were any 
main effects for major observed. 
5.8.5 Gender.  Gender was found to moderate treatment outcome on the AWQ at post-
treatment, with a marginally significant final model including the interaction terms, R2 ∆ 
= .05, F (2, 71) = 2.78, p < .07. Values for each dummy code were entered into the 
regression equation to evaluate the nature of this moderating relation. Simpleeffects tests 
were conducted to further decompose the interaction to shed more light on the 
significance of particular differences among the three groups. Becaus  the pattern 
revealed APS and WE showed similar regression lines, whereas EW showed a different 
pattern between males and females on the AWQ, an “EW vs. not EW” variable was 
entered in a new model to assess whether the effect of the moderator was indeed 
significantly driven by this difference between EW and “not EW” (the composite f the 
other two conditions). The final model for this regression was significant, R2 ∆ = .05, F 
(1, 78) = 5.51, p < .05, with a significant EW x gender interaction, β = 7.10, t (83) = 2.35, 
p < .05. The nature of this significant difference was such that those females assigned to 
EW did not perform as well as those females assigned to the other two conditions, while 
no differences between groups appeared for males. Although males who completed EW 
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appeared to perform more favorably than females in EW, simple effects tests sel c ing for 
each condition level and evaluating whether gender was a significant predicto  revealed 
that this difference was not statistically significant.   
5.8.6 GAD Status. GAD status at pre-treatment was not found to moderate treatment 
outcome; nor did GAD status have a significant main effect on outcome. Thus, whether 
participants entered the study meeting criteria for current GAD or not did not mpact 
treatment efficacy.  
5.8.7 Educational Status. Educational status (graduate/professional school vs. 
undergraduate) did not moderate treatment outcome and no significant main effects wer  
observed. 
5.8.8 Race and Ethnicity. Race/ethnicity did not moderate treatment outcome.  
5.9 Testing of Hypotheses: Aim 5  
5.9.1 Treatment Process Analyses 
5.9.1.1 Change in AWQ Scores During Treatment. Those in the WLC group did not 
show significant AWQ score decline across treatment (p = .19).  Those receiving the EW 
treatment did not show significantly steeper decline slopes than those assigned to WLC
(p = .38). In contrast, those assigned to WE [β = -1.37, t (368) = -2.25, p < .05] and APS 
[β = -1.41, t (368) = -2.21, p < .05] both showed significantly greater AWQ decline 
slopes across treatment than the waitlist control group. These decline slopes are shown in 
Figure 14. An identical analysis was conducted using the ITT sample. No differences 
between the two samples were observed. 
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5.9.1.2 Treatment Process Variables as Predictors of Change 
 Use of imagery in WE. Contrary to hypothesis, use of imagery did not predict 
outcome on the AWQ or PSWQ at post-treatment or follow-up. 
 Use of emotional expression in EW. Contrary to hypothesis, self-reports of degree 
to which participants expressed emotions during writing sessions was not associated with 
outcome on the either AWQ or PSWQ for either assessment period.  
 Ability to focus on content of worries during WE and EW. Degree of 
focus/concentration on worries (0 = not at all, 100 = completely) was marginally 
associated with AWQ scores at post-treatment, β = -.08, t (42) = -1.85, p = .07 and at 
follow-up, β = -.11, t (34) = -1.93, p = .06, such that greater focus on worries during self-
administration of the interventions was associated with more improvement on the AWQ 




 Distraction as a predictor of outcome for APS. Level of distraction did not predict 
AWQ scores at post-treatment. However, the same model with PSWQ at post-treatment 
as the dependent variable yielded a significant final model, F (2 21) = 8.27, p < .01, with 
a unique contribution made by level of distraction, β = .22, t (23) = 2.15, p < .05, such 
that higher levels of distraction during APS administration were associated with less 
improvement on the PSWQ. Findings were not significant at follow-up.  
 Relaxation as a predictor of outcome for APS. Contrary to expectation, level of 
relaxation during APS administration was not associated with post-treatment AWQ or 
PSWQ. However, a different pattern emerged at follow-up. Becoming more relaxd 
during administration of the APS during the acute phase of treatment was associated with 
poorer outcome by the three-month follow-up period on both the AWQ (approaching 
significance), β = .11, t (22) = 1.76, p = .09, and the PSWQ, β = .25, t (22) = 2.13, p < 
.05, suggesting that those who successfully became relaxed by the APS ended up not 
faring as well three months after discontinuation of the device administration. 
5.9.2 Mechanisms of Change During Treatment 
5.9.2.1 Worry Exposure and Expressive Writing: Fear Decline as Predictors of 
Outcome. Contrary to expectation, fear ratings did not significantly decline in either 
condition (p = .25), with no differences between groups ( = .73). Fear activation was 
significantly non-zero for both conditions (M = 45.55 for EW and 55.13 for WE;p < 
.001), with those in EW showing marginally lower fear activation than those in WE, t
(52) = -1.91, p = .06.  
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Despite the lack of significant fear decline overall across participants, individual 
slopes were still used to conduct the subsequent analyses (see “Statistical Analysis” 
section). However, because the second condition for mediation was not met for fear 
slopes, only fear activation was tested as a mediator (see Kraemer et al., 2002). Despite 
this, fear decline slopes were still entered into a model with pre-treatment AWQ scores in 
the first step and fear slope entered as a predictor in the second step, with AWQ at post-
treatment as the dependent variable, in order to test whether fear slope was a predictor of 
outcome.  
Fear decline slope did not predict outcome for the WE and EW conditions. In 
contrast, fear activation was found to mediate treatment outcome. When treatment 
condition, fear activation, and their interaction term were all entered into the second 
block of a linear regression (with AWQ at pre-treatment as the Block 1 predictor), the 
final model was significant, F (4, 40) = 5.25, p < .01. Fear activation uniquely 
contributed to the model, β = 1.65 (standardized β = .34), t (44) = 2.03, p < .05, such that 
higher fear activation in the two conditions was associated with higher AWQ scores at 
post-treatment.   
5.9.2.2 Expressive Writing: Predictors of Outcome. Neither average percentage of 
positive nor negative emotion words predicted outcome. Based on previous research, it 
was considered that the association between negative emotion words and treatment 
outcome may have been better explained by a quadratic function, with a moderate 
percentage of words predicting more positive outcome and high and low percentages 
predicting poorer outcome (see Pennebaker & Chung, 2007, for reviews). However, this 
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model did not account for a significant proportion of variance either. Likewise, changes 
in the percentage of positive and negative emotion words were not associated with 
outcome at post-treatment or follow-up. Contrary to prediction, use of self-referencing 
words, social words (average and across sessions), and sensory words were not associated 
with outcome.  
 In contrast to the aforementioned null findings, an increase in cognitive 
processing words across sessions was associated with more improvement at post-
treatment. The final model was significant, F (2, 19) = 9.43, p < .001, with an increase in 
use of cognitive processing words associated with more improvement on the AWQ at 
post-treatment, β = -1.61, t (21) = -2.28, p < .05. However, an increase in cognitive 
processing words no longer predicted level of academic worry by follow-up.  
In addition, another interesting finding emerged. Words in the “time” category 
were associated with AWQ, with significant final models at post-treatment and follow-up 
[F (4, 23) = 9.58, p < .001 for post-treatment and F (4, 17) = 5.84, p < .01 for follow-up]. 
When post-treatment AWQ was entered as the dependent variable, use of past, present, 
and future words all uniquely contributed to the model [β = 1.76, t (23) = 2.74, p < .05 
for use of past tense words, β = 1.01, t (23) = 2.70, p < .05 for use of present tense words, 
β = - 3.88, t (23) = -3.05, p < .01 for use of future tense words] such that greater use of 
past and present tense words was associated with less favorable outcome, whereas use of 
future tense words was associated with more favorable outcome (i.e., lower AWQ 
scores).  “Time” words continued to significantly predict outcome at follow-up, with use 
of more present tense words was associated with less improvement, β = 1.55, t (17) = 
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2.81, p < .05, while greater use of future tense words was associated with more 




Chapter 6: Discussion 
This study sought to examine the efficacy of two self-administered treatments for 
reducing excessive and uncontrollable academic worry: (a) worry exposure, an imagery-
based behavioral treatment, and (b) expressive writing, a verbal-based intervention. 
These interventions were compared to: (a) a placebo condition consisting of pulsed 
audio-photic stimulation and (b) a waitlist control group. Treatment fidelity was 
achieved, and participants viewed their respective interventions as equally credible. 
Several differences emerged between groups; several variables were found to moderate 
treatment outcome; and treatment process analyses yielded interesting findi s regarding 
the potential mechanisms of change in the two active treatment conditions. 
Below is a discussion of the treatment outcome findings including pre to post-
treatment change, between-group differences at post-treatment, post-treatment to follow-
up changes, and between-group differences at follow-up. The treatment outcome section 
is followed by a discussion of moderator findings and treatment process findings. Next, 
general findings and issues for the treatment conditions will be discussed. Overall 
treatment implications and public health implications will follow. Finally, study 
limitations and directions for future research are presented. 
6.1 Treatment Outcome 
6.1.1 Pre to post-treatment change  
Clinical self-report measures. Relative to non-treated wait-list participants who showed 
no significant improvement on any of the primary or secondary outcome measures, those 
assigned to worry exposure, expressive writing, or the pulsed audio-photic stimulation 
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placebo treatment all showed a general pattern of improvement from pre to post-
treatment on all psychometric outcome indices of worry and other clinical measures with 
the exception of depression for the expressive writing group. 
 On the primary outcome measure (Academic Worry Questionnaire), 
approximately one-half of participants in the worry exposure condition and one-third of 
those assigned to the expressive writing condition achieved clinically significant change, 
a stringent measure of treatment outcome indicating a statistically reliable response to 
treatment and clinically significant improvement. Pre to post-treatment iprovement was 
also observed on the measure of generalized anxiety (Penn State Worry Questionnaire), 
with one-third of those assigned to worry exposure achieving clinically significa t 
change. Although only one-fifth of participants assigned to expressive writing achieved 
clinically significant change on the generalized anxiety measure, continuous analyses 
revealed significant pre to post-treatment improvement. Penn State Worry Questionnaire 
scores at baseline were in the clinical GAD range across groups, indicati g that this 
improvement could be compared to clinically significant change in treatment studies 
using clinical GAD samples.   
While those assigned to waitlist control did not show statistically significa t 
improvement on the continuous analysis, it is noteworthy that their scores changed 
marginally in the direction of improvement on the academic worry measure. 
Furthermore, similar to that observed for the expressive writing condition, just under one-
third of waitlist control participants achieved clinically significant improvement. These 
findings indicate that the passage of time (and/or the weekly monitoring of academic 
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worry symptoms) may offer some beneficial effects for reducing excessive and 
uncontrollable academic worry, albeit not significantly. However, these marginally 
significant effects in the waitlist control group did not generalize to other rel vant areas 
of psychological well-being. 
Approximately two-thirds of participants in the placebo condition achieved 
clinically significant change on the measure of academic worry at post-treatment. Thus, 
those assigned to the placebo condition experienced significantly more reduction of 
academic worry than expected. Interestingly, although pre to post-treatment i provement 
was observed on the measure of generalized anxiety in the placebo condition, clinically 
meaningful change was only observed for a small percentage of participants. 
Health and Physiological Outcomes. A strikingly different pattern of pre to post-
treatment findings emerged for measures tapping change in physiological (i.e., cortisol 
response) and health (i.e. visits to the health center) outcomes. Specifically, no significant 
improvement was observed for any of the groups with respect to either cortisol resp nse 
or visits to the health center. On the SF-36, which measures overall physical and mental 
health, pre to post-treatment improvement was observed for all three interventions on the 
mental health factor, with no statistically significant improvement in the waitlist control 
group. On the physical factor, only those in worry exposure and placebo conditions 
showed pre to post-treatment improvement in self-reported physical health.  
Academic Achievement Outcomes. Only those assigned to expressive writing 
showed significant improvement in grade-point average during the semester in which 
they completed treatment. This change was achieved more rapidly than hypothesized. 
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Improvement in grade-point average was not significant for those assigned to placebo or 
waitlist control. 
Although only those in the expressive writing condition showed significant 
improvement in grade-point average when considering the completers sample, 
improvement was also observed for the worry exposure condition when considering only 
those participants whose baseline grade-point averages fell below the samplmean (M = 
3.31) and thus had more room for improvement. Marginally significant improvement was 
also observed in the placebo condition, whereas waitlist control group showed no such 
improvement. These findings suggest that there may have been a ceiling effect for grade-
point average when including all completers.  
No significant pre to post-treatment increase in number of course hours completed 
was observed for any of the conditions. 
6.1.2 Between-group differences at post-treatment 
Self-report Clinical Measures. In general, between-group comparisons of the 
magnitude of improvement revealed greater short-term improvement in the worry 
exposure and placebo groups relative to the expressive writing and wait-list groups, 
which did not differ significantly from each other. On the measure of academic worry, 
contrary to expectation, the placebo condition not only outperformed the waitlist control, 
but also outperformed expressive writing, with no differences between worry exposure 
and placebo.  
Furthermore, on the measures of stress and generalized anxiety, worry exposure 
and placebo outperformed expressive writing and waitlist control at post-treatment. 
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Those in the worry exposure condition showed the highest percentages of participants 
achieving clinically significant change on the Penn State Worry Questionnaire relative to 
other groups. These percentages were lower for the other conditions, although the only 
statistically significant difference was between worry exposure and witlist control, in 
which no participants achieved this meaningful level of change. Still, although moderator 
analyses did not reveal that those with GAD performed better in the worry exposure 
condition than other conditions, these findings provide some evidence that the worry 
exposure condition may have had a unique acute impact on generalized anxiety that was 
not observed in the other conditions to the same degree. 
The fact that the worry exposure and placebo conditions showed similar 
reductions in academic worry suggests that this symptom reduction may be at least in part 
due to expectancy effects. However, it is unclear why the placebo intervention would 
exert a larger effect than the expressive writing condition if only expectancy drove these 
changes. The possibility that those assigned to the expressive writing condition showed 
an initial worsening of symptoms is not supported by the data. Thus, the fact that placebo 
outperformed expressive writing despite non-significant differences in treatment 
credibility suggests the audio-photic stimulation may have exerted an unanticip ted 
active treatment effect. 
A somewhat different pattern of between-group differences emerged on the 
measure of academic worry at post-treatment when considering the intent-to- reat 
samples. Worry exposure no longer outperformed waitlist control, but did show more 
improvement than those assigned to expressive writing. Again, the placebo condition di 
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surprisingly well, showing more improvement at post-treatment than both expressive 
writing and waitlist control with no differences between placebo and worry exposure. 
The differences between the completers and intent-to-treat samples were most striking in 
the two active conditions. Although there were no statistically significant differences in 
the number of dropouts across treatment conditions, the impact of including dropouts in 
the analyses clearly had a differential impact on outcome. The placebo condition had the
fewest number of dropouts across the three interventions. The impact of the intent-to-
treat analysis is in large part influenced by the number of cases that included scores 
carried over from previous assessment periods, especially in the conservative an lysis. 
Because several dropouts completed post-treatment assessments, differences 
between completers and intent-to-treat samples also reflect differences in improvement 
between those who completed fewer than four sessions and those who completed four or 
more sessions. The differences between the two types of analyses suggest those in 
expressive writing who dropped out of the study fared much worse than those who 
dropped out of the placebo condition. Similarly, those in the worry exposure condition 
who dropped out did not perform as well as dropouts in the placebo condition. Although 
number of treatment sessions completed did not have a differential treatment impact on 
outcome, another possibility is that a dose-response relation may have been somewhat 
more evident in the two active conditions, or at least that those conditions required more 
sessions completed in order to show improvement.  
In addition to total Academic Worry Questionnaire scores, an item-by-item 
analysis was conducted to assess differential treatment outcome on several domains of 
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academic worry. At post-treatment, two of the four items that showed differential 
treatment outcome assessed the amount of time spent worrying about school. Both worry 
exposure and placebo participants reported (a) spending less time worrying overall; and 
(b) experiencing shorter worry episodes than those in waitlist control and expressive 
writing. Thus, these interventions had the most substantial and acute impact on frequency 
of symptoms, rather than distress or interference associated with the symptoms.  
Those who received worry exposure reported holding fewer negative beliefs about 
academic worry than those who did not undergo any intervention by the post-treatment 
assessment. This finding indicates that worry exposure may not only work to reduce
worry by habituation of anxiety associated with worry-provoking images, but by sending 
a message to the patients that worry must not be dangerous-otherwise a professional 
would not be instructing them to worry intentionally. This message is similar to the 
message sent in CBT for panic disorder, in which clinicians encourage patients to induce 
the bodily sensations they fear, sending the message that these sensations are harmless. In 
addition to the message sent about the harmless nature of worry, the actual act of 
worrying on purpose may also contribute to the weakening of this dysfunctional belief as 
more direct threat disconfirming evidence is presented that one can worry without 
negative consequences. Evidence has been found supporting the concept that engaging in 
actions that are in direct opposition to natural threat tendencies enhances the efficacy o  
exposure treatment (Wolitzky & Telch, in press).  As worry about worry is a key 
ingredient in the recipe for generalized anxiety disorder, the fact that this message can be 
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altered by just four total hours of prescriptive worrying (for someone who completed all 
12 sessions) is remarkable.  
Interestingly, those assigned to the placebo condition reported using fewer safety 
behaviors to reduce academic worry than those assigned to the other interventions. 
Although one could argue that putting a headset and goggles on in order to avoid 
worrying is a safety behavior in and of itself, the benefits of the device (presumably 
relaxation and distraction) may have mitigated anxiety enough so that participan s were 
not compelled to use alternative safety behaviors to reduce anxiety. In contrast, those 
whose interventions activated anxiety (i.e., expressive writing and worry exposure) did 
not have the device to use as a means to distract or relax themselves, and thus may have
looked elsewhere for safety aids.   
Health and Physiological Outcomes. The general pattern of between-group 
differences observed at post-treatment on the clinical self-report measures was similar to 
that of the self-report measure of overall physical health. Although no differences were 
found between groups at post-treatment on the mental factor, on the physical factor, 
placebo and worry exposure both outperformed expressive writing with placebo also 
outperforming waitlist control. In contrast, no between-group differences emerg d on the 
objective measures of health, cortisol levels and number of visits to the health center. 
Although randomization should have controlled for individual differences that 
could impact cortisol levels (e.g., non-school related stress, immune problems, amount of 
food eaten prior to coming to the lab, etc.), these individual differences were not 
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measured. Thus, the possibility that unknown between-group differences on factors such 
as these were present cannot be completely ruled out. 
Academic Achievement Outcomes. Although between-groups differences on 
grade-point average were not significant at post-treatment when including each of the 
four individual conditions, a planned comparison of active conditions vs. control 
conditions revealed that those assigned to the active treatment conditions obtaied 
significantly higher grade-point averages at post-treatment than those assigned to either 
of the control groups (although inspection of the data indicates expressive writing as 
driving this significant between-group difference). 
6.1.3 Post-treatment to follow-up change 
Self-report Clinical Outcome Measures. At the three-month follow-up, a different 
pattern emerged with respect to treatment outcome as indexed by the self-report 
measures. Participants in all conditions showed overall continued improvement from 
post-treatment to the three-month follow-up session on the primary outcome measure of 
academic worry (although improvement in the placebo condition was only marginally 
significant). Interestingly, participants assigned to the expressive wrting and placebo 
conditions showed continued improvement from post-treatment to follow-up on the 
measures of stress, generalized anxiety and depression as well, while those in e worry 
exposure condition maintained their pre to post-treatment gains but displayed no 
additional improvement during the post-treatment to follow-up period. 
The post-treatment to follow-up pattern of improvement on the continuous 
analyses was mirrored on the measure of clinically significant change, in which 
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percentages of participants achieving clinically significant change on the measure of 
academic worry rose to nearly three-quarters of participants in the worry exposure 
condition and approximately two-thirds for the expressive writing. The percentage of 
participants achieving clinically significant change in the placebo condition remained 
close to two-thirds of participants. Similarly, percentages of participants achieving 
clinically significant change on the generalized anxiety measure also increased across 
conditions by the three-month follow-up period.  
One might expect a strong placebo response acutely, as participants experience 
the effects of treatment expectancy. However, as time passes and participants are faced 
with their academic worries, one might expect this acute symptom reduction to be 
followed by a return of symptoms. Although those assigned to the placebo did not show 
statistically significant improvement at follow-up on the academic worry measure (but 
some change in the direction of improvement), they did maintain their gains and showed 
some post-treatment to follow-up improvement on other clinical measures, suggestin  
that the placebo effects were lasting. 
The continued improvement in the two active conditions is consistent with the 
expressive writing literature and emotional processing of fear literatur, both of which 
may expect (and have shown empirically) initial symptom increase before symptom 
decrease, presumably as the fear is being emotionally processed (Sloan & Marx, 2004b; 
Kamphius & Telch, 2000; Wolitzky & Telch, in press). However, Frattaroli’s (2006) 
meta-analysis examining the effects of expressive writing found that studie  evaluating 
outcomes within one month of the writing sessions showed larger effects than studies
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with follow-up assessments occurring one month or longer after the writing sessions. 
Perhaps the use of specific writing topics and specific populations may interact with 
length of follow-up and course of outcome severity over time. The heterogeneity among 
the studies in the meta-analysis may have obscured these potential interactions. 
Health Outcomes. Similar to the pre to post-treatment improvement observed on 
the mental factor of the SF-36, continued improvement on this factor was observed for all 
three intervention conditions from post-treatment to follow-up. Interestingly, on the 
physical factor, those in the expressive writing condition showed significant post to 
follow-up improvement, with marginally significant improvement for those assigned to 
placebo and a maintenance of treatment gains for those assigned to worry exp sur . In 
contrast, no post-treatment to follow-up change was observed on number of visits to the 
health center in any of the conditions. Thus, for all conditions, number of health visits did 
not significantly change across the three assessment periods. 
Academic Achievement Outcomes. Although grade-point averages were largely 
maintained from post-treatment to follow-up in the worry exposure and placebo 
conditions, those in the expressive writing condition showed a decrease in grade-point 
average from post-treatment to follow-up.  In other words, improvement in grade-point 
average in the expressive writing condition was observed only acutely and was not stable 
over time. By follow-up, the decline in grade-point average in the expressive writing 
condition essentially returned participants to grade-point averages similar to those they 
obtained for the semester before the intervention. That grade-point average improvement 
was observed only acutely for the expressive writing condition is consistent wi h 
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Frattaroli’s (2006) finding that shorter-term outcomes showed larger effects than longer-
term outcomes in expressive writing studies. Interestingly, these findings indicate that, in 
the expressive writing condition, improvement in worry symptoms was delayed, whereas 
improvement in academic achievement was observed only acutely. 
6.1.4 Between-group differences at follow-up 
Clinical Outcome Measures. The differential improvement observed during the 
follow-up period among the three treatment groups resulted in significant and equival nt 
levels of improvement from pre-treatment to follow-up for those who completed the 
worry exposure, expressive writing, and placebo interventions. No significant differences 
emerged between groups at follow-up on the measures of academic worry, stress, 
depression, or generalized anxiety. 
Examination of only post-treatment data would suggest that worry exposure 
outperforms expressive writing, lending support to Borkovec’s (1994) theory of cognitive 
avoidance in GAD. Had only post-treatment data been collected, one might argue that, 
when exposing patients to their own worries, imagery-based processing of worry-
provoking scenarios is necessary for the ultimate reduction of worry, whereas verbal-
based processing, presumably operating during expressive writing, may be 
contraindicated. Our findings provide a clear illustration of the importance of foll w-up 
assessments. Consistent with previous research on expressive writing, the benefits gai d 
from writing about the emotional topic (in this case, academic worry) led to imprvement 
several months after the intervention occurred (e.g., Pennebaker & Beall, 1986; Smyth, 
Stone, Hurewitz & Kaell, 1999). However, in the current health care system, rapid 
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change is often preferred over delayed improvement. Thus, while imagery may not be 
necessary for reduction of worry, it may lead to more rapid improvement, and thus may 
be preferred over expressive writing because of the more proximal benefits over 
expressive writing. 
As with the post-treatment analyses, between-group differences were examin d 
on individual items from the Academic Worry Questionnaire. It is important to note that, 
despite the between-group differences at post-treatment, no differences between the three 
interventions were observed on any individual items three months after the treatments 
were completed. Because there was a general pattern of improvement from post-
treatment to follow-up, this suggests that expressive writing also ultimately reduced 
negative beliefs about worry. Thus, “worrying,” or thinking consistently about worry-
provoking situations during specifically scheduled times can confer benefit without the 
use of imagery. This provides some evidence that scheduled worry time, another untested 
behavioral strategy seen in CBT manuals, which consists of having patients set aside time 
to worry each day as they would normally worry (presumably in verbal form), may be  
promising technique for the treatment of pathological worry.  
The general pattern of differences between the completers and the intent-to-tr at 
samples at follow-up on the measures of academic worry, generalized anxiety, stress, and 
depression was such that the intent-to-treat samples for the worry exposure and 
expressive writing conditions generally did not show as much improvement as those who 
completed the interventions, whereas no major differences were observed between the 
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two samples in the placebo condition. Implications will be discussed (see “Public Health 
Implications”).  
Perhaps one of the most clinically relevant indices of treatment outcome is the 
percentage of participants meeting diagnostic criteria for GAD at follow-up. Although a 
GAD diagnosis was not required for participation, over one-third of participants met 
criteria for a current GAD diagnosis as pre-treatment. Although differenc s did not attain 
statistical significance, more participants in the two active treatment conditions met for 
GAD at pre-treatment than those assigned to placebo or waitlist control. By follow-up, 
the proportion of participants meeting criteria for GAD declined in all three intervention 
conditions. However, these declines were particularly notable in the two active treatment 
conditions. Approximately one-half of participants in the worry exposure condition met 
for GAD criteria at pre-treatment. This percentage dropped to 13% by follow-up. 
Likewise, rates dropped from approximately one-third to 0% for those assigned to 
expressive writing. These findings are noteworthy in light of the low dose, self-directed 
nature, and specificity of the intervention, which did not even aim to combat GAD per se. 
Taken together, these findings indicate that  (a) worry exposure has lasting
effects; (b) those who were assigned to a placebo did not show a return of symptoms, as 
would be expected; and that (c) the effects of the expressive writing were delay d, 
consistent with hypothesis. 
Health Outcomes. Several interesting findings emerged with respect to the 
measures of health outcomes at follow-up. On the SF-36 physical factor, between-group 
analyses revealed that expressive writing outperformed worry exposure and that placebo 
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marginally outperformed worry exposure. This was the only measure in which expressive 
writing outperformed either of the two other interventions. Furthermore, it was the only 
analysis in which the placebo outperformed worry exposure in the completers sample
(albeit non-significantly). Although the effects of expressive writing on clinical indices 
are not often tested, several studies examining the efficacy of the expressive writing 
paradigm have used measures of physical well-being or disease activity. The current
finding is consistent with prediction and in accord with findings from the Frattaroli 
(2006) meta-analysis examining the effects of self-reported measures of disease activity.  
In contrast, no between-group differences emerged on the number of visits to the 
health center. Analyses examining the number of visits to the health center may have 
lacked power to detect statistically significant differences, as the base rates were 
relatively low (Mbaseline = 1.05, SD = 1.03). Still, the current findings suggest that group 
differences in health outcomes were null acutely after the intervention as well as during 
the semester following the intervention.  
Academic Achievement Outcomes. At follow-up, as with many of the self-report 
measures of symptom severity, the difference between the groups (i.e., active treatments 
vs. control groups) on grade-point average was no longer statistically significant.  
 Although grade-point average is not a clinical index of improvement, 
improvement in grade-point average for those who worry excessively about school is a 
relevant index for this population. The discrepancy between the improvement observed in 
the worry exposure and placebo conditions on self-report measures of symptom severity
and the general lack of improvement on objective measures of academic achievement 
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suggests that either: (a) self-report biases were present in two of the three intervention 
conditions, stressing the importance of collecting objective measures; (b) grade 
improvement and improvement in academic worry are not necessarily correlated; or (c) 
based on the findings that more improvement (at post-treatment) was observed when 
including only lower-half grade-point averages, perhaps the relation between academic 
worry and grade-point average is more complex.  
Further exploration of the relation between grade-point average and academic 
worry in a non-clinical, undergraduate sample revealed a quadratic function, such that 
those with high and low grades reported higher levels of academic worry, whereas those 
with average grades reported low levels of academic worry. Thus, the existing a sociation 
is non-linear. There may be two groups of students with academic worry: those who are 
perfectionistic, overachievers with high grade-point averages who may worry about being 
at the top of their class, and those who struggle with school and worry about doing well 
enough to succeed. Collapsing these groups together in the sample produced a mean 
baseline grade-point average similar to the average grade-point average at the University 
of Texas but obscured the larger picture.  
Because the target of the intervention was academic worry and did not include a 
grade improvement intervention, it still remains unclear whether we should expect 
participants who report an improvement in symptoms to report improvement in grade-
point average. Clearly, there is little to no room for improvement in the high-grade-point 
average subgroup. The quadratic relation between grade-point average and academic 
worry only explains the nature of the relation and nothing about the direction of change. 
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In other words, it is still unclear whether grade improvement in the low-grade-point 
average subgroup (presumably into the low-academic worry, average grade-point average 
range) will lead to lower academic worry, or whether decreases in academic worry will 
result in grade improvement. We can infer that a successful intervention should result in 
grade improvement for those in the low-grade-point average subgroup, as evidenced by 
the pre to post-treatment change in the three intervention groups for this subgroup.  
Taken together, the major findings of the academic achievement measures sugg t 
that: (a) consistent with hypothesis, the expressive writing condition showed 
improvement in grade-point average. However, contrary to hypothesis, this improveent 
was acute and not stable over time; (b) there was some evidence that grades improved in 
the worry exposure condition at post-treatment, particularly when considering those 
participants whose baseline grade-point averages were below the mean for the sampl ; 
and (c) no such improvement was observed in the control groups, although those in the 
placebo condition with grade-point averages below the mean showed marginally 
significant improvement at post-treatment. 
6.2 Treatment Moderators 
Although many of the putative moderators were not found to interact with 
treatment condition to significantly impact treatment outcome, several main effects 
emerged as general predictors of outcome. Overall, consistent with prediction, 
completing more home sessions was associated with greater improvement on the two 
self-report primary outcome measures, as well as on grade-point average. Thus, an 
association between number of sessions completed and outcome was observed for all 
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three interventions. Perhaps not surprisingly, completing more worry exposure session  
was associated with more positive outcome. This finding is in accord with previous 
research showing a positive relation between homework completion and treatment 
outcome in studies examining cognitive-behavioral interventions (e.g., Schmidt & 
Woolaway-Bickel, 2000). Interestingly, completion of more expressive writing was also 
associated with more positive outcome. This finding is somewhat consistent with the 
meta-analytical finding that three or more writing sessions yielded greater improvement 
than fewer than three writing sessions (Frattaroli, 2006), and calls into question the 
necessity of adhering to the traditional three to four session protocols used commonly 
with this paradigm (e.g., Pennebaker, Kiecolt-Glaser & Glaser, 1988).  
The average number of writing sessions completed in the intent-to-treat sample 
was similar to the number of sessions prescribed in the traditional expressive writing 
paradigm (M = 5.55, SD = 4.40), whereas the average number of writing sessions 
completed in the completers sample was M = 8.55 (SD = 2.82). By examining the 
difference in performance in the expressive writing condition between the completers and 
intent-to-treat samples, one can infer that those who dropped out of the expressive writing 
condition performed more poorly relative to the other conditions than those who 
completed. Thus, while three to four writing sessions may be beneficial for non-cli ical 
samples, additional writing sessions may be indicated in the treatment of pathological 
worry. 
Interestingly, completion of more home sessions was also associated with more 
positive outcome in the placebo condition. One possibility is that the audio-photic 
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stimulation was administering some active treatment ingredient that showed incr mental 
benefit over time. Alternatively, completing more sessions may have simply activated 
greater expectation for improvement. 
In addition to the impact of sessions completed on outcome, several interesting 
findings emerged with respect to the meta-cognitions reported at baseline. Overall, these 
findings were consistent with prediction that holding more dysfunctional beliefs about 
worry would be associated with poorer outcome. Although not a significant treatment 
moderator, follow-up main effects tests revealed that endorsing more positive beliefs
about worry at baseline was associated with higher scores on the academic worry 
measure at post-treatment for all three interventions. Occupational and academi  
worriers, in particular, may be susceptible to holding this belief because there are natural 
activities in the workplace and academic environment that can easily mutate into worry 
and its associated beliefs and behaviors. For example, students may confuse the act of 
studying with worrying, spending endless hours imagining what might be on the next 
exam or going over flashcards hundreds of times. These students, especially those 
without acute test anxiety, may actually perform well because in the midst of all of their 
worrying, they also accomplished a good amount of studying and attribute their 
performance to this “studying,” which actually included a great deal of unnecessary 
worry. Additionally, students who worry excessively about academics may hold the 
belief that worry prevents negative outcomes from occurring, which is a commonly 
reported belief about worry (Freeston, Rheaume, Letarte, Dugas & Ladouceur, 1994). 
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Experiences like those fuel the erroneous belief that it was their worrying that 
helped them to succeed, rather than their studying of the material (which could have been 
accomplished in a much shorter period of time and without as much distress had they not 
worried during the study period). The beliefs that worrying is essential for motivation and 
for doing well are only reinforced when bosses or instructors encourage specific 
organizational or studying strategies that may lead to over-preparation in worr ers, but 
ultimately result in higher performance. One possibility in the current study is that 
participants who began the study with strongly held beliefs that their worries wer  
important for their academic success may have been less inclined to let go of their 
worrying during treatment.  
In addition to this main effect, two other Meta-Cognition Questionnaire factors 
significantly moderated treatment outcome with treatment differential impact. The two 
factors were similar and the findings were consistent. Endorsing more negative beliefs 
about worry (e.g., “worrying will cause me harm”) and exhibiting cognitive self-
consciousness (i.e., worrying about one’s own worry) was associated with more favorable 
outcome in the placebo condition and less favorable outcome in the expressive writing 
and worry exposure conditions. These findings were particularly striking in the 
expressive writing condition on the “negative beliefs” factor and particularly striking in 
the worry exposure condition on the “cognitive self-consciousness” factor.  
The findings with regard to the expressive writing and worry exposure conditions 
are consistent with prediction, such that holding more dysfunctional beliefs about worry 
would be associated with poorer outcome. These interventions were not specifically 
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designed to address dysfunctional beliefs about worry. Thus, strongly held beliefs may 
have interfered with treatment. Unfortunately, although change in meta-cognitions was 
not evaluated, these findings may suggest that neither intervention had a significant 
impact on chipping away at these potentially worry-maintaining beliefs simply by having 
participants intentionally worry. Because these interventions were self-directed, it was 
considered that those who held strong negative beliefs about worry may have been 
apprehensive to implement interventions at home that consisted of confronting their 
worries directly by intentionally bringing them to mind. These participants may not have 
fully engaged in the interventions, thereby resulting in less improvement. Perhaps with 
more therapist involvement, these interventions could have had the most dramatic impact 
on those who endorsed these beliefs, rather than having less of an impact. If negative 
beliefs are truly maintaining factors that can be challenged through exposure to worry, it 
would be expected that these participants would show dramatic improvement once these 
beliefs are weakened.  
To assess the possibility that those who held more dysfunctional beliefs about 
worry in the two active conditions were reluctant to fully engage in treatment, 
correlations were conducted between the relevant Meta-Cognitions Questionnaire factor 
for each condition (i.e., “negative beliefs about worry” for the expressive writing 
condition and “worry about worry” for the worry exposure condition) and presumed 
indices of treatment engagement (i.e., number of home sessions completed, degree of 
focus on worry content, emotional expression in expressive writing, and use of imagery 
in worry exposure). Although no significant correlations were observed in the worry
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exposure condition, a negative correlation between home sessions completed and scores 
on the “negative beliefs” factor in the expressive writing condition was observed such 
that holding more negative beliefs about worry was associated with completing fewer 
home sessions. This finding supports the idea that those in the expressive writing 
condition who held negative beliefs about worry had difficulty fully engaging in 
treatment. However, this hypothesis is not supported with regard to the worry exposure 
condition.  
Coupled with the fact that the item-by-item analysis of the Academic Worry 
Questionnaire showed a decrease in negative beliefs about worry in the worry exposure 
condition at post-treatment, these moderator findings suggest that there may bepotential 
for worry exposure to change cognitions, but that the protocol of the current study may 
not have had as positive of an impact on those who held very strong beliefs that worry is 
dangerous and harmful. 
Interestingly, more dysfunctional negative beliefs about worry were associated 
with more improvement in the placebo condition. Perhaps participants who feared their 
own worry were relieved to be assigned to a treatment in which they could avoid their 
worry and distract themselves. It was considered that these participants may have been 
more actively involved in completing their interventions. However, no significant relation 
was observed between dysfunctional beliefs about worry and number of home sessions 
completed in the placebo condition. Although it is not entirely clear why those who 
underwent the placebo would improve more if they endorsed negative beliefs about 
worry at baseline, the fact that a different pattern of outcome was observed for the 
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placebo condition emphasizes the importance of conducting moderator analyses in 
treatment outcome studies. The major implication of this finding is that audio-photic 
stimulation may be particularly indicated for those who hold dysfunctional negative 
beliefs about worry. These participants may have been well matched for an intervention 
thought to be relaxing. 
In addition to the effects of dysfunctional beliefs about worry on outcome and 
their interactions with condition on outcome, other predictors of treatment outcome 
emerged. Although no interaction with treatment condition was observed, time during 
semester when randomized to treatment was significantly associated with outcome as a 
main effect variable. Interestingly, while those who were randomized during the second 
half of the semester were more likely to drop out of the study, those who were 
randomized later and did complete the study showed more improvement than those 
completers who were randomized during the first half of the semester.  Although this 
finding is contrary to prediction, there may be a clear explanation for the direction of this 
association. Participants who entered the study at the beginning of the semester ay have 
been more motivated for treatment. These participants may have known already that they 
had a problem with academic worry even during, say, the winter break or summer 
vacation, and sought out this opportunity at the beginning of a new semester, likely 
before their workloads were at their peak. These participants may have had more severe 
symptoms, or may have already had GAD. Additionally, these participants may have 
been more organized or better planners, as evidenced by their commitment to work on 
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their problem before the semester was fully underway. Thus, they may have compl ted 
the study but began with more chronic symptoms. 
In contrast, participants randomized later in the semester were already attempting 
to cope with the demands of school when they entered the study, and may have done so 
because they began to realize they were worrying excessively about academics and were 
having difficulty managing. These participants may not have experienced chronic 
symptoms of pathological worry before, and may have been responding to a newer 
problem. Perhaps frantically searching for help to alleviate this problem, these 
participants may have either (a) decided to drop out because they may have been looking 
at the short-term effects of their current situation and saw the study requirements as one 
more burden to their already overwhelming workload; or (b) showed more improvement 
if they decided to finish the study because they were addressing a new problem before it 
spiraled out of control. An examination of the data provides compelling support for this 
idea: GAD diagnosis within the past year was higher for participants who entered th  
study during the first half of the semester (46%) compared to those who entered during 
the second half (22%), χ2  (1) = 4.91, p < .05.  
These findings suggest that there may be two distinct types of participants 
entering the study with different motivations and levels of chronicity. Recall, however, 
that (a) time randomized during the semester did not moderate treatment outcome, 
suggesting that these types of participants are not particularly better sui ed for any 
particular intervention; and (b) importantly, there were no between-condition differences 
on this variable.  
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Although other variables were found to moderate treatment outcome, the only 
demographic variable found to moderate treatment outcome was gender. Females 
completing the expressive writing condition showed less improvement than females in 
the other conditions, with no differences between conditions for the males. In addition, 
while not statistically significant, males who completed the expressive writing 
intervention appeared to respond somewhat more favorably to the intervention than did 
females. This finding (although non-significant) is consistent with the earlier meta-
analysis of expressive writing interventions (Smyth, 1998) but inconsistent with the more 
comprehensive and methodologically sound meta-analysis (Frattaroli, 2006). It is also 
important to interpret these findings with caution, as there were significantly more 
females enrolled in the study than males. Thus, scores for a few males could have driven 
these findings. However, inspection of the data suggests there were no outliers. 
The fact that certain variables did not moderate treatment outcome is also of 
interest. Contrary to prediction, GAD diagnostic status did not moderate treatment 
outcome. This finding suggests that none of the interventions appear to be particularly 
well-suited or ill-suited for participants meeting criteria for GAD as compared to those 
without GAD.  This suggests that alternatives to behavioral treatment may be promising 
approaches to the treatment of GAD. Furthermore, the fact that no interaction or mai  
effects for putative moderators of major and race/ethnicity were observed suggest  that 
these interventions may be useful for a wide range of students and racial/ethnic groups. 
6.3 Treatment Process Analyses 
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Several a priori and exploratory treatment process analyses were conducted in 
order to elucidate the mechanisms of change during the interventions. Contrary to 
hypothesis, anxiety ratings across sessions did not decline for either of the active 
treatment conditions. For the worry exposure condition, a lack of fear habituation would 
be expected to result in minimal to no change in symptoms at post-treatment (Foa & 
Kozak, 1986). Although worry exposure did show significant change on all outcome 
measures, this finding may suggest that the worry exposure was not successful in 
reducing anxiety through fear habituation. Whether other, untested mechanisms were at
work, or whether this finding simply reflects an unsuccessful treatment interve ion is 
unclear. Considering these findings in combination with the fact that worry exposure did 
not outperform placebo supports the possibility that expectancy played a large role in the 
changes in symptoms. 
 The lack of significant fear decline across writing sessions is even more difficult 
to interpret for a number of reasons. One possibility is that the emotional processing 
theory does not adequately explain the change observed in expressive writing; other 
theories may more adequately explain the changes observed in expressive writing. Rather 
than conceptualizing the expressive writing sessions as a means to disinhibit oneself r 
emotionally process the fear associated with academic situations, participants may have 
benefited from the expressive writing by using it as means for problem-solving r 
emotional expression. Alternatively, expressive writing did not outperform waitlist 
control on several measures at post-treatment, indicating that perhaps fear habituation is 
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an important mechanism of change in expressive writing, and that this particular 
intervention was not successful in facilitating that change. 
 Although no differences between groups were observed on fear decline slopes, 
participants assigned to worry exposure reported marginally higher fear activation than 
those in expressive writing. This finding is consistent with previous work demonstrati g 
that worry-related imagery produces more anxiety than worry-related verbal thoughts 
(Vrana et al., 1986). Interestingly, greater fear activation at the beginnin  of treatment 
was associated with poorer outcome. This finding is consistent with a growing body of 
literature finding this same pattern (Wolitzky &Telch, 2008; Kamphius & Telch, 2002; 
Telch et al., 2004; Telch, Valentiner, Ilai, Petruzzi &Hehmsoth, 2000), and calls into 
question Foa & Kozak’s (1986) assertion that fear activation is necessary for successf l 
emotional processing.  
Several other measures were collected during the course of treatment to shed light 
on the treatment process. Few of these variables examined for each particular 
intervention proved helpful in accounting for the improvements observed for each 
treatment. Contrary to prediction, the ability to form images was not predictive of change 
in the worry exposure condition, adding to the growing evidence from this study that 
imagery is not a necessary component of exposure to worry-provoking thoughts for the 
reduction of worry. Because imagery does not seem necessary for anxiety habituation 
associated with worry, yet those in worry exposure showed more rapid improvement than 
those in expressive writing, it is unclear what mechanism was operating to resul  in more 
rapid improvement in the worry exposure condition compared to the expressive writing 
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condition. Neither treatment showed significant fear decline across sessions; both 
interventions imposed “start and stop rules” to address controllability of worry. One 
possibility is that there was more control imposed in the worry exposure condition 
regarding the specificity of the worries per session. Despite the instructions to focus on 
academic worries in the expressive writing condition, participants could explore this topic 
in a number of ways. While they may not have been granted the flexibility to jump from 
one worry sphere to another, they certainly were allowed to move from one academic-
related worry to another, which participants may have done to avoid anxiety associated 
with particular worries. Thus, worry exposure may have exerted a more acute effec  by 
instructing participants to focus on one very specific worry at a time.  
Although the use of imagery was not associated with outcome, some evidence 
was found indicating that focusing on the content of the worries during both of the active 
interventions was associated with more improvement. This finding would be expected 
based on the emotional processing theory (Foa & Kozak, 1986), as well as Borkovec’s 
(1994) theory that would expect those who can stay focused on one sphere of worry 
without using avoidance strategies (e.g., skipping from one worry to another) would see a 
reduction in worry and GAD symptoms. This finding provides some support for the idea 
that the interventions contained active and specific treatment effects, despite the fact that 
they did not outperform placebo. This finding also supports the hypothesis that worry 
exposure outperformed expressive writing at post-treatment because the worry xposure 
intervention focused more specifically on worry as well as on more narrowly define  
worries. Regardless of whether or not participants reported different levels of focus on 
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worries between the two conditions, inherent in the worry exposure intervention is the 
use of refined, precise, worry-specific focus that may require more concentratio  han the 
focus required in the expressive writing condition.  
Interestingly, higher levels of distraction from worries in the placebo conditi  
were associated with poorer outcome. Although distraction from worry is one of the 
primary rationales a proponent of audio-photic stimulation would have for using this 
method, and thus seems counter-intuitive at first, this finding is actually in accord with 
research demonstrating the negative impact of distraction during treatment in co fronting 
subsequent anxiety (Telch et al., 2004). Furthermore, according to the cognitive 
avoidance theory of GAD, worry is a means to distract oneself from more intense anxiety 
(Borkovec, 1994). Thus, the use of specific distraction techniques would be 
contraindicated for GAD.  
Similarly, although level of relaxation during the audio-photic stimulation dd not 
predict outcome at post-treatment, ability to relax during the intervention was associated 
with poorer outcome at the three-month follow-up. Although it is surprising that 
relaxation was not associated with improvement at post-treatment, given the previous 
demonstrations of relaxation as an efficacious treatment for GAD, the follow-up findings 
are not surprising. Those who became relaxed using the device learned no relaxation 
skills that they could use once the device administration was discontinued. Thus, 
participants instructed to rely on a device to relax fared more poorly when they 
discontinued the use of the device and had no skills for relaxing themselves, nor any 
other skills for coping with worry. Taken together, these findings suggest that those w  
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experienced the presumed or potential active agents of the placebo intervention did not 
show as much improvement as those in the placebo condition who experienced no active 
agents (or benefited from the audio-photic stimulation in a way which was not 
examined). This raises the question of what was exerting the strong effect at ollow-up 
observed in the placebo condition since the audio-photic stimulation was still performing 
as well as the other two conditions at follow-up. Perhaps other untested mechanisms in 
the audio-photic stimulation related to brain wave activity were at work. 
 Finally, the analysis of writing session content yielded some interesting findings. 
First, this study failed to replicate previous findings with regard to the role of emotion 
words and self-referencing words in predicting outcome. However, consistent wih 
previous reports, an increase in cognitive processing words was associated with more 
improvement, suggesting that participants who were able to develop insight, use 
reasoning to make sense of their anxiety or academic situation, or perhaps engage in 
problem-solving as an active coping strategy for dealing with anxiety showed mor  
improvement than those who did not address their worries in this manner. Providing 
support for the cognitive processing theory of emotional disclosure, this finding is i  
accord with a significant body of work in the area of expressive writing and suggests that 
perhaps participants who showed more improvement used the expressive writing sessions 
as a cognitive, problem-solving outlet. 
 Interestingly, “worrying” during the expressive writing sessions waassociated 
with more improvement (i.e., greater use of the future tense), while rumination about p st 
events (as may be expected with more depressed participants) and/or focus on present 
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events (e.g., listing what needed to be accomplished that day, describing how they felt at 
the moment) was associated with less favorable outcome. This finding is not surprising 
given that rumination about past events may maintain psychopathology, particularly 
depression (e.g., Singer & Dobson, 2007). These findings suggest that those who 
followed the instructional set more closely by writing about academic worries (with 
worry typically considered future-oriented) showed more improvement than those who 
ruminated about past events or described present issues.  
6.4 General Discussion of Issues Relevant to the Interventions  
In hindsight, each intervention showed the most improvement in domains in 
which it would be expected to show improvement. For example, those assigned to the 
expressive writing condition showed particular improvement in grade-point average (at 
least acutely) and health outcomes (at least self-report), whereas they did not show as 
much improvement on clinical measures. This finding is consistent with the Frisina et al. 
(2004) meta-analysis of expressive writing which showed a small effect siz  of less than 
d = .20 on outcomes for clinical populations, and found that expressive writing showed 
larger effects for physical conditions than mental conditions. In addition, worry exposure, 
a strategy developed with Borkovec’s GAD theory of cognitive avoidance in mind, 
seemed to exert a unique impact on generalized anxiety and GAD. However, moderator 
analyses did not suggest that participants meeting criteria for GAD were particularly 
well-matched for worry exposure. 
 Although several findings were consistent with prediction, perhaps the most 
surprising finding of the current study was that the placebo condition not only showed 
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significant and lasting improvement, but that neither of the active treatment condi ions 
outperformed this intervention. In particular, that worry exposure did not outperform the 
placebo calls into question the value of including worry exposure in CBT manuals 
alongside treatment techniques that have been received empirical support for GAD, such 
as cognitive restructuring and progressive muscle relaxation. Although those assigned to 
worry exposure did show significant improvement, this improvement did not consistently 
go beyond the effects of the pulsed audio-photic stimulation. Thus, there is compelling 
evidence to suggest that worry exposure produced little to no more than expectancy 
effects or non-specific treatment effects. The fact that the placebo condition performed so 
well on the primary outcome measure suggests that future studies examining active 
treatments for GAD ought to consistently include placebo conditions to determine 
whether the effects of the presumed active treatments go beyond that of expectancy 
effects.  
However, because the literature to date on psychosocial treatments for GAD has 
consistently excluded placebo conditions, no direct comparisons of psychological placebo 
interventions to treatment strategies founded in behavioral and cognitive principles have 
been generated. Thus, it is difficult to draw firm conclusions about (a) whether the audio-
photic stimulation was unusually more efficacious than previously tested placebos for 
generalized anxiety; and (b) whether the potency of the presumed active treatment(s) 
went beyond non-specific treatment effects.  
The first possibility to address is whether the audio-photic stimulation may have 
been unusually efficacious for a placebo control group. Although a few studies have 
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included “treatment control” groups such as supportive psychotherapy and non-directive 
therapy, these treatments differ from true placebos in that they are not only wide
delivered in clinical settings, but more importantly, would be expected to exert some 
active treatment effect (e.g., Maina, Forner & Bogetto, 2005; Stice, Burton, Bearman & 
Rohde, 2006).  
In an extensive literary search, only one GAD treatment study was found that 
included an active treatment (biofeedback) as well as a “pseudomeditation” placebo and a 
waitlist control group (Rice, Blanchard & Purcell, 1993). Participants in both the 
biofeedback and placebo conditions showed significant improvement in anxiety, with no 
significant change in the waitlist control group. However, no significant differences were 
observed between the pseudomeditation and the biofeedback groups. Firm conclusions 
cannot be drawn from one study, especially one in which the active treatment is not a 
widely studied or accepted evidence-based treatment for GAD. However, the placebo 
response in this particular study is consistent with the response in the current study and 
indicates a need for more research in this area.  
The current findings raised questions about the nature of placebo controls and 
highlight the importance of investigating placebo response rates. Those assigned to 
audio-photic stimulation reported feeling relaxed by administration of the device and 
reported that it distracted them from their worries. At what point do researchers draw the 
line between treatment expectations exerting these effects and the possibility that the 
intervention contains unanticipated active ingredients? The creators of the audio-photic 
stimulation deliver this intervention as a bona fide treatment they believe is ff ctive in 
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treating anxiety. Thus, one difficulty with psychological placebos is that sometimes one 
researcher’s placebo is another’s active treatment. Although it is currently unknown 
whether audio-photic stimulation contains an active treatment element beyond 
expectancy effects, future research is needed before this possibility can be ompletely 
ruled out.  
One line of evidence to support the current conceptualization of the audio-photic 
stimulation as a true placebo comes from the pharmacological research on GAD 
treatment. A review of several randomized clinical pharmacology trials for GAD 
treatment (examining diazepam, imipramine, venlafaxine, paroxetine, and escitalopram) 
found placebo response rates ranging from 41-47%, compared to 62-73% response rates 
for the active pharmacological agent (Rickels, Downing, Shneizer & Hassman, 1993; 
Gelenberg et al., 2000; Rickels et al., 2003; Davidson, Bose, Korotzer & Zheng, 2004). 
The placebo response rate across these studies is surprisingly high and consistent with he 
placebo response in the current study (at least on the Academic Worry Questionnaire). It 
also suggests that perhaps the two active conditions in the current study were exerting no 
more than what would be expected of a placebo control. However, it is unclear how much 
of a comparison can be made between the pill placebo response in GAD and 
psychological placebo response in sub-clinical GAD. Furthermore, the response rate on
the measure of generalized anxiety in the audio-photic stimulation condition did not 
compare favorably to the aforementioned pharmacological placebo rates. 
In order to most comprehensively test whether the audio-photic stimulation was 
an active treatment that produced more than expectancy effects or non-specific treatment 
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effects would be to compare it directly to an established, evidence-based treatment 
technique for GAD that had already been shown to outperform a different placebo 
treatment. Because of the lack of research comparing evidence-based treatment 
techniques for GAD (e.g., progressive muscle relaxation or cognitive restructuring) to a 
psychological placebo, this test would be difficult to conduct. To date, the only study that 
comes close to being able to extend our knowledge in this area is the Borkovec & 
Costello (1993) study showing that cognitive therapy and applied relaxation both 
outperformed non-directive therapy. Because non-directive therapy may produce little 
more than non-specific treatment effects, comparing audio-photic stimulation to cognitive 
therapy or applied relaxation may elucidate the effects of the presumed placbo control. 
However, non-directive and supportive psychotherapies are not inert interventions, 
whereas a true placebo would be expected to contain no active component. Still, a 
comparison of the pre to post-treatment effect size on the Penn State Worry 
Questionnaire between the non-directive condition in the Borkovec & Costello (1993) 
study (d = 0.83) and that of the audio-photic stimulation in the current study (d = 0.51) 
indicates that the non-directive therapy was showing larger effects. This suggests the 
audio-photic stimulation may not have been exerting more than non-specific treatment 
effects. However, although the Borkovec & Costello (1993) study did not use the 
Academic Worry Questionnaire as an outcome measure, the effect size was huge for the 
audio-photic stimulation condition (d = 1.66) and suggests that audio-photic stimulation 




Other ways to test whether the audio-photic stimulation exerts an active effect 
include comparing audio-photic stimulation to a treatment that had outperformed a pill 
placebo, testing audio-photic stimulation against a pill placebo, or having the audio-
photic stimulation creators program devices that would be contraindicated for anxiety and 
compare those to the program used in the current study on a GAD sample. 
The issue of what constitutes an active treatment is a much grayer area in 
psychosocial treatment research as compared to psychiatric research investigating 
pharmacological agents. After a landmark study found that cognitive therapy, behavioral 
activation, and social skills training all performed equally well in the treatm nt of 
depression (Zeiss, Lewihsohn & Munoz, 1979), the authors concluded that any treatment 
that: (a) provides a rationale; (b) encourages patients to do something based on that 
rationale outside of the treatment session; and (c) attributes improvements to the patient’s 
new skill would be an effective treatment for depression. The audio-photic stimulation 
administration in this study at least meets the first two of these three crit ria. Similar to 
the Zeiss et al. (1979) study, Stice et al. (2006) found that CBT, supportive therapy, 
bibliotherapy, expressive writing, and journaling all showed significant depression 
symptom decline at post-treatment. Especially considering the high comorbidity between 
GAD and depression, perhaps these criteria are true of treatments for sub-clinical GAD as 
well.  If this is the case, this finding has important public health implications, as a number 
of simple interventions such as audio-photic stimulation could be used to address 
problems such as academic worry. Clearly, further research described above would need 
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to be conducted before offering audio-photic stimulation to patients as an active 
treatment. 
Given the above findings, if a “placebo” or “alternative treatment control” 
demonstrates its efficacy, or is at least comparable to other currently administered 
treatments, it may be advantageous to administer it to patients who may not be willing or 
able to undergo other treatments such as worry exposure.  In the current study, the audio-
photic stimulation intervention seemed to be the most palatable, with more sessions 
completed in that condition than in the other conditions, particularly expressive writing. 
This may have been because all participants had to do was recline, close their eyes, and 
relax during the administration of pulsing noises and flashing lights, rather than conjuring 
up distressing thoughts and images and activating the fear structure. Moreover, even if it 
was just expectation that made participants feel relaxed, the participants’ subjective 
experience was of relaxation. Audio-photic stimulation may be an alternative treatment 
option to explore for those unable or unwilling to engage in other types of interventions. 
However, future research, as described above, must be conducted before administering 
audio-photic stimulation with the intent of treating a patient with an active intervention to 
reduce generalized anxiety symptoms. At this point, the conceptualization of audio-photic 
stimulation as an inert intervention would suggest the treatments did not produce effects 
beyond non-specific treatment effects or expectancy effects.  
If it is possible that the audio-photic stimulation did generate more than a typic l 
placebo response, it is thus also possible that the other two interventions did produce 
effects that went beyond non-specific and expectancy effects. Thus, the second issue to 
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address is the potency of these presumed active interventions.  In order to compare the 
worry exposure and expressive writing interventions to existing single-component 
evidence-based interventions, Cohen’s d effect sizes were calculated within each 
condition from pre to post on the Penn State Worry Questionnaire. Considering that these 
studies consisted of multi-session, therapist-directed treatment protocols, the effect sizes 
for the active interventions in the current study were consistent with the effects o  several 
of the other treatments. The pre to post-treatment effect sizes on the Penn Stat Worry 
Questionnaire were d = 1.08 and d = 0.46 for the worry exposure and expressive writing 
conditions, respectively (and d = 1.24 and d = 0.90 for the Academic Worry 
Questionnaire). Single-component behavioral treatment pre to post-treatment effect sizes 
on the Penn State Worry Questionnaire ranged from d = 0.21 (Ost, 2000) to d = 2.75 
(Borkovec, 1993). The research community accepts these treatments (i.e., applied 
relaxation, self-control desensitization, and behavior therapy) to be evidence-based, 
despite their lack of comparison to a placebo control. Thus, this line of evidence suggests 
that the worry exposure and expressive writing interventions compare favorably to 
acceptable evidence-based treatment techniques for GAD. However, despite the large 
effects, it would be interesting to evaluate whether these treatment strategies (e.g. applied 
relaxation, self-control desensitization, and behavior therapy) outperform the audio-
photic stimulation. Based on the findings from the Borkovec & Costello (1993) study, it 
is reasonable to assume that cognitive therapy and applied relaxation should outperform a 
true placebo because these interventions outperformed a control treatment that may exert 
some (albeit weak) treatment effect. However, if these treatments do not outperf rm 
 
159
audio-photic stimulation, this may provide evidence for the unexpected potency of audio-
photic stimulation in the treatment of worry.  
6.5 Overall Treatment Implications 
 The current findings suggest that worry exposure and expressive writing targeting 
academic worry significantly improve not only symptoms of academic worry but other
relevant clinical indices as well. Unfortunately, these interventions did not consistently 
outperform a placebo control group. This finding suggests that these interventions may 
not have produced more than expectancy or non-specific treatment effects. However, the 
effects of these interventions are large and consistent with the effect sizes found for other 
evidence-based behavioral treatments for GAD. Furthermore, an examination of 
treatment process variables suggests that specific factors relevant to the interv ntions 
were associated with improvement.  
 More specifically, those who followed the protocol and instructional sets most 
closely (e.g., completed their sessions, focused on worries, worried instead of ruminated) 
in both treatment conditions showed more improvement than those who did not. This 
suggests that if more control and direction is imposed in future studies (or in clinical 
practice), the efficacy of these interventions may be increased. 
There are important clinical implications for the findings that those in the 
expressive writing condition who focused more on worries (i.e., future events) showed 
more improvement whereas those who ruminated about past events showed less 
improvement. Several techniques such as worry exposure, worry time, and expressive 
writing (as designed in this study), all include “ intentional worrying” to some degree. 
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Clinicians using these interventions for pathological worriers should emphasize the 
importance of future-oriented thoughts/images/writing, rather than allowing patients to 
explore past and present issues as well.  
In addition, completing more home sessions was associated with greater 
improvement in both the expressive writing and worry exposure conditions. This finding 
provides direction for clinicians who train patients to administer these interventions for 
worry. Clinicians may see more improvement in their patients if they encourage them to 
engage in more than the four sessions required to be considered a completer in the current 
study. Despite the marginal differences in number of sessions completed, the factat 
there were no significant differences between conditions in actual dropout status i  
promising, and suggests that those who are motivated to complete a minimum of 4-12 
worry exposure sessions or expressive writing sessions may show significant 
improvement in their academic worry. 
Examination of the fear parameters during treatment also may provide direction 
for clinicians administering worry exposure (as well as exposure treatments for other 
anxiety disorders). Because this study added to the growing body of research howing 
that greater initial activation of anxiety is associated with poorer outcome, perhaps 
attempting to evoke a moderate level of fear with the first hierarchy item is not indicated; 
rather, beginning with a less anxiety-provoking item on the hierarchy may be more 
therapeutic. 
Because the primary aim of the study was to test the efficacy of a specific, 
imagery-based behavioral strategy for reducing worry and compare it to an alternative, 
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verbal-based technique, it was imperative that these treatments were delivere  in 
isolation. This is an important distinction because the majority of treatment outcome 
studies, particularly for GAD, compare their control groups to multi-component CBT 
protocols. Thus, it is difficult to compare the effects of a single treatment component to 
the effects of multi-component protocols. Although it was not expected that the 
magnitude of the effects would compare favorably to treatment protocols that include 
four to five components, worry exposure and expressive writing did compare somewhat 
favorably to a few multi-component treatment packages for GAD (Butler et al., 1991; 
Borkovec & Costello, 1993) on the Penn State Worry Questionnaire index of clinically 
significant change, suggesting they may be useful interventions.  
Despite the efficacy of worry exposure and expressive writing, whether they 
deserve a place in published treatment manuals is a different issue. In the interest of 
conserving resources, it is important to dismantle multi-component protocols to 
determine what components are most effective and which can be eliminated. Since most 
of the multi-component treatment protocols include evidence-based techniques such as 
progressive muscle relaxation and cognitive therapy, the findings of the current study 
suggest that the incremental utility of including worry exposure in these protocols may be 
low. If future studies with clinical samples show that worry exposure does not outperf rm 
alternative treatment or placebo control groups, worry exposure should be eliminated 
from clinician treatment manuals and worry exposure and expressive writing should not 
be delivered as first-line treatments in clinical practice. However, th ir ability to be self-
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administered and easily disseminated suggests that implementation of these in erventions 
could make a significant impact on public health.  
6.6 Public Health Implications 
It is important to highlight the public health impact of the current findings. 
Participants who completed a problem-specific treatment self-administered b tween four 
and twelve 20-minute sessions of their home practices after one brief training session in 
the laboratory. That all of these interventions, including a presumed placebo treatment, 
had any impact at all on general worry, overall stress, and depression is signif cant. The 
fact that the placebo also showed this improvement means either it takes only the 
expectancy of treatment effects to achieve these results, or that perhaps the udio-photic 
stimulation did exert some sort of unexpected active treatment effect. Regardless, these 
findings suggest that there may be several options for primary care doctors, clinicians, 
and college and university counselors to implement with little time, effort, or cost.  
Although the percentages of participants achieving clinically significant change 
are somewhat lower than what one would expect in an efficacy study of a twelve-session, 
therapist-directed GAD treatment (particularly more recent GAD treatment studies with 
higher efficacy), it is important to keep in mind the small dose of treatment, the self-
directed nature, and the specificity of the interventions, all of which have significant 
potential to weaken the potency of a treatment technique. Although it is unlikely that a 
clinician would deliver only one treatment component to a patient in the real world, 
primary care doctors may only have time to teach patients one self-administered 
intervention. Still, GAD treatment outcome studies to date that report percentages of 
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those achieving clinically significant change have reported percentages r nging from 
16% (Butler et al., 1991) to 77% (Ladouceur et al., 2000), suggesting the current findings 
are clearly within that range. 
Although the worry exposure and expressive writing conditions did not 
outperform placebo, from a public health standpoint, they may still be useful 
interventions compared to strategies such cognitive restructuring. The advantage of worry 
exposure and expressive writing is that they lend themselves well to self-administration, 
whereas strategies such as self-control desensitization and cognitive res ructuring do not. 
If worry exposure can reduce worry in a sizeable percentage of participants, it may still 
be worth disseminating to primary care doctors as a self-administered treatment, as even 
some improvement is better than no improvement for those who would otherwise not be 
treated. Additionally, if future research with the audio-photic stimulation indicates that 
this program does outperform alternative treatments or known placebos, audio-photic 
stimulation may also be a useful tool for reducing worry.  
The current findings also emphasize the importance of conducting attrition and 
intent-to-treat analyses in treatment outcome research, particularly for self-administered 
interventions. The feasibility of successful self-administration as well as what one would 
expect in a “real-world” setting are important public health questions to address. Those 
who dropped out of the study in the expressive writing and worry exposure conditions 
fared much more poorly than those who completed (perhaps an index of a successful 
treatment) and those who dropped out in the audio-photic stimulation condition. 
Furthermore, slightly more participants dropped out of the study in the two active
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conditions, presumably because their interventions required more effort. From a public 
health perspective, the audio-photic stimulation was the most palatable intervention. 
Future research should explore whether the device is efficacious when compared to oth r
relaxation strategies that teach skills, such as progressive muscle relaxation. 
In addition to the public health implications of the outcome analyses, the fact that 
participants randomized later in the semester (and seemed to have less chronic 
symptoms) showed more improvement than those randomized earlier (more of whom met 
criteria for GAD) has important implications for prevention interventions. Addressing the 
problem of academic worry before patients meet criteria for GAD or experi nc  chronic 
symptoms seems to produce more benefit than waiting until a patient is already 
experiencing chronic symptoms. If researchers and/or clinicians can develop m thods for 
motivating patients and/or students to enter prevention programs before their worry 
becomes a chronic problem, this may alleviate the monetary and mental health costs of
treatment later, when patients may not respond as well to treatment. As soon as pr blems 
with academic worry are identified, motivational interviewing may be auseful tool in 
helping students to enter and stay in prevention programs.   
6.7 Limitations and Directions for Future Research 
There were several limitations to the current study worth noting. One limitation 
common to all studies investigating the efficacy of a self-administered int rvention is that 
the researchers must rely on the participants’ reports of their home practice. Although 
several measures were in place to track participant compliance, it is nearly impossible to 
know for certain how much time participants spent at home practicing their interve ions. 
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Thus, the study is limited by the assumption that participants completed the home 
practice logs accurately and honestly. Similarly, this study suffer from the same 
limitations of all studies gathering self-report data, in that research rs must assume that 
participants are reporting accurately and honestly to the questions posed to them. 
Although this study also included a number of objective measures, the clinical symptom 
measures were primarily self-report.  
 In addition, the study is limited by the use of a sub-clinical, or analogue-GAD 
sample, in that we cannot generalize the findings of the current study to clinical samples 
of GAD patients or to other worries beyond academic worries. Although participants 
were all treatment-seeking (i.e., they were not psychology students seeking experim ntal 
credit), only about one-third of participants met diagnostic criteria for GAD and they 
were seeking help only for their academic worry. Future studies should evaluate the 
efficacy of worry exposure and expressive writing with clinical GAD samples. In 
particular, typical GAD patients worry about many aspects of everyday life. It would be 
interesting to see whether differences in the efficacy of either of these int rventions 
emerge when participants are asked to imagine scenes related to, or writeabout many 
different spheres of worry (e.g., family, work, money, health).  
 Finally, for ethical reasons, the waitlist control group was not evaluated at follow-
up on the self-report or diagnostic measures. Thus, it is unclear whether the significant 
improvement observed for the other conditions from post-treatment to follow-up was 
simply due to the passage of time. It is unlikely that this is the case, given that the waitlist 
control group did not significantly improve from pre-treatment to post-treatment. 
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However, this possibility cannot completely be ruled out and thus remains a limitation of 
the current study. This limitation is common to most randomized clinical trials in keeping 
with ethical guidelines that encourage researchers to treat waitlist participants as soon as 
possible. 
Although not necessarily considered a limitation, there was one issue relevant to 
the study that deserves comment. Including a placebo condition (a) before the research 
community has established a typical psychological placebo response rate for GAD; and 
(b) that had not been used as a placebo in previous GAD studies made it difficult to 
interpret the findings given that the presumed active interventions did not consistently 
outperform placebo, particularly by follow-up. While the inclusion of a placebo is 
actually a strength of the study, the interpretation of the findings is limited perhaps also 
because of the limited previous research. At this point, we can only conclude that the 
worry exposure and expressive writing conditions did not perform better than an 
intervention that may have produced only non-specific treatment effects.  
In addition to these issues, the findings of the current study generated questions 
that should be subjected to future research. First, in line with previous recommendations 
(Huppert, 2004), future research is needed to further investigate the placebo response 
rates for the anxiety disorders, particularly generalized anxiety disorder. Researchers 
should develop placebo treatments and test them with specific populations against 
already established treatments, preferably on disorders in which something is already 
known about the placebo response, even if it is only response to a pill placebo. Once 
placebo conditions have been developed, researchers should consistently use these 
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placebo control groups in clinical trials when investigating new treatment techniques in 
order to determine the true efficacy of the new treatment under investigation.   
Second, the moderator analyses yielded interesting findings with regard to meta-
cognitions. Unfortunately, because change in meta-cognitions over time was not as essed 
in the current study, it is difficult to know whether specific treatments may have changed 
specific types of dysfunctional beliefs about worry. Future research should evaluat  
whether these treatments increase or decrease certain types of worry beliefs. In particular, 
the item-by-item analysis of the academic worry measure revealed that those in the worry 
exposure condition showed significant improvement in negative beliefs about worry as 
compared to waitlist control. Future research should (a) evaluate the impact of worry 
exposure on beliefs about worry; and (b) compare cognitive restructuring to worry 
exposure in reducing dysfunctional beliefs about worry, as this finding also adds to the 
body of literature showing that a purely behavioral intervention can lead to cognitive 
change (e.g., Jacobsen et al., 1996; Wolitzky, Pai & Telch, in prep).  
Third, based on the findings that increased focus on worry content and writing 
about future events was associated with more improvement in the expressive writing 
condition suggests that future research should re-design and evaluate an expressive 
writing intervention that encourages participants to focus more narrowly on specific, 
future worry-provoking scenarios. Future studies are needed that compare writing about 
future events versus writing about past or current events. Based on the current findings, t 
would be predicted that the efficacy of expressive writing for pathological worry might 
be enhanced by focusing the writing on future events. 
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Fourth, because the current study did not find that use of imagery was associated 
with more improvement in the worry exposure condition, future research should compare 
worry exposure to scheduled worry time. If worry time compared favorably to or 
outperformed worry exposure, there could be significant public health implications, as 
worry time could also very easily lend itself to self-administration and would be even 
easier to teach primary care patients than would worry exposure. 
Fifth, the dose-response relation observed in the current study suggests that future 
research should evaluate whether higher prescribed doses of worry exposure and 
expressive writing show larger effects. A study that manipulates the dose parameter of 
treatment could help to discover the optimal dose for each of these interventions.    
In general, although the current study does not provide strong evidence that these 
interventions produced significantly more than expectancy effects, if further res arch 
with clinical samples and alternative treatment control groups support the efficacy of 
expressive writing and worry exposure, these brief, easy, cost-effective interve tions 










The screening procedure contains five steps: 
(1) Greeting, overview of session, informed consent 
(2) Screening Questionnaire and Demographic Information 
(3)  Online assessments: Academic Worry Battery Pre-intervention 
(4) CIDI Interview 
(5) Debriefing 
RUNNING THE SUBJECT 
1. GREETING, OVERVIEW OF SESSION, AND CONSENT 
Greet the subject and introduce yourself. Say: 
Hi. My name is ________________. I am the experimenter for the academic worry 
study and I will run today’s session. Please have a seat. Today’s session includes 
several phases. First, I will have you read a consent form and sign it when finished. 
Then I will have you fill out some online questionnaires, and then I will conduct a 
comprehensive interview with you. Finally, I will go over the results of your 
assessment to determine whether you will be eligible to participate in the academic 
worry intervention.  Do you have any questions? [Answer questions as briefly as 
possible and hand them the clipboard with the consent form]. Say: Here is a form we 
need you to read and sign before we can get started. Please let me know if you have 
any questions. 
After they sign informed consent, tell them they can have a copy if they want. If the 
want one, give them a copy (make the copy while they’re doing the online testing). 
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2. SCREENING QUESTIONNAIRE AND DEMOGRAPHICS 
Say: The information you provide during the following interview, and your answers 
on all the questionnaires, are confidential. Only the graduate student who is the 
principal investigator for this experiment will have access to the information, and the 
data is analyzed anonymously. [This means that we do not look at a particular 
individual’s answers—they are coded by number]. There are a couple of exceptions 
to this confidentiality however. If you mention that you intend to hurt yourself or hurt 
another person, or that you were aware of any on-going child abuse, we would need 
to ensure your safety or the other person’s safety. Any questions? 
 
Ask them the questions on the Screening Questionnaire and Demographic 
Information form and fill them out. If they are on medications, write these on the 
form. If they are stable and willing to not change them during the course of the month
intervention, they can still participate. 
 
3. ONLINE TESTING  
Say: The next thing we’re going to do is that I’m going to set you up to take some 
online questionnaires. They will take about 20-25 minutes to complete. I will be in the 
other room if you have any questions or concerns while you’re filling out the 
questionnaires. Go to www.telchlab.com. Click “clinical services,” then “online 
testing and interview system,” have the participant enter his/her username ad 
password, then select the Academic Worry Intervention Battery Pre and leave th  
participant in the room for about 20 minutes. Check on participant after 15 minutes 
and every 5 minutes after than until done. 
 
After participant is done, say: I just have one more paper and pencil questionnaire for 
you to complete. I’m just going to take a few moments to review some of your scores 
while you finish that last one. Give them the MCQ hard copy from the packet. Check 
the AWQ. Make sure the AWQ scores for items 5 or 9 are at last a 2. Check BDI 
item 9 and contact PI if suicide assessment is necessary. 
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If the scores on the AWQ are too low for eligibility, discuss them with the participant.  
 
*If the scores are too low, say: It looks like you’re experiencing some significant 
worry about school, but we are looking for people who are experiencing more 
distress and impairment because of their worry. Unfortunately you’re not eligible for 
the study. Thank you for your time. Then give them the debriefing and they’re done. 
Their packets should be taken out of the hanging file, put in a file folder, and moved 
into the “ineligible” hanging file. A new packet should be put in the original hanging 
file so the participant number can be reassigned. 




Say: Now I’m going to be asking you several questions about problems you may be 
experiencing. Some areas will be more relevant than others, and as you’ll see, we’ll 
be spending more time discussing those. Set up the CIDI, enter the participant’s 
initials and participant # for the ID, get any other demographic information necessary, 
and begin the CIDI. Make sure you have the online interview for GAD printed out 
and at your side. If you notice any discrepancies, ask for clarification. After the CIDI 
is done, pull up the results and print them out. Any diagnosis is fine except for a 
psychotic disorder. They do not need to have GAD. 
 
5. DEBRIEFING  
Say: You have just finished the pre-treatment assessment. You are eligible for the 
treatment phase of the study. Before we begin talking about that, I need to give you 
this form. It explains that you have just finished the first phase of the study. Please 
read and sign this form, and let me know if you have any questions. [Give participant 
Phase I debriefing form]. 
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6. PRINT OUT AND SCORE ALL QUESTIONNAIRES. PRINT 
OUT CIDI RESULTS AND LABEL AS PRE-TX CIDI. PUT 
EVERYTHING IN PARTICIPANT’S FILE AND CLIP ALL 
PRE-INTERVENTION MATERIALS TOGETHER. MAKE 
SURE DATE AND PARTICIPANT NUMBER ARE ON ALL 
FORMS. LABEL ALL PRINTOUTS WITH PARTICIPANT ID 
NUMBER AND CROSS OUT ALL NAMES AND PERSONAL 
INFO. PAPERCLIP CONSENTS AND DEBRIFING AND PUT 
IN APPROPRIATE HANGING FILE 
 
Note: If participant reports suicidal plan or says will attempt suicide at any time during 
the assessment visit, do not let the participant leave without finding a graduate student in 
the lab (preferably the PI if available). If no grad student is around and neither is Dr. 
Telch, go to the clinic down the hall and ask for help. You must always check BDI-II 
item 9 to see if the participant is reporting suicidality. If item 9 is a 2 or higher, you must 




















Procedures Before Intervention Training 
AND 








(3) Tape recorder 
 




The intervention phase procedure contains five steps 
 
(1) Overview of session, sign consent 
 
(2) Randomization, RTQ 
 
*(3) Intervention training (see detailed separate protocols for each 
condition) 
 
(4) Show participant how to access the intervention record forms online 
and give printed instructions, reiterate expectations for intervention 
practice and get a verbal agreement, explanation of completing online 
questionnaires 
 







RUNNING THE PARTICIPANT 
 
1.  OVERVIEW OF SESSION AND INFORMED CONSENT 
Say: We’ve determined that you’re eligible for the treatment phase of the study. 
Treatment consists of one month of self-administered treatment, or home practice. We 
expect that all the interventions in this study are effective ways to reduce excessive 
and uncontrollable worry. We are going to randomly assign you to one of the 4 
treatment conditions and will give you training today so you will feel confident in 
your ability to apply these interventions to your life at home. Before we can assign 
you to a condition, I’ll need you to sign another consent form. Because we are 
entering the intervention phase of the study, we need to do another consent form. 
Please read and sign this form and let me know if you have any questions. Before you 
do, I just want to point out a few things. We will be asking you to spend about 20-30 
minutes practicing your intervention three times a week for one month. Every week 
we’ll have you complete a brief online questionnaire and at the end of the month, 
we’ll ask you to fill out a longer battery of questionnaires, much like the one you did 
earlier today. After the month you do not need to do any more of the intervention, but 
we will contact you three months later to complete another set of questionnaires and 
an online interview. We will also be calling you to do a brief phone questionnaire. In 
addition, I want to point out that by signing this form you agree to let us get some 
basic information from UT. We will find out how many times you went to the 
University Health Service and your GPA. We will not get any detailed information 
about specific medical problems or classes you took. Do you have any questions? 
[Answer any questions]. Have participant sign consent. Ask participants if theygo to 
any other doctor besides the UT student health service. If they do, ask them if they’d 
be willing to complete a voluntary release form for us to get the same informati n 





Look on the randomization sheet. Cross off the next condition and assign participant to 
that condition. Circle the demographic and screening form with the correct intervention  
 
3. INTERVENTION TRAINING: USE INTERVENTION-SPECIFIC  
MANUALS! 
 
4. HOME PRACTICE HANDOUTS 
Get out the online instructions form and circle the appropriate link. Tell the 
participant to go to that website to do the online practice forms. Also show participan  
the first page explaining how to get to the online testing system to do the weekly 
AWQ and the 1-month and 3-month questionnaire batteries, as well as the 3-month 
GAD interview. Make sure they feel comfortable with the instructions. Reiterate 
instructions for home practice and online questionnaires, get a verbal agreement and 
remind them we will be tracking their use of the intervention and will give them 
reminders for completing the questionnaires.  
 
5. BEFORE THEY LEAVE AND BEFORE YOU LEAVE: 
Make sure  
• they have your email address should they have any questions.  
• they are in the excel spreadsheet 
• you are aware of when to give the participant reminders.  
• all intervention-phase information is clipped and filed 




Intervention Training Manual for Worry Exposure 
 
1. PRESENT RATIONALE AND GIVE RTQ 
Say:  You have been randomly assigned to the worry exposure condition. Worry exposure 
is a behavioral technique used for people with generalized anxiety disorder. We are 
going to be using it specifically for academic worry. Worry exposure consists of 
gradually exposing you to worry-provoking images such as failing an exam or forgetting 
to turn in your homework. 
You may be thinking, “I already worry enough. Why would you tell me to worry 
on purpose?” Well that’s a good question. My guess is that when you worry, you let your 
mind wander to all sorts of topics. I would bet that you also have lots of thoughts that 
come into your mind, but you may not focus on any one particular image that might make 
you anxious. These may be some reasons why your anxiety may not decrease when you 
worry on your own. Worry exposure is thought to work by having people focus on the 
same worry over and over again, using imagery instead of words to really confront what 
you’re afraid of.  
This technique can be applied to all sorts of anxiety problems. For instance, there 
is a great deal of research showing that people who are afraid of things, such as heights, 
can eliminate their fear by repeatedly going up to a high place. The idea is that exposing 
you to images that are normally distressing to you over an over again should begin to 
make your anxiety while imagining those situations decrease over time. Eventually yo  
will not worry about those situations and may no longer become anxious when you think 
about them. Worry exposure might also work because it begins to introduce times to start 
and stop worrying on purpose, which may help you to control your worry. Do you have 
any questions so far? [Answer questions, and then give participant the RTQ]: 
 
 177
Say: Now that you’ve learned about what type of treatment you will be getting, I’d like 
you to fill out this brief questionnaire. [Participant fills out RTQ]. 
 
2. ORIENTATION TO BASIC INSTRUCTIONS AND 
EXPECTATIONS 
When ready to start, say:  
 We will construct a hierarchy of worry provoking images, beginning with one 
that produces only a moderate level of distress or anxiety, and finishing with one that 
generally produces a lot of distress if you were to imagine it happening, such as failing a 
class. Today we will construct this hierarchy and make a tape for you to take home with 
all your worries on them. Before going into more detail, I want to briefly teach you about 
rating your level of anxiety. [Teach them the 0-100 anxiety rating scale]. After learning 
how to rate anxiety from 0-100, say: 
 Again, you will be asked to listen and really focus on the images on this tape for 
at least 20 minutes a day, three times a week, for one month. You should start with the 
first image on the tape and listen to it over and over for the 20 minutes. You will be 
completing online record forms of your home practice which ask you to rate your peak 
level of anxiety. When you can listen to the image on the tape and have an anxiety or 
distress rating of only 30 on a 0-100 scale, you can move onto the next worry on the tape, 
even if this takes several 20 minute sessions of listening and focusing on the image. 
 One thing I want to point out is that, much like other anxiety problems that are 
treated by confronting what it is you’re afraid of, you may experience a slight increase in 
anxiety at first. This is completely expected. You may have been avoiding confronting 
some of the images you have put on your tape today. It is normal that at first, these 
confrontations with the images may make you a bit anxious. That does not necessarily 
mean that the worry exposure is not working. Do you have any questions? 
 
3. INTERVENTION TRAINING 
Say: We are now going to go over how to do your intervention at home.  
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First I am going to help you make a list of situations which you feel you could 
imagine in detail. Let’s brainstorm and then we’ll put them in order from easiest to 
hardest. We’re going to come up with about 5 scenes. We’d ideally want to start with 
an image that would produce about a 40 or 50 on the 0-100 scale of anxiety or 
distress. We’d like to end with something in the 90-100 range. Help participant come 
up with ideas. Write them down and rank order them. Make sure the participant is 
confident she/he could imagine these scenes. Make sure they are very specific and 
detailed. Say, It is important that you describe these on the tape in detail, describing 
any sensory experiences, including visual, auditory, or bodily sensations. For 
example, if one of your images is coming into class late during an exam, you could 
say something like, “I’m walking into class late, the door is creaking behind me and 
everyone turns around and stares. My heart is racing and I feel my backpack heavy 
on my shoulders and I grab the nearest seat. It has gum stuck to the desk.” [Or use 
and example from the list created earlier]. Make sure to describe the scenes in the 
present tense, and really try to put yourself there as you describe the scenes. Any 
questions? [Assess how well the participant feels she/he can create images in her/his
head.  Do the practice imagery scene. Have the participant close his/her eyes as you 
describe a scene of the participant walking down staircase onto a sandy beach with 
the wind blowing and the ocean crashing, etc. Make sure to describe scene in the 
present tense].  
 
When ready to start worry tape, say: OK, let’s start. I’m going to put the tape in and 
start recording [test for volume ahead of time. Start recording.] OK, we’re starting 
with worry image #1, [fill in the name of the situation you and participant have 
ranked easiest]. Go ahead and lay back in your chair and close your eyes and relax. 
Take some deep breaths and clear your mind. When you’re ready, begin to bring the 
image into your mind and begin describing it. [Participant describes image #1. When 
done, turn off tape and given any necessary feedback. Turn tape back on and 
announce second worry image. Have participant describe it. If done correctly, do not 
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stop tape, just keep announcing the next scene to describe. Scenes can be any length, 
usually around 3 minutes each. Continue until all scenes are done. Rewind tape and 
give it to participant.] At the end, say: it’s really important that you really try to focus 
on these images and not let yourself get distracted while you listen to them at home. 





Intervention Training Manual for Expressive Writing 
 
1. RATIONALE AND RTQ 
Say: You have been assigned to the expressive writing condition. There is a huge 
and exciting body of research showing that writing about highly emotional topics such as 
a traumatic event or starting college can have lasting psychological and physical health 
benefits, and can even improve grades. For this study, we will be asking you to write 
about your academic worry repeatedly over the course of the next month. We ask that you 
focus on the topic of your academic worries as much as possible, and explore your 
deepest thoughts and emotions about your academic worry. While we ask you to try to 
stay focused on the topic, this topic is actually pretty loosely defined. For example, you 
may choose to write about your fears such as failing a test, getting a bad grade, or 
forgetting to turn in an assignment. But we also encourage you to explore other areas 
such as pressures you feel from yourself, family, or others to do well academically, 
concerns about not getting the summer internship or job you want because of potential 
academic issues, or anxiety about being called on in class or taking tests. Of course these 
are just examples. Some of them may sound familiar to you, some may not. But please be 
sure to explore YOUR feelings and thoughts, and let your worries about school really 
come out in whatever form and on whatever issues pertain to you. We expect that this 
should help you emotionally process some of your academic concerns and should lead to 
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psychological and physical improvements. Do you have any questions? [Answer 
questions, and then give participant the RTQ]: 
 
Say: Now that you’ve learned about what type of treatment you will be getting, I’d like 
you to fill out this brief questionnaire. [Participant fills out RTQ]. 
 
2. ORIENTATION TO BASIC INSTRUCTIONS AND 
EXPECTATIONS 
 Say: You will be asked to write for 20 minutes a day, three times a week, for one month. 
You will be able to do all your writing online and will be asked to complete a brief online 
record form at the end of each home practice. Do you have any questions? 
 
3. INTERVENTION TRAINING AND PRACTICE 
 Say: We’re going to begin the intervention now. Later, I’m going to give you a sheet that 
gives you the link to get onto the website to complete your writing. First you’ll just be 
doing one writing session here in the lab. Here is the form to do the writing on. It will 
alert you when 20 minutes has elapsed. Please try to finish up your last thought or 
sentence when you see the 20 minutes have elapsed.  When you’re done writing, click the 
button at the bottom of the page to go onto the next page. It will take you to a brief 
questionnaire that you’ll need to complete after each home writing session. Remember, 
try to explore your deepest thoughts and feelings about your academic worries. Don’t 
worry about sentence structure, spelling, or grammar.  I’m going to leave you in here to 
do your writing. Once you begin writing, please continue to do so until your time is up.  
I’ll be in the other room. Come get me if you have any questions, and I’ll be back in 20 








Intervention Training Manual for APS 
 
1. RATIONALE AND RTQ 
Say: You have been assigned to the relaxation condition, in which we use a special 
device called audio-photic stimulation, or “APS” for short. This device has a 
headset which emits a pulsing noise and goggles that flash lights. The device is 
programmed specifically for people who experience anxiety and worry. 
 Recent evidence suggests that phobia-related thoughts and emotions are 
stored in the brain and that different emotional states have patterns of brain wave 
activity associated with them. The procedure of introducing pulsed flickering lights 
into the visual field and pulsed audio tones into the auditory system, which has been 
studied for decades, has been called brainwave entrainment (BWE) or more 
recently, “Audio Photic Stimulation” (APS). Some clinical studies suggest that APS 
may be beneficial in the treatment of anxiety, phobias, and stress-related problems. 
The device will deliver pulsed light through these goggles and pulsed tones through 
these headphones at a special frequency designed to induce a pattern of brain wave 
activity called alpha that is associated with deep states of relaxation and 
meditation. During the procedure, it is important that you keep your eyes closed 
and focus only on the lights and sounds. For the procedure to have maximum 
benefit, it is important that you keep your mind free of any thoughts and focus only 
on the flickering lights and pulsing sounds. If you find your mind wandering, focus 
your attention back to the pulsing lights and sounds. 
We have experience using the APS in our laboratory. Research in our 
laboratory has shown that the APS can successfully reduce fears of specific objects 
and situations.   
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Do you have any questions? [Answer questions, and then give participant the 
RTQ]: 
 
Say: Now that you’ve learned  about what type of treatment you will be getting, I’d like 
you to fill out this brief questionnaire. [Participant fills out RTQ]. 
 
2. ORIENTATION TO BASIC INSTRUCTIONS AND 
EXPECTATIONS 
This device records how often you are using it, so we will know how much 
practice you’re getting at home when you return it at the end of the month. But we 
would also like you to complete online record forms after each home practice. They 
are very brief. The APS is also pre-programmed, such that it will automatically turn 
off at the end of its course, after about 20-30 minutes. We ask that you use the APS 
at least three times a week for a month. If you are unable to complete the entire 
session for some reason, you may turn it off in the middle by holding these two 
buttons down at the same time (demonstrate), which will end your session in two 
minutes. You may not get all the benefits if you repeatedly end sessions early, so we 
ask that you try to do the entire pre-programmed session each time. We will also 
ask you to return the device when you’re done. Do you have any questions? 
3. INTERVENTION TRAINING 
Say: We’re going to start the intervention now. This is the APS device. Here is the button 
to press to turn it on. Then you’ll need to press these buttons to get the program started 
[get this information from the APS manual in the cabinet and have them follow along]. 
You’ll want to do this reclining in a comfortable chair or lying down. Just put these 
goggles on and the headphones on, sit back and relax, and close your eyes. I will leave 
you alone and come back in a while when the program is done. Then I’ll ask you to 
complete a brief online record of your practice, which I’ll ask you to do after every home 
session. I will give you a handout later on with the link for you to access the home 
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practice logs. [Set participant up with APS and leave room. After done and you come 
back in, review the instructions for turning it on and off.] 
 
 
What to tell participants if they are assigned to Waitlist Control: 
Say: You have been assigned to the wait-list control group. Because this is a research 
study, one group of participants will act as a control group. They will not get any 
treatment and will not participate in any intervention until after the initial month-long 
intervention phase. This is the group to which you have been assigned. You will be asked 
to complete a brief questionnaire once a week and a longer battery of questionnaires at 
the end of the month. After the month is over, you are encouraged to make an 
appointment with me to come in for an intervention training. You will be given 
instructions and training that will give you the tools to complete one of the active 

















Questionnaire Assessments Administered Online 
Participant #____________ 
Date___________________     Condition______________ 
Assessment Time (circle one):   pre post fu 
 
Academic Worry Questionnaire 
The following questions refer to your worry about school. Please rate the degreeto which 
you have experienced each of the following in the PAST WEEK: 
 
1. Frequency: How often you worry about school performance. 
0=never  
1=rarely (1-2 worry episodes per week) 
2=sometimes (3-5 worry episodes per week) 
3=often (worry episodes almost every day or every day) 
4=constantly (multiple worry episodes per day) 
 
2. Duration: Total time spent worrying about school. 
0=no time spent worrying 
1=mild (less than 3 hours per week) 
2=moderate (3-6 hours per week) 
3=severe (between 1-3 hours per day) 
4=extreme (more than 3 hours per day) 
 
3. Average duration of a typical worry episode about school. 
0=no time 
1=mild (less than 15 minutes) 
2=moderate (15-30 minutes) 
3=severe (30-60 minutes) 
4=extreme (more than 1 hour) 
 























7. Rate the degree to which your worry assists you in coping with the demands or 
pressures of school. 
0=worry is not at all helpful 
1=minimally helpful (worry provides some assistance in helping me cope with school) 
2=moderately helpful (worry provides moderate assistance in helping me cope with 
school demands) 
3=very helpful (worrying provides a great deal of assistance in helping me cope with 
academic demands) 
4=extremely helpful (I couldn’t function in school without worrying about it) 
 
8. Rate the degree to which you believe your worry is harmful or dangerous to your 
physical or emotional well being. 













10. Use of specific actions taken in response to threats associated with academic 
worry (e.g. over-preparing for class or presentations, excessive studying, arriving 
extremely early to class, excessive assistance from other students or teaching assistant, 




3=most of the time 









Date___________________     Condition______________ 




This questionnaire consists of 21 groups of statements. Please read each group of 
statements carefully, and then pick the one statement in each group that best describes the 
way you have been feeling during the past two weeks, including today. Circle the numb r 
beside the statement you have picked. If several statements in the group seem to apply 
equally well, circle the highest number for that group. Be sure that you do not choose 
more than one statement for any group, including Item 16 or Item 18. 
 
1. Sadness 
0 I do not feel sad 
1 I feel sad much of the time 
2 I am sad all of the time 
3 I am so sad or unhappy that I can’t stand it 
 
2. Pessimism 
0 I am not discouraged about my future 
1 I feel more discouraged about my future than I used to be 
2 I do not expect things to work out for me 
3 I feel my future is hopeless and will only get worse 
 
3. Past Failure 
0 I do not feel like a failure 
1 I have failed more than I should have 
2 As I look back, I see a lot of failures 
3 I feel I am a total failure as a person 
 
4. Loss of Pleasure 
0 I get as much pleasure as I ever did from the things I enjoy 
1 I don’t enjoy things as much as I used to 
2 I get very little pleasure from the things I used to enjoy 
3 I can’t get any pleasure from the things I used to enjoy 
 
5. Guilty Feelings 
0 I don’t feel particularly guilty 
1 I feel guilty over many things I have done or should have done 
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2 I feel quite guilty most of the time 
3 I feel guilty all of the time 
 
6. Punishment Feelings 
0 I don’t feel I am being punished 
1 I feel I may be punished 
2 I expect to be punished 
3 I feel I am being punished 
 
7. Self-Dislike 
0 I feel the same about myself as ever 
1 I have lost confidence in myself 
2 I am disappointed in myself 
3 I dislike myself 
 
8. Self-Criticalness 
0 I don’t criticize myself more than usual 
1 I am more critical of myself than I used to be 
2 I criticize myself for all of my faults 
3 I blame myself for everything bad that happens 
 
9. Suicidal Thoughts or Wishes 
0 I don’t have any thoughts of killing myself 
1 I have thoughts of killing myself, but I would not carry them out 
2 I would like to kill myself 
3 I would kill myself if I had the chance 
 
10. Crying 
0 I don’t cry anymore than I used to 
1 I cry more than I used to 
2 I cry over every little thing 
3 I feel like crying, but I can’t 
 
11. Agitation 
0 I am no more restless or wound up than usual 
1 I feel more restless or wound up than usual 
2 I am so restless or agitated that it’s hard to stay still 
3 I am so restless or agitated that I have to keep moving or doing something 
 
12. Loss of Interest 
0 I have not lost interest in other people or activities 
1 I am less interested in other people or things than before 
2 I have lost most of my interest in other people or things 





0 I make decisions about as well as ever 
1 I find it more difficult to make decisions than usual 
2 I have much greater difficulty in making decisions than I used to 
3 I have trouble making any decisions 
 
14. Worthlessness 
0 I do not feel I am worthless 
1 I don’t consider myself as worthwhile and useful as I used to 
2 I feel more worthless as compared to other people 
3 I feel utterly worthless 
 
15. Loss of Energy 
0 I have as much energy as ever 
1 I have less energy than I used to have 
2 I don’t have enough energy to do very much 
3 I don’t have enough energy to do anything 
 
16. Changes in Sleeping Pattern 
0 I have not experienced any change in my sleeping pattern 
1a I sleep somewhat more than usual 
1b I sleep somewhat less than usual 
2a I sleep a lot more than usual 
2b I sleep a lot less than usual 
3a I sleep most of the day 
3b I wake up 1-2 hours early and can’t get back to sleep 
 
17. Irritability 
0 I am no more irritable than usual 
1 I am more irritable than usual 
2 I am much more irritable than usual 
3 I am irritable all the time 
 
18. Changes in Appetite 
0 I have not experienced any change in my appetite 
1a My appetite is somewhat less than usual 
1b My appetite is somewhat greater than usual 
2a My appetite is much less than before 
2b My appetite is much greater than usual 
3a I have no appetite at all 
3b I crave food all the time 
 
19. Concentration Difficulty 
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0 I can concentrate as well as ever 
1 I can’t concentrate as well as usual 
2 It’s hard to keep my mind on anything for very long 
3 I find I can’t concentrate on anything 
 
20. Tiredness or Fatigue 
0 I am no more tired or fatigued than usual 
1 I get more tired or fatigued more easily than usual 
2 I am too tired to do a lot of the things I used to do 
3 I am too tired or fatigued to do most of the things I used to do 
 
21. Loss of Interest in Sex 
0 I have not noticed any recent change in my interest in sex 
1 I am less interested in sex than I used to be 
2 I am much less interested in sex now 











































Date___________________     Condition______________ 
Assessment Time (circle one):   pre post fu 
 
WORRY QUESTIONNAIRE 
INSTRUCTIONS:    Rate each of the following items according to how typical each is of 
you.  Put your rating (1-5) next to the number of each item. 
 
1  2  3  4  5 
Not at all   Somewhat      Very  typical 
typical    typical 
 
_____ 1.  If I don’t have enough time to do everything, I don’t worry about it. 
_____ 2.  My worries overwhelm me. 
_____ 3.  I don’t tend to worry about things. 
_____ 4.  Many situations make me worry. 
_____ 5.  I know I shouldn’t worry about things, but I just can’t help it. 
_____ 6.  When I am under pressure, I worry a lot. 
_____ 7.  I am always worrying about something. 
_____ 8.  I find it easy to dismiss worrisome thoughts. 
_____ 9.  As soon as I finish one task, I start to worry about everything else I have to do. 
_____ 10. I never worry about anything. 
_____ 11. When there is nothing more I can do about a concern, I don’t worry about it 
anymore. 
 
_____ 12. I’ve been a worrier all my life. 
_____ 13. I notice that I have been worrying about things. 
_____ 14. Once I start worrying, I can’t stop. 
_____ 15. I worry all the time. 




Meta Cognitions Questionnaire 
Participant #____________ 
Date___________________     Condition______________ 




Adrian Wells & Samantha Cartwright-Hatton (1999) 
 
This questionnaire is concerned with beliefs people have about their thinking. 
Listed below are a number of beliefs that people have expressed.  Please read each 
item and say how much you generally agree with it by circling the appropriate 
number. 
Please respond to all the items, there are no right or wrong answers. 
 













1. Worrying helps me to avoid problems 










2. My worrying is dangerous for me 
 
1 2 3 4 
3. I think a lot about my thoughts 
 
1 2 3 4 
4. I could make myself sick with worrying 
 
1 2 3 4 
5. I am aware of the way my mind works 










6. If I did not control a worrying thought, 






















8. I have little confidence in my memory 












9. My worrying thoughts persist, no 










10 Worrying helps me to get things sorted 










11. I cannot ignore my worrying thoughts 
 
1 2 3 4 
12. I monitor my thoughts 
 
1 2 3 4 
13. I should be in control of my thoughts 










14. My memory can mislead me at times 1 2 3 4 
15.  My worrying could make me go mad 
 
1 2 3 4 
16. I am constantly aware of my thinking 1 2 3 4 
17. I have a poor memory 1 2 3 4 
18. I pay close attention to the way my 
mind works 
 
1 2 3 4 
19. Worrying helps me cope 1 2 3 4 
20. Not being able to control my thoughts 
is a sign of weakness 
 
1 2 3 4 
21.  When I start worrying, I cannot stop 1 2 3 4 
22. I will be punished for not controlling 
certain thoughts 
 
1 2 3 4 
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23. Worrying help me to solve problems 
 
1 2 3 4 
24. I have little confidence in my memory 
for places 
 
1 2 3 4 
25. It is bad to think certain thoughts 1 2 3 4 
26. I do not trust my memory 1 2 3 4 
27. If I could not control my thoughts, I 
would not be able to function 
1 2 3 4 
28. I need to worry, in order to work well 
 
1 2 3 4 
29. I have little confidence in my memory 
for actions 
1 2 3 4 























Date___________________     Condition______________ 
Assessment Time (circle one):   pre post fu 
Perceived Stress Scale 
Directions: The questions in this scale ask you about your feelings and thoughts d ring
the last month. In each case, you will be asked to indicate how often you felt or thought 
a certain way. 
For each question choose from the following alternatives:  
1. never  
2. almost never  
3. sometimes  
4. fairly often  
5. very often  
1. In the last month, how often have you been upset because of something that 
happened unexpectedly?  
never  
almost never  
sometimes  
fairly often  
very often 
2. In the last month, how often have you felt that you were unable to control the 
important things in your life?   
never  
almost never  
sometimes  
fairly often  
very often 
3. In the last month, how often have you felt nervous and "stressed"?  
never  




fairly often  
very often 
4. In the last month, how often have you felt confident about your ability to handle 
your personal problems?  
never  
almost never  
sometimes  
fairly often  
very often 
5. In the last month, how often have you felt that things were going your way?  
never  
almost never  
sometimes  
fairly often  
very often 
6. In the last month, how often have you found that you could not cope with all the 
things that you had to do?  
never  
almost never  
sometimes  
fairly often  
very often 
7. In the last month, how often have you been able to control irritations in your life?  
never  




fairly often  
very often 
8. In the last month, how often have you felt that you were on top of things?  
never  
almost never  
sometimes  
fairly often  
very often 
9. In the last month, how often have you been angered because of things that were 
outside of your control?  
never  
almost never  
sometimes  
fairly often  
very often 
10. In the last month, how often have you felt difficulties were piling up so high that 
you could not overcome them?  
never  
almost never  
sometimes  

















This survey asks you for your views about your health. This information will help us track how 
you feel and how well you are able to do your usual activities. Answer every question by 
selecting the answer as indicated. If you are unsure about how to answer a question, please give 
the best answer you can. 
 







2. Compared to one year ago, how would you rate your health in general now? 
Much better now than one year ago 
Somewhat better now than one year ago 
About the same as one year ago 
Somewhat worse than one year ago 
Much worse now than one year ago 
 
The following questions are about activities you might do during a typical day. Does your health 
now limit these activities? If so, how much? 
 
 Yes, limited a 
lot 
Yes, limited a 
little 
No, not limited 
at all 
3. Vigorous activities, such as running, 
lifting heavy objects, participating in 
strenuous sports 
   
4. Moderate activities, such as moving a 
table, pushing a vacuum cleaner, 
bowling, or playing golf 
   
5. Lifting or carrying groceries    
6. Climbing several flights of stairs    
7. Climbing one flight of stairs    
8. Bending, kneeling, or stooping    
9. Walking more than a mile    
10. Walking several hundred yards    
11. Walking one hundred yards    
12. Bathing or dressing yourself    
 
During the past 4 weeks, how much of the time have you had any of the following problems with 
your work or other regular daily activities as a result of your physical health? 
 All of the 
time 








13. Cut down on the amount of 
time you spent on work or 
other activities 
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14. Accomplished less than 
you would like 
     
15. Were limited in the kind of 
work you would like 
     
16. Had difficulty performing 
the work or other activities (for 
example, it took extra effort) 
     
 
During the past 4 weeks, how much of the time have you had any of the following problems with 
your work or other regular daily activities as a results of any emotional problems (such as feeling 
depressed or anxious)? 
 All of the 
time 








17. Cut down on the amount 
of time you spent on work or 
other activities 
     
18. Accomplished less than 
you would like 
     
19. Did work or activities 
less carefully than usual 
     
20. During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered with your normal social activities with family, friends, neighbors, or groups? 
Not at all 
Slightly 
Moderately 
Quite a bit 
Extremely 
 








22. During the past 4 weeks, how much did pain interfere with your normal work (including both 
work outside the home and housework)? 
Not at all 
A little bit 
Moderately 
Quite a bit 
Extremely 
 
These questions are about how you feel and hoe things have been with you during the past 4 




 All of the 
time 








23. How much of the time 
during the past 4 weeks did 
you feel full of life? 
     
24. How much of the time 
during the past 4 weeks have 
you been very nervous? 
     
25. How much of the time 
during the past 4 weeks have 
you felt so down in the 
dumps that nothing could 
cheer you up? 
     
26. How much of the time 
during the past 4 weeks have 
you felt calm and peaceful? 
     
27. How much of the time 
during the past 4 weeks did 
you have a lot of energy? 
     
28. How much of the time 
during the past 4 weeks have 
you felt downhearted and 
depressed? 
     
29. How much of the time 
during the past 4 weeks did 
you feel worn out? 
     
30. How much of the time 
during the past 4 weeks have 
you been happy? 
     
31. How much of the time 
during the past 4 weeks did 
you feel tired? 
     
32. During the past 4 weeks, 
how much of the time has 
your physical health or 
emotional problems 
interfered with your social 
activities (like visiting 
friends, relatives, etc.)? 
    
 
How TRUE or FALSE is each of the following statements for you? 
 Definitely 
true 






33. I seem to get sick a little 
easier than other people 
     
34. I am as healthy as 
anybody I know 
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35. I expect my health to get 
worse 
     














































Assessment of Treatment Activities 
 
Participant ID Number____________ 
 
Please think back to the treatment intervention you were assigned to complete. 
There were four different treatment conditions, and each of them was meant to 
do certain things and help in different ways.  
 
Remember to answer the questions based on what happened and what you did 
WHILE you were practicing your intervention at home, rather than how you felt 
afterwards or after the study. There are no right or wrong answers. Some 
statements may sound like things you did a lot, and some things not at all. 
 
PART A 
Please choose YES or NO for the following 5 items if you did them as an integral 
part of your treatment. 
 
1. I listened to a tape 
YES/NO 
 
2. I wrote about my academic worries 
YES/NO 
 
3. I used a programmed headset and goggles 
YES/NO 
 
4. I focused on mental images that make me worry 
YES/NO 
 




Please indicate on a 0-10 scale how much you agree with each statement. 
Please choose any whole number between 0 and 10: 
 
1. The treatment usually made me feel relaxed WHILE I was administering it 
0=disagree completely; 10=completely agree_________________ 
 
2. The treatment distracted me from my worries WHILE I administered it 
0=disagree completely; 10=completely agree_________________ 
 
3. I expressed my inner thoughts and feelings about academic worry-related 
topics DURING the administration of my intervention 
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0=disagree completely; 10=completely agree_________________ 
 
4. I focused on and paid attention to the content of the worries I was having 
WHILE I practiced my intervention 
0=disagree completely; 10=completely agree__________________ 
 
5. I usually created and focused on mental images related to worry-provoking 
scenarios I had about school DURING the administration of my intervention 
0=disagree completely; 10=completely agree__________________ 
 
6. I focused on worry-related images DURING my home practice of my 
intervention 
0=disagree completely; 10=completely agree_________________
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